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Zusammenfassung 
In vielzelligen Organismen bewirkt die selektive Expression bestimmter Gene die Entstehung 
verschiedener Zelltypen, die in vielen verschiedenen Organen unterschiedliche Funktionen 
wahrnehmen. Die temporäre und zellspezifische Kontrolle der Genexpression ist einer der 
fundamentalsten Prozesse der Biologie. Die Frage der Regulierung, der Zusammensetzung 
aber auch der Kommunikation der verschiedenen Komplexe, die für die Genexpression 
erforderlich sind, ist elementar für das Verständnis der molekularen Mechanismen, die der 
Entstehung vieler Erkrankungen, wie zum Beispiel Krebs zugrunde liegen. Die DNA im Kern 
eukaryotischer Zellen ist mit Histonen und Nicht-Histon-Proteinen assoziiert. Dies ermöglicht 
die Verpackung und die Kondensierung der DNA aber auch die Regulierung der 
Genexpression. Die Chromatinstruktur stellt neben der Rekrutierung von DNA-bindenden 
Faktoren einen zusätzlichen komplexen Prozess der nukleären Regulierung in Bezug auf die 
Gentranskription, DNA Replikation, die Rekombination und die DNA Reparatur dar. Für die 
Transkription ist diese Struktur eine Barriere, da sie die Bindung von Transkriptionsfaktoren 
verhindert.  
Nukleäre Hormonrezeptoren gehören zu einer Gruppe von Transkriptionsfaktoren, die die 
Fähigkeit besitzen, ihre Bindungsstellen in dieser kompakten Chromatinstruktur zu finden 
und zu binden. Die Aktivität solcher sequenzspezifischer Transkriptionsfaktoren, welche 
entweder reprimierend oder aktivierend auf die Expression wirken, wird von Kofaktoren 
beeinflusst, mit denen sie im Komplex vorliegen. Diese Kofaktoren verändern die 
Chromatinstruktur lokal und steuern so die Genexpression. Zusätzlich zu den erforderlichen 
Änderungen der Chromatinstruktur durch Histon-ATP-abhängige und unabhängige 
Modifizierungen sind die Zusammensetzung der Kofaktorkomplexe und die Regulierung ihrer 
Aktivitäten von Bedeutung für die Transkriptionsregulation. Die Transkriptionsaktivität 
nukleärer Rezeptoren ist nicht nur durch hormonale Signale reguliert. Sie wird sowohl von 
der Vielfalt der anwesenden Koregulatoren als auch von deren Aktivitätszustand beeinflusst. 
Die Integration der Vielfalt der anwesenden Koregulatoren und deren Aktivierungszustand an 
einem bestimmten Promoter führt zu einer zellkontext- und zelltypspezifischen 
Genexpression. Eine unausgewogene Rekrutierung von Koregulatoren (Koaktivatoren bzw. 
Korepressoren) an spezifischen Promotorregionen führt zu der Dysregulation der Expression 
bestimmter Gene und ist für die Entstehung vieler Krankheiten verantwortlich. Die fehlerhafte 
Rekrutierung von Korepressoren wie N-CoR ist die Ursache der genetischen RTH 
(resistance to thyroid hormone) Krankheit und verschiedener Leukämien. Darüber hinaus ist 
die N-CoR vermittelte Repression für die Entwicklung von Säugern entscheidend. N-CoR 
Knockoutmäuse sterben in der mittleren Phase der Embryonalenentwicklung und zeigen 
Defekte in der Reifung von Erythrozyten, Thymozyten und in der Entwicklung verschiedener 
neuronaler Strukturen. Dies ist zum Teil auf die Störung der Repression zurückzuführen, die Zusammenfassung 
 
von nuklearen Hormonrezeptoren wie Retinsäure- und Thyroidhormonrezeptoren vermitteltet 
wird. Diese nukleären Rezeptoren können in Abwesenheit ihrer Liganden spezifische DNA 
Sequenzen binden und durch die Rekrutierung des N-CoR Korepressorkomplexes 
Repression vermitteln. 
N-CoR ist in der Zelle mit Histondeacetylasen (HDACs) komplexiert. Diese Enzyme bewirken 
im Zusammenspiel mit den Histonacetyltransferasen durch Deacetylierung beziehungsweise 
Acetylierung von Histonen eine dynamische Modifikation des Chromatins und beeinflussen 
so die Transkription von Genen. Obwohl N-CoR ein seit längerer Zeit bekanntes Protein ist, 
enthält es noch uncharakterisierte Domänen wie die äußerste carboxyterminale Region, 
welche in dem homologen Protein SMRT konserviert ist. Diese Domäne spielt vermutlich in 
der Transkriptionsregulation eine Rolle und wurde als Köder in einem Hefe-Zwei-Hybrid 
Screen zur Identifizierung von Interaktionspartnern des N-CoR C-Terminus eingesetzt. 
Verschiedene potentiell interagierende Proteine wurden isoliert. Die Proteine, für die eine 
direkte Interaktion in vitro nachgewiesen worden ist, wurden in der vorliegenden Arbeit weiter 
untersucht. Da nur das Protein NonO/p54nrb (non POU domain containing octamer binding 
protein) in Koimmunopräzipitationen (Fig. 11) und Kolokalisationsstudien (Fig. 13) auch in 
vivo Interaktion zeigte, wurde die biologische Bedeutung der Interaktion dieses Proteins mit 
N-CoR erforscht. NonO ist ursprünglich als Splicing-Faktor charakterisiert worden, da es 
RNA Erkennungsmotive besitzt und in Splicing-Komplexen nachgewiesen wurde. Seitdem 
wurde beschrieben, dass NonO in verschiedenen Komplexen eine Rolle spielt und es wird 
jetzt als multifunktionales Protein bezeichnet. Die Wechselwirkungen zwischen NonO und 
Splicing-Faktoren, RNA Polymerase II und nukleären Rezeptoren, aber nicht Korepressoren, 
waren bei Beginn des Projektes schon beschrieben, allerdings blieb die genaue Funktion 
dieser Interaktion ungeklärt. Für das NonO homologe Protein PSF (polypyrimidine tract-
binding protein-associated splicing factor) aber, welches mit NonO interagieren kann, wurde 
gezeigt, dass es rezeptorabhängig und ligandunabhängig Transkription reprimieren kann. 
NonO und PSF zeigen besonders in den RNA Erkennungsmotiven (RRM) hohe Homologie 
in der Aminosäureabfolge, PSF unterscheidet sich jedoch von NonO in den umliegenden 
Domänen und vornehmlich in seinem erweiterten Amino-Terminus. Folglich ist es nicht 
auszuschließen, dass beide Proteine unabhängige Funktionen übernehmen können.  
Unter dem Einfluss des überexprimierten NonO Proteins oder von Deletionsmutanten wurde 
die Repressionskapazität des Korepressors N-CoR in 293T Zellen untersucht. Als alternative 
Strategien wurden mit Hilfe der RNA-Interferenz Technik funktionelle Untersuchungen in der 
Abwesenheit von in 293T endogen exprimiertem NonO oder N-CoR durchgeführt. Dies 
führte jedoch nicht zum Erfolg, da das Wachstum der Zellen bei der spezifischen 
Herunterregulierung der Proteine N-CoR oder NonO stark beeinträchtigt war. Aufgrund 
seiner hohen Stabilität und der niedrigen Umsatzrate (Fig. 22) sind selbst nach signifikanter 
Degradierung der entspechenden mRNA (Fig. 20), noch detektierbare Mengen des NonO Zusammenfassung 
 
Proteins vorhanden, was aber keinen Einfluss auf die Regulierung der Transkription der 
Reportergene hat. Die Interaktion zwischen NonO und der N-CoR carboxyterminalen 
Domäne wurde zunächst in GST-Pulldown Experimenten auf die amino-terminale Hälfte des 
Proteins NonO eingegrenzt, die die RRM Motive enthält. Diese Motive können vermutlich 
sowohl bei der RNA-Interaktion als auch bei Protein-Protein Wechselwirkungen eine Rolle 
spielen. Es wurden Deletionsmutanten hergestellt, denen jeweils eines der zwei RRM Motive 
(RRM1 bzw. RRM2) fehlt. Im Pulldown-Experiment konnten Interaktionen gezeigt werden 
zwischen dem in vitro translatierten und radioaktiv markierten N-CoR C-Terminus und dem 
Glutathion-S-Transferase (GST)-fusionierten NonO Wildtyp oder NonOΔRRM2 aber nicht mit 
der NonOΔRRM1 Mutante (Fig. 26 A). Unter der Annahme, dass das RRM1 Motiv für die 
Interaktion mit N-CoR entscheidend ist, wurde dieses mit GST fusioniert und untersucht. Die 
beobachtete Assoziation des N-CoR C-Terminus mit dem rekombinanten GST-NonO RRM1 
Protein bestätigte diese Hypothese (Fig. 26 B). Die Deletion der Domänen RRM1 und RRM2 
zeigte keine Auswirkung auf die nukleäre Lokalisation der Mutanten. Allerdings wurde die 
Zellzyklus-abhängige posttranslationale Modifikation bei der ΔRRM2 Mutante beeinträchtigt. 
Beide Mutanten wurden in funktionellen Experimenten eingesetzt und deren Effekte wurden 
mit NonO Wildtyp verglichen. Zwei verschiedene transient transfizierte Reportergene wurden 
zur Untersuchung der Repressionskapazität von N-CoR eingesetzt. Der UAS-TK-
Luziferasereporter, welcher in der Thymidin Kinase (TK) Promoterregion Erkennung-
sequenzen des Gal4 Transkriptionsfaktors (UAS) enthält, ermöglicht die Bewertung der 
Transkriptionskapazität von Proteinen, wenn sie mit der Gal4 DNA-bindenden Domäne 
fusioniert sind. Der RARE-Luziferasereporter, dessen Expression von Retinsäure-
Rezeptoren (RAR) reguliert wird, ermöglicht die Auswertung der Rekrutierung von N-CoR 
und Koregulatoren.  
Im Gal4-reporterAssay wurde zunächst die Repressionskapazität des Fusionsproteins Gal4-
DBD-N-CoR Wildtyp untersucht. Die Transkriptionsrepression hängt bei diesem Reporter 
von der Korepressorkomplexbildung und der Rekrutierung von Histondeacetylasen zum 
Promoter ab. Diese wurde nicht beeinträchtigt in Gegenwart von exogenem NonO und 
NonOΔRRM2; NonOΔRRM1 hingegen erhöhte die Gal4-DBD-N-CoR vermittelte Repression 
konzentrationsabhängig (Fig. 31). Da NonOΔRRM1 das RRM1 Motiv fehlt, das entscheidend 
für die Interaktion mit N-CoR ist, deutet dieser unerwartete Effekt darauf hin, dass es sich 
möglicherweise um einen dominant-negativen Effekt handelt. Aus diesem Experiment ist zu 
schließen, dass NonO nicht in die Bildung des Korepressorkomplexes involviert ist sondern 
eher in die Modulation der Kapazität von N-CoR die Transkription zu reprimieren. 
  Es ist denkbar, dass NonO und andere Kofaktoren an der Regulation der Aktivität des 
Korepressorkomplexes beteilig sind. NonOΔRRM1 könnte in einer deregulierten Weise mit 
diesen interagieren und ferner deren regulatorische Funktion beeinträchtigen. Im RARE-
Reporterassay erhöht exogenes NonO die Transkriptionsaktivität des Reporters in Zusammenfassung 
 
Abwesenheit des Liganden und in Anwesenheit des Agonisten. Dagegen bleibt die 
Antagonist-induzierte Repression unverändert (Fig. 33). Aus diesen Beobachtungen ist zu 
schließen, dass NonO eine regulatorische Rolle in der Hormonrezeptor-abhängigen 
Transkription spielt. Dass NonOΔRRM1 einen ähnlichen Effekt wie Wildtyp NonO zeigte, 
deutet darauf hin, dass NonO die Assoziation von N-CoR mit den nukleären Rezeptoren und 
die N-CoR Repressionskapazität beeinflussen kann. Im RARE-Reporter Assay, konnte 
ligandunabhängig ein stärkerer aktivierender Effekt mit exogenem NonOΔRRM2 gezeigt 
werden. Vermutlich konnte diese Mutante die Rekrutierung von Korepressoren zum 
Promoter verhindern. Allerdings zeigte die Proteinanalyse von Zelllysaten aus 
synchronisierten Zellen, dass die N-CoR Proteinmenge in Gegenwart von NonOΔRRM2 
reduziert war, was das Ergebnis im RARE-Reporterassay erklären könnte.  
NonO interagiert mit dem N-CoR C-Terminus. Gal4-DBD-N-CoR-Ct weist im UAS_TK-
Reporterassay keine Repressionsaktivität auf. Allerdings reprimiert Gal4-DBD N-CoR 
weniger als Gal4-DBD fusioniert mit der amino-terminalen Hälfte des Proteins N-CoR, 
welche die Repressionsdomäne I enthält (Fig. 41). Diese Beobachtung ist überraschend, da 
von dem intakten Korepressorprotein durch die Bildung eines stabileren vollständigen 
Komplexes eine stärkere Repression zu erwarten wäre, es sei denn, dass der C-Terminus 
die Repressionskapazität des N-Terminus moduliert. Die Hypothese, dass beide Termini an 
einer intramolekularen Wechselwirkung beteiligt sind und sich gegenseitig regulieren 
könnten, wurde durch die Interaktionsstudien dieser Domänen in vitro getestet. In GST-
Pulldown-Experimenten konnte eine direkte Interaktion von N-CoR C-Terminus und N-
Teminus gezeigt werden (Fig. 40). Ferner weist die Überexpression der C-terminalen Hälfte 
von N-CoR, welche die Rezeptor Interaktionsdomäne (RID) enthält, einen Einfluss auf die 
Transkriptionsakitvität des RARE-Reporters auf. Die exogene Expression des N-CoR C-
Terminus beeinträchtigte die basale und die aktivierte Transkription. Die agonistinduzierte 
Transkription war vermindert, während die Repression der Transkription in Abwesenheit von 
Ligand verstärkt war (Fig. 42). Dies deutet darauf hin, dass der N-CoR C-Terminus ohne den 
Amino-Teil nicht dissoziieren kann und die Regulierung der Repressionsaktivität des 
endogenen Proteins beeinflusst. Wenn diese Proteindomäne tatsächlich eine regulatorische 
Rolle spielt, könnte die Interaktion von modulierenden Faktoren mit dem überexprimierten 
Carboxy-Terminus der erhöhten Repressionsaktivität des endogenen Proteins zugrunde 
liegen. NonO könnte somit zu den N-CoR regulierenden Proteinen gehören. 
Auf Grund der Vermutung, dass die Termini des N-CoR Proteins in der Tertiärkonformation 
nah beieinander liegen und der Beobachtung, dass bestimmte Kofaktoren sowohl mit dem 
Amino-Terminus als auch mit dem Caboxy-Terminus interagieren, wurde die Interaktion 
zwischen NonO und der amino-terminalen Hälfte von N-CoR untersucht. Diese Interaktion 
konnte in GST-Pulldown-Experimenten gezeigt werden und wurde auf die SANT Domänen 
eingegrenzt. Diese Domänen sind umgeben von den Repressionsdomänen I und II des N-Zusammenfassung 
 
CoR Amino-Terminus. Das SANT1 Motiv ist sowohl für die Aktivierung von HDAC3 als auch 
für die Bindung von acetylierten Histonen von Bedeutung. Dagegen ist das SANT2 Motiv für 
die Bindung von SUMO-modifizierenden Enzymen verantwortlich. Die Transkriptionsaktivität 
von N-CoR und verschiedenen Koregulatoren kann durch post-translationale SUMO 
Modifizierung beeinflusst werden. Interessanterweise wurde eine Interaktion zwischen dieser 
regulatorischen Region und NonO nachgewiesen (Fig. 44) und eine mögliche 
SUMOylierungsstelle in NonO gefunden (Fig. 46). Ob die Bindung von NonO mit der N-CoR 
SANT Domäne und die SUMO Konjugation für die Modulierung der NonO abhängigen N-
CoR Aktivität relevant sind, konnte im Rahmen dieser Arbeit nicht mit Sicherheit festgestellt 
werden. Es wurde jedoch gezeigt, dass dieses RNA-Erkennungsmotive enthaltende Protein 
eine regulatorische Rolle in der Hormonrezeptor-abhängigen Transkriptionsregulation spielt, 
und dass das RRM1 Motiv für die Interaktion mit N-CoR entscheidend ist. Ferner wurde 
festgestellt, dass NonO sowohl die Interaktion zwischen nukleären Rezeptoren und N-CoR 
als auch die N-CoR Repressionsaktivität beeinflussen kann. Diese Ergebnisse, unterstützt 
von publizierten Daten, weisen darauf hin, dass der extreme N-CoR C-Terminus 
möglicherweise eine regulierende Domäne ist, welche die N-CoR Repressionsaktivität des 
Amino-Terminus modulieren kann. Diese Region kann mit einem Sensor verglichen werden, 
der das Verhältnis von Koaktivator und Korepressor registriert. Die Akkumulation von 
Kofaktoren wie z.B. NonO am Promoter könnte die Sensitivität von nukleären Rezeptoren 
gegenüber transkriptionsaktivierenden Stimuli erhöhen und die N-CoR Repressionsaktivität 
beschränken. Dagegen würde eine lokale Verringerung der NonO Konzentration die 
Interaktion von Korepressoren mit nukleären Rezeptoren begünstigen und diese in eine 
repressive Form zurückzubringen. Die Konzentration von Koregulatoren wie NonO, die an 
nachfolgenden Ereignissen wie der RNA Polymerase II Komplexbildung und -aktivierung, 
Spliceosom Komplexbildung und der Bildung des RNA Polyadenylierungskomplexes beteiligt 
sind, könnte die Menge und Art der Splicing-Varianten eines RNA Transkriptes beeinflussen, 
abhängig von der Konzentration des Stimulus und dem Zellkontext. 
Bevor die Koordination und Gleichzeitigkeit von Transkriptions- und Splicingprozessen 
bekannt wurde, waren Interaktionen von Splicing-Faktoren und Splicing-assoziierten 
Proteinen mit dem RNA Polymerase II Komplex beschrieben worden. In vergleichbarer 
Weise konnte anhand meiner Ergebnisse gezeigt werden, dass NonO die physische 
Verbindung zwischen transkriptionsakivierenden und -reprimierenden Prozessen sein kann, 
da es auch mit dem Korepressor N-CoR interagiert. Ferner wird ein Modell vorgestellt, 
welches die biologische Relevanz dieser Interaktion aufzeigt (Fig. 49). Die Modulation der N-
CoR Repressionsaktivität durch NonO stellt folglich ein bislang nicht bekanntes 
Regulationselement in der Kontrolle der Genexpression dar.  Summary 
 
Summary 
Although in general cells are genetically identical in multicellular organisms, the differential 
expression of genomic information enables cell type definition and specific organ function. In 
eukaryotic cells the DNA is associated with histones and non-histone proteins into a 
restrictive structure called chromatin. It is now clear that this structure does not only protect 
and package the linear double-stranded DNA in the nucleus but is fundamental for the 
execution of diverse genetic programs. Local chromatin modifications at the gene promoter 
region play a determinant role in the regulation of transcription. Nuclear receptors are 
transcription factors that bind specific target sequences on the DNA and recruit 
transcriptional coregulators at the promoter. These are able to modify the chromatin structure 
in an activating or repressing manner. Recruitment of coactivators mediates decondensation 
of the chromatin structure, which enhances the binding of general transcription factors and 
the formation of the RNA polymerase complex whereas corepressor recruitment enhances 
structural changes that mediate transcriptional repression. The contribution of corepressors 
to the biological actions of nuclear receptors has turned out to be essential. Impaired 
corepressor function can be the cause of endocrine malfunctions, neoplastic diseases or 
severe developmental abnormalities. To better understand the role of the nuclear receptor 
corepressor N-CoR, the unknown function of the extreme C-terminus was investigated.  
During my thesis, I could confirm the in vivo interaction of the non-POU-domain containing 
octamer-binding protein NonO/p54nrb with N-CoR in co-immunoprecipitation and confocal 
microscopy experiments. NonO was previously found to interact with N-CoR C-terminus in a 
yeast-two-hybrid screen (Ducasse 2002). This protein contains two RNA recognition motifs 
(RRM) and is described as a multifunctional protein since it is involved in transcription 
initiation as well as in pre-mRNA processing. In GST-pulldown experiments, the RRM1 motif 
was determined to be essential and sufficient for the interaction with N-CoR. Therefore, 
deletion mutants were generated lacking RRM1 and RRM2, respectively. The biological 
significance of the NonO/N-CoR interaction was then investigated in different functional 
reporter assays expressing exogenous NonO wild type versus NonO deletion mutants. In the 
Gal4-reporter assay the repression activity of N-CoR full-length fused to the Gal4-DBD was 
enhanced in the presence of the ΔRRM1 mutant in a concentration-dependent manner 
whereas exogenous expression of the ΔRRM2 mutant or NonO wild type did not affect N-
CoR repressive activity. As this effect is concentration-dependent and NonO RRM1 lacks the 
interaction domain, it may result from a RRM1 mutant-related dominant-negative effect. 
These observations support the possibility that NonO is involved in the modulation of the 
repression activity of N-CoR. In the retinoic acid receptor-dependent reporter assay (RARE-Summary 
 
reporter), the recruitment of N-CoR by the nuclear receptor is induced in the absence of 
ligands or in the presence of antagonists. In comparison to the Gal4-reporter assay, which 
was not influenced by NonO wild type overexpression, the result obtained in the RARE-
reporter assay suggests that NonO can affect the nuclear receptor-dependent recruitment of 
N-CoR. Taken together these results suggest that NonO modulates the capacity of N-CoR to 
repress and its recruitment to targeted promoters by nuclear receptors.  
N-CoR repressive activity is mainly contained in the N-terminal half. As it was observed that 
NonO, which interacts with the extreme C-terminus, affected N-CoR repressive activity, 
questions remained if NonO binds to the N-terminus and if both N-CoR termini are involved 
in intramolecular interactions. This was assessed in in vitro binding assays. Indeed, NonO 
interacts with the N-CoR N-terminus within the SANT domain and both N-CoR termini 
interact in GST-pulldown assays. Further results obtained in reporter assays suggest that the 
N- and C-terminus of N-CoR regulate each other. In the last few years the regulation of 
nuclear receptor-dependent transcription has turned out to be more complicated than 
expected. It is now clear that nuclear receptors integrate at the target promoter a multitude of 
parameters including their abundance, affinity and their transcriptional activity as well as 
those of recruited coregulators. This increases the number of possible levels of regulation 
and the cell-specific gene expression patterns. Together, my results supplemented by 
published data support the functional model proposed here. The capacity of the C-terminus 
of N-CoR to modulate the repressive activity of the N-CoR N-terminus would depend on the 
concentration of coregulators such as NonO in the nuclear receptor environments. 
Accumulation of NonO at the promoter would enhance nuclear receptor sensitivity to 
stimulation and reduce N-CoR repressive activity; whereas a decrease of NonO local 
concentration would favor the interaction of nuclear receptors with corepressors (Fig. 49). 
The variation of the local concentration of coregulators such as NonO that are involved in 
events downstream of the activation of nuclear receptors associating with the Pol II complex, 
spliceosome and polyadenylation complexes, and involved in the regulation of repression 
would enable the coordination of these different processes. This would be physiologically 
relevant to regulate the amount and the quality of transcribed RNAs in response to 
stimulation intensity and cellular context.  Introduction 
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1 Introduction 
In multicellular organisms, the differential expression of the genomic information is essential 
for cell type definition and specific organ functions. Even though most cells are genetically 
identical, specificity is ensured by the expression of a defined set of proteins. The synthesis 
of functional proteins is a multi-step process taking place in different cell compartments. In 
eukaryotic cells, DNA which contains the genetic information is located in the nucleus. 
Transcription and RNA processing enable synthesis of mature RNA messenger which 
translocates out of the nucleus. mRNA is then translated into amino acids and folding of the 
polypeptide chain completes protein synthesis. Thus, transcription and RNA processing are 
the determinant initial nuclear events that ensure protein synthesis. Each step of this process 
is tightly regulated; however the regulation of gene transcription remains the most important 
step. To achieve initiation of transcription a series of ordered events is required. The 
transcriptional machinery has to be recruited to target promoter regions and has to overcome 
the restrictive chromatin structure into which DNA is packaged. Transcription factors that 
bind to target DNA sequences are essential for both recruitment of protein complexes which 
mediate modifications of the chromatin and for the formation of the transcription initiation 
complex. Their presence in the nucleus and their binding to DNA is essential for target gene 
expression. A subfamily of transcription factors, the nuclear receptors are able to activate as 
well as to repress transcription actively. Bound to their response element they can recruit 
transcriptional coregulators including coactivators and corepressors. In this context it is 
expected that a dysregulation of coregulators is likely to influence the expression of target 
genes. Indeed, impaired nuclear receptor-dependent transcription is involved in the 
pathogenesis of a number of diseases, particularly cancer. Therefore, transcription control 
exerted by nuclear receptors continues to be an intensively investigated area in the 
perspective to find novel therapy targets. The key protein of this project is N-CoR, the 
nuclear receptor corepressor that mediates transcription repression in a nuclear receptor-
dependent manner. To better understand the importance of N-CoR function in gene 
expression some details about the chromatin structure and its regulation will be described as 
well as the role of nuclear receptors in transcriptional regulation  
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1.1  Chromatin: more than DNA packaging 
The organization of DNA into chromatin is an advantageous structure to protect and package 
the linear double stranded DNA (in the order of meters) into the nucleus (a few micrometers) 
with the lowest level of compaction. The hypothesis of R. Kornberg (1974) that chromatin 
structure is fundamental for the execution of diverse biological programs has turned out to be 
true. It is now clear that DNA packaging into chromatin plays a determining role in the 
regulation of nuclear processes such as transcription, replication, repair and recombination 
and this dynamic structure even contains heritable epigenetic information that is not 
contained in the DNA sequence. 
1.1.1 Chromatin  structure 
The basic organization of chromatin is a succession of nucleosomes. A nucleosome consists 
of 146 bp of DNA wrapped 1.7 times around an octamer of core histones. Each nucleosome 
core particle is separated by a linker region of approximately 50 bp. The main histone 
variants that are involved in the assembly of a nucleosome are histone H2A, H2B, H3 and 
H4. These histones heterodimerize in H3-H4 and H2A-H2B dimers and each are represented 
twice in the nucleosome core particle. A H3-H4 tetramer assembles first onto the double 
stranded DNA (dsDNA) and two separate H2A-H2B dimers associate later in a cooperative 
manner. Each histone dimer contains three regions of interaction with the dsDNA and two 
additional interactions occur at the entry and exit points of the nucleosome with the histone 
tails from each H3 histone (Luger et al. 1997). Interaction is formed mainly by tight hydrogen 
bonds between the histone main chain amide and the phosphate oxygen of the DNA, 
assisted by electrostatic interactions between basic side chains and negatively charged 
phosphate groups and additional nonpolar interactions. This allows nucleosomes to form on 
any DNA sequences. The lowest compacted chromatin structure is the 10 nm fiber known 
descriptively as beads on a string (Kornberg 1974). This chain of nucleosomes can arrange 
to a more compact structure, the 30 nm fiber, which is stabilized by linker histones (H1) (Fig. 
1 A and B) (Oudet et al. 1975; Schalch et al. 2005). For the organization of chromatin into a 
30 nm fiber two models were suggested the solenoid and the zigzag model. The latter model 
is the nucleosome arrangement that is adopted in the cell (Bednar et al. 1998). The relative 
positioning of nucleosomes is based on the entry and exit paths of the DNA in the presence 
of histone H1 (Box. 1 C and D). Compared to the solenoid architecture based on protein-
protein interactions, zigzag pattern results from the alternate positioning of the nucleosomes. 
Thus, nucleosomes are physically closer and present minimal internucleosomal attraction 
energy (Cui and Bustamante 2000). This structure allows dramatic changes in compaction 
level to occur without a concomitant change in topology. Further compaction levels are 
known and require additional interaction with non-histone proteins.  Introduction 
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Figure 1: Nucleosomes, linker DNA and linker histone form a unique structural motif that 
directs the higher-order folding and compaction of chromatin 
Left panel, linker histones induces a “stem” conformation of linker DNA segments (A) and (B) from 
(Bednar et al. 1998), electron cryomicroscopy images of segments of unfixed, unstained chromatin 
fibers released from chicken erythrocyte nuclei into low-salt buffer and observed in frozen hydrate 
state. Right panel from (Khorasanizadeh 2004), schematic representation of the 30nm fiber, the 
histone octamer is shown in two shades of blue an the DNA is shown in magenta. The linker histone 
H1 is shown in orange. (C) The alternating aspect of adjacent nucleosomes creates a zigzag pattern 
of packing. (D) The consecutive arrangement of six nucleosomes in a turn of helix can form a 
solenoid. 
Chromatin is a structural support for a defined genomic organization in eukaryotic cells in 
which heterochromatin and euchromatin distinguish transcriptionally inactive from active 
chromatin, respectively. It provides also a great structural flexibility in dividing cells in which 
DNA has to be replicated (DNA is accessible to the replication machinery) and sequentially 
compacted into the highest ordered chromatin organization level which is the chromosome. 
The required modulations of the chromatin structure during cell growth, differentiation and 
division are ensured by modifications that occur on the DNA and mainly at nucleosomes, the 
structural unit of chromatin. 
1.1.2 Chromatin  regulation 
In the past three decades a number of chromatin related events including DNA methylation, 
incorporation of histone variants, histone postranslational modifications and ATP-dependent 
chromatin remodeling have been discovered. These have been correlated to the regulation 
of chromatin structure and are involved in major reactions with chromatin substrates such as 
transcription, replication, recombination and repair. Distinct multiprotein complexes 
participate in the regulation of chromatin accessibility and higher order structure formation Introduction 
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ensuring proper regulation of downstream events. This regulation is mediated by 
modifications at the DNA and the nucleosome level.  
DNA modification 
Methylation is a covalent modification that can occur at cytosines within CpG rich regions in 
the DNA and is important for gene repression in mammals and plants although is does not 
occur in a number of eukaryotes including yeast. DNA-methylation status contributes to 
epigenetic inheritance, allele-specific expression, inactivation of the X chromosome, genomic 
stability and embryonic development. The loss of methylation control can contribute in 
initiation and progression of tumorigenesis (reviewed in (Plass and Soloway 2002)). The 
majority of methylated CpG islands are located within repetitive elements including 
centromeric repeats, satellite sequences and gene repeats encoding ribosomal RNAs. In the 
euchromatin CpG regions are found at the 5´end of genes and are typically unmethylated. 
DNA methylation enhances transcriptional repression recruiting methyl-CpG binding domain 
(MBD) proteins that in turn associate with corepressors. It is now clear that there is a 
connection between DNA methylation and other silencing mechanism including histone 
modifications and chromatin remodeling (reviewed in (Holmes and Soloway 2006).  
Nucleosome remodeling  
In contrast to histone posttranslational modifications (see below) nucleosome remodeling is 
an ATP-dependent process that modifies chromatin structure in a noncovalent manner. 
Nucleosome ATP-dependent remodeling complexes increase access of transcription factors 
to DNA sequences that originally interact with the histones by disrupting DNA-histone 
interactions. Loss-of-function mutations in several chromatin remodeling factors were 
reported to have serious consequences. This indicates that the role of ATP-dependent 
chromatin remodeling in activation and repression of transcription can affect the control of 
cell cycle, cell differentiation and hence the development of multicellular organisms. A 
number of complexes have been determined that can change the position of the 
nucleosomes on DNA. These complexes were divided into three classes based on the 
identity of their catalytic ATPase subunit. These ATPase subunits display homology only 
within the ATPase domain and contain different additional domains. For example, the 
SWI/SNF family contains an additional bromo domain whereas the ISWI family contains a 
SANT domain and the Mi-2/NURD family a chromo domain. Each ATPase associates with 
different subunits to form distinct multiprotein complexes. These other subunits may be 
involved in the regulation or targeting of the remodeling activity. Recent discoveries provide 
evidence for mechanistic differences between each of the ATP-dependent remodelers and 
this may be correlated to their specific biological tasks. Two models are considered for the 
mechanism of ATP-dependent nucleosome remodeling (Fig. 2).This first described Introduction 
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mechanism was the nucleosome sliding which result in changes in the position of the 
nucleosome on the DNA and a second mechanism which allows exposure of DNA within the 
region bound by a histone octamer (reviewed in (Narlikar et al. 2002)). Nagaich and 
colleagues studied in vitro the interaction between the glucocorticoid receptor and an array of 
highly positioned nucleosomes assembled on the mouse mammary tumor virus long terminal 
repeat. They observed that receptor binding to nucleosomal DNA is enhanced by SWI/SNF 
and is accompanied by sequential reorganization of histone proteins within the nucleosomes. 
The action of SWI/SNF is proposed to lead to changes in the position of histone H2B within 
the nucleosome that accompanies the recruitment of GR to a new binding site within the 
nucleosomal DNA. (Nagaich et al. 2004). In addition to promote DNA accessibility, the action 
of the SWI/SNF ATPase appears to prepare nucleosomes for further posttranslational 
modifications although it does not drive these reactions per se. A number of studies support 
the coupling of ATP-dependent remodeling with histone posttranslational modifications. 
Genetic studies in yeast suggest that remodelers and covalent modifiers function 
interdependently since combination of mutation in subunits of the ySWI/SNF complex and 
SAGA complex containing histone acetyltransferase (HAT) activity is lethal in contrast to 
single mutants that display no severe growth defects. Together nucleosome remodeling and 
histone covalent modification are the major processes involved in gene activation and 
repression or other reactions with chromatin substrate (reviewed in (Becker and Hörz 2002)). 
 
 
 
 
 
 
 
 
Figure 2: Two models for the mechanism of ATP-dependent nucleosome remodeling 
(A) Nucleosome sliding.The histone octamer is repositioned on the DNA by sliding. DNA sequences 
which were originally interacting with the histones, becomes nonnucleosomal. (B) Nucleosome 
conformational change. Hypothetical structures for intermediates and products of a non sliding 
mechanism that could involve changes in the conformation of DNA, histone, or both. Models from 
(Narlikar et al. 2002) Introduction 
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Histone posttranslational modifications 
Histones are subjected to posttranslational modifications such as methylation, citrullination, 
acetylation, phosphorylation, SUMOylation and ADP-ribosylation (Fig. 3 B). The combination 
of different modifications is thought to constitute the histone code (Strahl and Allis 2000; 
Jenuwein and Allis 2001) and to correlate with specific events required for transcription, DNA 
repair or the regulation of chromosome condensation. These modifications do not exert their 
biological function by significantly modulating the nucleosome structure, but rather act as 
marks for the specific recruitment of proteins that bring additional regulatory functions to 
these units. The histone structure is highly conserved through evolution and relatively similar 
in the different variants. Two main domains are distinguished within the histone, the folded 
core and the unstructured tail. The histone core is a globular domain folding in a helix turn 
helix turn helix motif allowing easy dimerization. Histone tails or terminal extensions 
protruding from the nucleosome core particle do not adopt defined conformations in crystal 
structures except bound to their recognition proteins. The tail domains contain a number of 
conserved amino acid residues (lysine, arginine and serine) that can undergo 
postranslational modifications (Fig. 3 A). Covalent modifications at the N-terminus tail of all 
four histone proteins and at C-terminus tails of the histone H2A and the linker histone H1 are 
relevant in the regulation of chromatin structure and transcription. 
 
 
 
 
 
 
 
 
 
 
Figure 3: Histone posttranslational modifications 
(A) The histone octamer portion of the nucleosome core particle is shown. The sites of modifications 
are marked. For clarity, the modifications are shown on one copy of each protein. (B) The covalent 
modifications of the amino acids are shown. Figure from S. Khorasanizadeh review (Khorasanizadeh 
2004). Introduction 
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Due to their basicity histone tails can electrostatically interact with the polyanionic backbone 
of the core DNA; however they marginally contribute to the nucleosome stability (Hayes et al. 
1991). Histone tails are thought to play a role in the regulation of nucleosome mobility. They 
mediate interactions outside the nucleosome core and in the condensation state of chromatin 
fiber, mediate interchromosomal interactions (Wolffe and Kurumizaka 1998). Furthermore the 
histone tails can either alter the accessibility of nuclear factors to DNA (Vitolo et al. 2000) or 
enable the recruitment of factors involved in transcription or chromatin assembly pathways. 
To better understand the central role of the nucleosome in the regulation of chromatin 
structure and transcription the most important reversible covalent histone modifications will 
be presented briefly. 
Histone methylation on conserved residues of the histone amino tails was first thought to be 
mainly implicated in epigenetic inheritance. Indeed methylation is fairly stable in comparison 
to other modifications such as ubiquitination, phosphorylation, SUMOylation or acetylation 
and until recently no enzyme was identified which could actively remove methylation. In 
addition H3 lysine 9 methylation was found to be a mark of heterochromatin initiation and 
maintenance mediating interaction with the heterochromatin protein 1 (HP1) required for the 
formation of higher order chromatin structure (Nakayama et al. 2001) (Richards 2002). 
Similarly, polycomb proteins that are involved in gene silencing during development interact 
with H3 methylated at lysine 27 (Fischle et al. 2003). However, further investigations 
indicated that methylation is not a permanent mark on histones and can be removed by 
active processes necessary in the regulation of gene expression. Histone methylation at 
lysine and arginine residues has been reported to enhance transcriptional activation. Histone 
methylation at H3 lysine 4 (Wang et al. 2001) or H3 lysine 36 (Kizer et al. 2005) was 
correlated with transcriptionally active genes as were H3 methylated arginines (2,17 and 26) 
(Schurter et al. 2001) and H4 arginine 3 (Strahl et al. 2001). Although the precise mechanism 
by which histone methylation contributes to physiological processes is mostly unresolved, 
several chromatin associated factors and methyltransferases contain a well defined chromo 
domain which is a binding motif for methylated lysine. The state of methylation (mono- di- 
and trimethylation) was also determined to be of functional significance which was 
emphasized by the discovery of histone methyltransferases which catalyze distinct 
methylation states (Rice et al. 2003). In transcriptionally active chromatin, mostly mono- and 
di-methylation of lysine or arginine residues is found in contrast to histone trimethylation, 
which is thought to be a biochemically irreversible covalent modification. This observation 
supported that active turnover mechanisms for methyl groups on histone tails should exist. 
Indeed, enzymes have been recently discovered which can prevent arginine 
monomethylation (Cuthbert et al. 2004) or catalyze demethylation of mono- and dimethylated 
lysine (Shi et al. 2004). These findings indicate that methylation can be antagonized and Introduction 
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reversed by distinct enzymatic activities in addition to histone replacement that was proposed 
to be the most likely mechanism for the removal of methylated histones from chromatin. 
Histone deposition occurs mainly during DNA replication; however different histone variants 
are incorporated at different regions of chromatin by replication-independent histone 
assembly mechanisms (Ahmad and Henikoff 2002). More recently, response-mediated 
replacement of histones has been reported to require the process of active transcription 
(Schwartz and Ahmad 2005). Although further investigations are necessary to understand 
the function of histone methylation in details in various biological processes it is now clear 
that this modification is part of the histone code and offers a multitude of distinct 
combinations of marks.  
In 1964 Allfrey and colleagues found a correlation between increased histone acetylation and 
increased transcription (Allfrey et al. 1964). Since then several mechanisms by which histone 
acetylation and deacetylation regulate gene activity have been elucidated. Recently, new 
roles for histone acetylation have been uncovered, not only in transcription but also in DNA 
replication, repair and heterochromatin formation in yeast as well as in humans (reviewed in 
(Kimura et al. 2005)). Hyperacetylation of histone tails at lysine residues is associated with 
transcriptional activity. It is thought to weaken DNA-histone contacts by neutralizing the 
positive charge of the histone tails and decreasing their affinity for negatively charged DNA, 
thereby allowing access for transcription factors to promoters in the chromatin. Conversely, 
histone deacetylation is believed to prevent access by restoring the positive charge and 
strengthening the interaction between DNA and histones. Although this charge-neutralization 
model has become popular, more recent studies support that histone 
acetylation/deacetylation rather regulate transcription by altering higher-order folding 
properties of the chromatin fiber and by providing specific binding surfaces for the 
recruitment of repressors and activators. Observations by Turner and colleagues support this 
latter model. These suggest that histone modification mediates not only promoter-specific 
gene expression but also longer-range gene expression. They observed distinct lysine 
acetylation patterns in specific chromosomal regions (euchromatin, heterochromatin and 
hyperactive male X chromosome) in Drosophila megalogaster polytene nuclei (Turner 1991). 
Many of the enzymes that catalyze histone acetylation and deacetylation were previously 
identified as transcriptional cofactors. This observation underscores the importance of these 
dynamic modifications in transcriptional regulation.  
Acetylated lysine residues of histones are recognized by bromodomains that are contained in 
a number of histone acetyltransferases and chromatin associated factors. In euchromatin at 
promoter sites, acetylation of histone amino-termini provides binding surfaces for 
transcription factors of the TFIID transcription initiation complex as well as for proteins in Introduction 
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chromatin-remodeling complexes. Agalioti and colleagues have shown progressive 
acetylation of the human interferon (IFN)-β gene upon transcriptional activation. Each 
acetylation pattern correlated with the recruitment of a specific protein. The general 
transcription factors GCN5 and TAFII250, the largest subunit of the TFIID complex, are 
recruited to target promoter regions and sequentially acetylate H4 lysine 8 and H3 lysine 9 
and 14, respectively. In turn, H4 lysine 8 acetylation provides a binding site for BRG1 that is 
part of the SWI/SNF complex that promotes ATP-dependent nucleosome remodeling 
(Agalioti et al. 2002). The first cloned histone acetyltransferase (HAT) was from Tetrahymena 
thermophilia (Brownell et al. 1996) and sequence similarity with previously identified 
transcription factors, such as CBP/p300, TAFII250 and SRC-1 revealed that these 
transcriptional coactivators all contained HAT activity (reviewed in (Kimura et al. 2005)). 
These findings strengthened the idea that local acetylation of histones by transcription 
factors contributes to the activation of promoter-specific gene expression. Histone acetylases 
act as part of large complexes in vivo and additional subunits can modulate HAT activity and 
substrate specificity. Homozygous deletions of the different histone acetylases in mice exhibit 
distinct developmental defects, suggesting differences in function of these highly regulated 
HAT subunits. Histone acetylase activity can directly be affected by sequence-specific 
transcription factors and adjacent histone modification. However, for the proper regulation of 
gene expression antagonistic activity is required. Histone deacetylases (HDACs) were 
identified almost in parallel to HAT enzymes and promote gene repression and silencing by 
catalyzing removal of acetyl moiety from acetyl-lysine within histones (reviewed in (Gregoretti 
et al. 2004)).  
In 1996 the first mammalian HDAC enzyme was identified related to the yeast transcriptional 
regulator, Rpd3 (Taunton et al. 1996). Since then, a number of HDACs have been 
discovered and subdivided into subclasses. This classification was based on sequence 
homology with the yeast homologues. The human class I histone deacetylases include 
HDAC 1, 2, 3 and 8 that are similar to Rpd3, whereas class II including HDAC 4, 5, 6, 7, 9 
and 10 are similar to the yeast Hda1. The third class also named the sirtuins shows 
significant sequence and functional divergence to class I and II subgroups. Class III HDACs 
present NAD-dependent deacetylase activity like the yeast Sir 2 protein and play an essential 
role in epigenetic silencing (Blander and Guarente 2004). Class II deacetylases have an 
additional level of regulation in comparison to class I and III since they shuttle between the 
nucleus and the cytoplasm and their subcellular distribution appears to be under control of 
the classic cellular signaling pathways. Substrate specificity of each HDAC remains unclear 
but they all can deacetylate acetylated lysine residues of histone in vitro. Phylogenetic 
analysis (Gregoretti et al. 2004) revealed that HDACs evolved in the absence of histone 
proteins suggesting that key HDAC substrates might not be histones, nevertheless they are Introduction 
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by far the most abundant substrate. Meanwhile it is clear that a variety of biological 
processes in addition to transcription such as DNA repair, replication or recombination are 
regulated by acetylation and deacetylation of nonhistone proteins (reviewed in (Minucci and 
Pelicci 2006)). HDACs and HATs that are involved in the chromatin changes that regulate 
transcription associate with corepressor and coactivator complexes, respectively. They are 
recruited to gene regulatory regions directly or indirectly by DNA binding factors. A number of 
complexes containing acetylase or deacetylase activity have been described and variations 
remain in the exact complex composition. The differences might reflect heterogeneity 
essentially due to cell type and stages of differentiation in which these studies were 
performed. In a number of cancers, correlation between pathogenesis and imbalance in 
acetylation/deacetylation has been characterized. The interest in these enzymes is growing 
because HDAC inhibitors appear to be promising therapeutic agents against cancer and a 
variety of other diseases (Krämer et al. 2001; Minucci and Pelicci 2006).  
Strahl and Allis proposed that distinct histone modifications, on one or more tails, act 
sequentially or in combination to form a 'histone code' that is read by other proteins to initiate 
distinct downstream events. Although a number of combinations remain unelucidated, 
distinct patterns have been correlated to different events. For example, H3 lysine 9 and 14 
acetylation, in combination with H3 lysine 4 methylation and H4 lysine 8 acetylation are 
marks for transcriptional activation, whereas H3 lysine 9 trimethylation is a heterochromatin 
mark and H2B serine 14 phosphorylation is a mark for apoptotic chromatin condensation 
(Fernandez-Capetillo et al. 2004). In addition to this level of regulation, other histone 
modifications such as ubiquitination, SUMOylation and phosphorylation have been described 
to be involved in the histone crosstalk which characterizes modification of histones that 
influence other histone modifications (Fischle et al. 2003). Indeed, methylation of H3 lysine 9 
and 27 have been shown to be dependent of H2B and H2A lysine ubiquitination, respectively 
(Dover et al. 2002) (Wang et al. 2004), H3 serine 10 phosphorylation enhances H3 lysine 14 
acetylation (Clements et al. 2003) and H4 SUMOylation induces HDAC1 recruitment (Shiio 
and Eisenman 2003). Together these few examples illustrate the dynamic and the complexity 
of the regulation of the chromatin structure by histone posttranslational modifications. The 
discovery of histone variants incorporation that has been shown to have several effects on 
chromatin expands this complexity. Locally it affects nucleosome structure as well as the 
propensity of variant containing chromatin to be remodeled through specific sequence 
changes in the histone domain. Hence, histone variant incorporation can alter nucleosome 
stability, mobility and histone modifications patterns, with possible effects on higher order 
structure or downstream events (Ahmad and Henikoff 2002) (Meneghini et al. 2003) 
(Chakravarthy et al. 2005). Regulation of the chromatin structure by nucleosome remodeling, 
histone posttranslational modification and the incorporation of histone variants emphasize Introduction 
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the central role played by the nucleosome and the histone code in the regulation of gene 
expression (reviewed in (Mellor 2005)).  
While the regulation of the chromatin structure is necessary for regulating gene expression, it 
is not sufficient: functions of sequence-specific activators and repressors, mediator 
complexes and general transcription factors are also required to ensure proper regulation. 
When transcription of a gene is altered, a specific event, frequently the binding of gene-
specific factors to specific DNA binding sequences triggers a cascade of spatially and 
temporally coordinated reactions. These reactions result in a chromatin template, 
appropriately remodeled, which is bound by regulatory factors and the general transcription 
machinery. The precise order in which ATP-dependent remodeling, covalent modification of 
histones, or binding by regulatory factors or the transcription machinery occur seems to 
depend upon the nature of the promoter, chromatin structure in which the promoter resides 
and the complement of present transcription factors. The sole requirement is that the end 
point, which is the structure of the template and association of appropriate components of the 
general transcription machinery, is reached in a timely manner (Narlikar et al. 2002). Thus, 
each cell type may establish its unique repertoire of expressed genes. 
1.2 Nuclear  receptor-dependent  regulation of transcription  
Transcription factors are able to bind to specific sets of short conserved sequences 
contained in each promoter and are divided into three groups. The general transcription 
factors are subunits of the Polymerase II complex which transcribes template DNA into 
messenger RNA. The second group, the upstream transcription factors are ubiquitous and 
recognize specific short consensus elements located in promoter regions and increase the 
efficiency of transcription initiation. General transcription factors and upstream transcription 
factors require accessible chromatin structure for DNA binding which is mediated by the third 
group of transcription factors. This consists of the inducible factors which have a regulatory 
role since they are synthesized or activated at specific times and in specific tissues. The 
nuclear receptors constitute a large family of ligand-inducible transcription factors. They 
regulate many biologically important processes in development and homeostasis by their 
bimodal function as repressors and activators of gene transcription. 
1.2.1  Nuclear receptors are ligand-inducible transcription factors 
Nuclear receptors are intracellular receptors that perform hormone-dependent signal 
transduction. The superfamilly of nuclear receptors is subdivided in three groups and the 
steroid and the non-steroid hormone receptors correspond to type I and II, respectively. Sex 
hormone receptors including androgen, estrogen, progesterone, glucocorticoid and 
mineralocorticoid receptors bind steroid hormones. The type II nuclear receptors include non-Introduction 
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steroid ligand binding receptors such as the vitamin A, D, retinoid and thyroid hormone 
receptors as well as receptors that bind diverse products of the lipid metabolism such as fatty 
acids and prostaglandins (peroxisome proliferators activated receptor (PPARs) and liver X 
receptors (LXRs)). A number of nuclear receptors that do not have any known ligands are 
so-called orphan receptors (reviewed in (Gronemeyer et al. 2004). All nuclear receptors can 
exert their effects via sequence-specific binding to target genes and via ligand-dependent 
regulation of transcription. Steroid and non steroid hormones are small lipophilic molecules 
that easily penetrate biological membranes. Type I receptors interact with their cognate 
ligand in the cytoplasm and then translocate to the nucleus whereas type II receptors reside 
in the nucleus in the presence or absence of their ligand. An essential step is the interaction 
of the receptors with specific DNA sequences, called hormone-response elements (HREs). 
These response elements position the receptors, and the complexes recruited by them, close 
to the genes that are targeted. HREs are bipartite elements that are composed of two 
hexameric core half-site motifs. The identity of the response element resides in three 
features: the nucleotide sequence of the two core motif half-sites, the number of base pairs 
separating them and the relative orientation of the motifs. Class I receptors, preferentially 
bind as homodimers to identical or very closely related response elements with a palindromic 
consensus sequence GGTACAnnnTGTTCT (Beato et al. 1989). In contrast, non-steroid 
receptors have the highest binding affinity for direct repeats that are asymmetric and can be 
variably spaced as heterodimers with the retinoic X receptors (Mangelsdorf et al. 1995). 
However, nuclear receptor structure plasticity enables either some nuclear receptor to 
heterodimerize with other transcription factors on composite response elements (Flick et al. 
2002) or to regulate transcription in a DNA-independent manner being recruited by other 
DNA-bound transcription factors to target promoter regions (Almawi and Melemedjian 2002). 
1.2.2  Nuclear receptor structure 
Nuclear receptors share a common modular structure composed of independent but 
functionally related domains. The well conserved DNA-binding domain (DBD) centrally 
located comprises two zinc-finger motifs. Residues in the first module determine the 
specificity of the target DNA sequence, while residues in the second module are involved in 
dimerization. As mentioned previously homo-and heterodimerization are correlated with the 
response element type. Furthermore, the DNA-binding domain is involved in several other 
functions including nuclear localization, and interaction with transcription factors and co-
activators. The DNA-binding domain therefore plays a central role, not only in the correct 
binding of the receptors to target genes, but also in the control of other activities of nuclear 
receptors. The ligand-binding domain (LBD) located in the carboxyl terminal half folds into a 
canonical α-helical sandwich generally consisting of 12 helices (H1-H12). Helix 12 adopts Introduction 
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different positions depending on the presence or absence of ligand and the type of the 
ligand, agonist or antagonist. Its position is crucial in forming interaction surfaces for 
coactivators or corepressors. This LBD region also contains ligand-dependent nuclear 
translocation signals, binding surfaces for chaperone proteins, dimerization interfaces, and a 
potent ligand-dependent activation domain AF-2. A ligand-independent activation domain, 
AF-1 which synergistically acts with AF-2, is encoded within the amino-terminal region of the 
receptors which is the most variable region in terms of length and amino acid sequence (Fig. 
4) (reviewed in (Smirnov 2002)). Receptor domains are functionally interlinked. After ligand 
and DNA binding, the interaction of distant receptor domains with other molecules may be 
changed due to conformational receptor plasticity. For example, unliganded steroid receptors 
are retained in the cytoplasm in a complexe with heat shock proteins, which dissociate upon 
ligand binding, receptors can subsequently translocate to the nucleus. For all nuclear 
receptors, the binding of ligand changes the affinity of the DNA bound receptors for other 
proteins that do not exclusively interact within the ligand binding domain. 
 
 
 
Figure 4: Domain organization of nuclear receptors 
The A/B domain is the most variable region and contains the ligand-independent activation domain 
(AF-1) which mediates interactions with tissue-specific cofactors. The C region contains three 
modules, the DNA binding domain which recognizes enhancer-likes DNA sites called the hormone-
response elements (HRE), a surface involved in receptor dimerization and a C-terminal extension 
(CTE) which is involved in the binding specificity of HRE and protein-protein interaction with other 
factors. The hinge region D provides great flexibility between the DBD and the ligand binding domain 
as a surface for receptor interaction with some coregulators. The E region contains the ligand binding 
motif and the ligand-dependent activation domain AF-2. The extreme carboxyl region F is not present 
in all receptors. Scheme adapted from Smirnov review (Smirnov 2002).  
1.2.3  Nuclear receptor cofactors 
In addition to their capacity to bind to condensed chromatin templates (Hebbar and Archer 
2003) the response of a given receptor to a particular ligand depends on the set of proteins 
with which the nuclear receptor is able to interact. Recruited coregulators are factors that 
covalently modify histones and ATP-dependent chromatin remodeling factors. In turn, these 
determine the specificity of recruited factors and modulate the promoter accessibility to 
transcription factors as well as to the basal transcriptional machinery, respectively. 
Coregulators provide the appropriate mechanistic and enzymatic requirements for effective 
transcriptional regulation. In general, agonist binding is believed to increase the affinity for 
coactivators and inversely antagonist binding enhances interaction with corepressors. 
However, for some receptors variations are observed concerning their state of activation and Introduction 
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recruited coregulators. Receptors such as retinoid and thyroid hormone receptors, residing in 
the nucleus are capable to bind DNA in the unliganded state and are associated with 
repressor complexes that actively repress transcription. Moreover, distinct corepressor 
complexes have been identified to interact with agonist bound nuclear receptors (Traish et al. 
1997). Although ligand-binding mainly controls association of the coregulators with nuclear 
receptors, composition of the DNA response element as well as posttranslational 
modifications of amino acid residues in different receptor domains can also affect 
transcriptional activation and/or nuclear receptor stability. The modulation of the nuclear 
receptor transcriptional activity through allosteric changes that occur upon specific DNA 
binding was reported for several nuclear receptors. Glucocorticoid, thyroid or retinoic acid 
receptors bound to their cognate agonist were found to repress transcription when bound to 
negative hormone-response DNA elements (reviewed in (Dostert and Heinzel 2004)). This 
suggests that binding to these DNA elements, differing from canonic HREs by nucleotide 
sequence in half-sites and in the size of the separating spacers, can affect the recruitment of 
coregulators. Posttranslational modifications such as phosphorylation, acetylation, 
ubiquitination and SUMOylation can also affect nuclear receptor transcriptional activity 
enhancing or inhibiting directly interaction or inducing conformational changes. For example 
serine phosphorylation in the
 DBD of thyroid receptor β1 (TRβ1) leads to allosteric changes 
in the proximal region
 of the LBD resulting in dissociation of corepressor (SMRT) from TRβ1 
(Davis et al. 2000). On the other hand phosphorylation of a serine residue in the AF-1 
domain of estrogen receptor α (ERα) enhances interaction with steroid receptor RNA 
activator (SRA) in a ligand-independent manner (Deblois and Giguere 2003). In addition 
acetylation of lysine residues in the LBD of androgen receptor regulates ligand sensitivity and 
specificity (Fu et al. 2003). Recently discovered as a posttranscriptional modification 
SUMOylation of lysine residues within the hinge region of ERα which occurs strictly in the 
presence of hormone has been described to modulate ERα-dependent cellular response 
(Sentis et al. 2005). The interplay between the functional domains and the allosteric changes 
that are induced by modification in the different regions suggest that nuclear receptor 
transcriptional activity is not simply due to ligand binding. Thus, nuclear receptors enable at 
the target promoter the integration of a variety of information derived from extracellular 
signals, cell context and chromatin environment.  
Nuclear receptor-mediated transcription requires several different protein complexes that can 
act sequentially, combinatorially or in parallel. In recent years a multitude of proteins and 
protein complexes have been shown to be nuclear receptor cofactors. Upon ligand binding 
conformational changes in the ligand binding domain occur. The position of helix 12, which 
contains the transactivation domain AF2 was determined by crystal structure analysis to be Introduction 
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critical for the binding of coregulators. Agonist binding induces position variation of the helix 
12 forming a hydrophobic coactivator-binding surface which allows recruitment of 
transcription factors containing the leucine-rich motif (L-X-X-L-L) (Fig. 5).  
 
 
 
 
 
 
 
Figure 5: Nuclear receptor coregulator interaction motifs 
The schematic representation illustrates conformational changes induced by ligand binding in the 
ligand binding domain of nuclear receptors which are critical for the interaction with coactivators and 
corepressors. Figure from (Perissi and Rosenfeld 2005) review. 
ATP-dependent remodeling complexes such as SWI/SNF, complexes with histone acetylase 
activities (such as SRC/p160 family, CBP/p300 proteins or ADA complexes), and proteins 
with histone methylase activities (including CARM1 and PRMT1) are recruited to modify the 
chromatin structure. Subsequently, mediator complex (TRAP/DRIP/ARC) which coactivates 
NR-regulated gene expression are recruited. These facilitate the recruitment and the 
activation of the RNA polymerase II-associated basal transcription apparatus. In addition to 
these coactivators involved in the regulation of the chromatin structure and the assembly of 
the transcriptional initiation complex, factors containing E3 ubiquitin-protein ligase activities 
are required for efficient transcriptional activity. These are involved in the regulation of the 
nuclear receptor and coregulator turnover. Ubiquitination of nuclear receptors has been 
described for receptors from class I and II, and was linked to ubiquitin proteasome-mediated 
degradation (Reid et al. 2003). The nuclear receptor degradation is ligand-dependent and 
influenced by several activating events such as phosphorylation and acetylation, coactivator 
binding and crosstalk between different receptors. Whether all of these events contributing to 
the regulation of the nuclear receptor turnover are independent or are part of an 
interconnected mechanism is yet not clear (reviewed in (Nawaz and O'Malley 2004)). 
Preventing degradation has been shown to be deleterious to the regulation of transcription by 
certain receptors (Lonard et al. 2000). This suggests that nuclear receptor degradation and 
transactivation are mutually interdependent. It seems that this mechanism prevents cells Introduction 
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from overstimulation (Dennis et al. 2001); however coactivators also undergo proteasome-
mediated degradation that may be required to exchange coactivator complexes for 
transcription initiation, elongation and RNA processing. Nuclear receptors in a repressive 
conformation (receptors bound to antagonist or unliganded thyroid and retinoid receptors) 
recruit repressive complexes to target promoters; these include ATP-dependent remodeling 
complexes and corepressors such as SMRT (silencing mediating of retinoid and thyroid 
hormones receptors) and N-CoR (nuclear hormone receptor corepressor) which associate 
directly or indirectly with histone deacetylases. These complexes generate a local chromatin 
environment that actively restricts transcription (Privalsky 2004). 
1.2.4  Regulation of nuclear receptor-dependent transcription 
Biochemical and structural studies have determined that initiation of transcription progresses 
through a series of ordered events. However, integrating time into the analysis of 
transcription with chromatin immunoprecipitation (CHIP) assays and fluorescence recovery 
after photobleaching (FRAP) revealed the dynamic, cooperative, functionally redundant and 
cyclical nature of gene expression. These techniques permit the evaluation of transcriptional 
processes kinetically with time resolutions from sub-seconds (FRAP) to minutes (CHIP). 
Real-time, single live cell imaging of transcription factors tagged with fluorescent proteins has 
shown that nuclear receptors are highly mobile in the nucleus and suggests that 
transcriptional activation is achieved through stochastic mechanisms. Whereas FRAP 
experiments mainly detect the bulk, rapid and potentially transient binding of factors, CHIP 
assays only detect the productive association of promoter sequences with specific 
transcription factors. With this latter technique, a number of groups analyzed the estrogen 
receptor-α-mediated transcription of the pS2 promoter in MCF-7 cells in the presence of 
estrogen. They observed a cyclical recruitment of different complexes which correlated with 
defined histone modification patterns. In the presence of estrogen histone methyltransferase, 
histone acetyltransferase, transcription factors, RNA polymerase II, remodeling complex and 
histone deacetylases associate sequentially and periodically (Fig. 6). Interestingly 
coactivators and corepressors are alternately recruited; suggesting that promoter clearance 
provoking the promoter to return to a basal state is required for productive cycling. It was 
also observed that a given enzymatic function could be provided by functionally redundant 
enzymes which supports that coactivator or corepressor complexes may vary in their 
composition and that different routes may lead to transcription initiation (reviewed in (Metivier 
et al. 2006)).  
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Figure 6: Cyclical and combinatorial recruitment of cofactors on a natural target promoter 
Kinetics of cofactor recruitment to the pS2 promoter determined by CHIP analysis (Metivier et al. 
2003) simplified and reviewed in (Perissi and Rosenfeld 2005). Different factors that have the same 
enzymatic activities have been grouped together. Cyclical and combinatorial recruitment of cofactors 
is required for transcription activation. 
Metivier and colleagues proposed a model that integrates the high mobility of nuclear 
receptors as observed by FRAP with the longer cycle times determined by CHIP. They 
postulate that transcriptionally productive complexes have a slower mobility than 
transcription factors not engaged on the promoter. Progression through the cycle would 
depend on productive events that are less frequent than unproductive associations of factors 
resulting from rapid, stochastic and transient interactions. Consequently, progress is made 
when a specific and required factor becomes recruited at an appropriate time. The direction 
of the progression to transcription initiation would be determined by posttranslational 
modifications as well as by allosteric changes that occur on histones, chromatin associated 
factors, and interacting proteins at the promoter. This transcriptional cycling model is 
supported by discovery that nuclear receptors and coreguators can be ubiquitinated and 
degraded in the course of their activation. This proteasome-dependent degradation is 
required for the cycling of nuclear receptors on hormone-responsive promoters (Reid et al. 
2003). Nuclear receptor turnover may also play a role in resetting the transcriptional 
apparatus in preparation for a subsequent response. Physiologically, a cycling mechanism 
and transcription-dependent degradation would enable continuous sampling of hormone 
exposure to ensure an appropriate response to stimulation. This mechanism suggests the 
strong interconnection between distinct processes including chromatin structure regulation 
and general transcription machinery which may be extended in the near future to 
downstream processes which are also regulated by nuclear receptors such as splicing and 
RNA maturation.  
The regulation of nuclear receptor-dependent transcription results actually from the 
integration at the target promoter of a multitude of parameters including abundance, affinity 
and activity of nuclear receptors as well as coregulators ensuring gene-specific expression 
pattern cell-context and cell-type-dependent. In addition to previously described possible 
mechanisms of nuclear receptor transactivation modulation another level of regulation is Introduction 
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ensured by the differential expression of nuclear receptor types and isoforms. Distinct 
nuclear receptor isoform may be expressed depending on the cell type and/or the 
developmental stage. Each isoform can act as a functionally distinct transcription factor 
exerting synergistic or antagonistic effects. For example, the RARα isoform represses target 
gene expression in the absence of hormone, whereas RARβ and γ do not repress 
(Hauksdottir et al. 2003). The differences in their transcriptional regulation reflect the 
corepressor binding properties of each isoform. The tissue-specific variation of the cellular 
level of coregulators is believed to create cell- and temporal-specific transcriptional 
conditions. Indeed some coregulators are limiting factors for the transcriptional regulation of 
a specific receptor and are differently regulated. Coregulator expression can be modulated in 
a time and/or cell type-specific manner, resulting in the presence of different protein-protein 
complexes involved in transcriptional regulation. Variation of the nuclear localization and 
concentration of coregulators may also be controlled by regulation of the shuttling of 
coactivators and corepressors between the nucleus and the cytoplasm. This is still little 
understood; however recent discoveries support this supplementary level of regulation. 
Proteolysis of some cofactors has been shown to be a mechanism for modulating their 
cellular level. Transcriptional regulation by modulation of the enzymatic activity of nuclear 
receptor coregulators has also been investigated. Indeed, posttranslational modifications 
including phosphorylation, acetylation, methylation or SUMOylation under the influence of 
upstream signaling cascades are able to modulate the function of coregulators (Hermanson 
et al. 2002). In addition to regulation mechanisms altering protein-DNA interaction, complex 
formation and enzymatic activity, some preliminary data suggest that non-protein-coding 
RNAs are involved in the transcriptional regulation of steroid and non-steroid hormone 
receptors, besides their currently known regulatory functions in the cell (reviewed in (Mattick 
2003)). The steroid receptor RNA activator (SRA) is an RNA transcript that functions as a 
eukaryotic transcriptional coactivator for steroid hormone receptors (Lanz et al. 2002). It was 
shown recently that SRA is also a thyroid hormone receptor coactivator directly interacting 
with a RNA binding motif lying between the DNA binding domain and the ligand binding 
domain of this receptor (Xu and Koenig 2004). It is now clear, that the transcriptional activity 
of nuclear receptors can be modulated in vatious manner. However, subsequent 
transcriptional regulation remains completely dependent on the structure of the promoter. 
Thus the combinatorial pattern of gene-specific factors and common coregulators on a 
promoter, in combination with expression levels and post-translational modifications, will 
establish a context-specific recruitment of required molecules and enzymatic activities. 
Transcriptional regulation by nuclear receptors and coregulators is thus an extremely 
complex but very specific and delicately regulated event, involving many sophisticated 
modes of modulation to achieve and maintain homeostasis in the cell and the organism. In Introduction 
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this context, it is likely that any perturbation of the balance of coregulators influences the 
expression of target genes and thus participates in the development of disorders in an 
important manner. Indeed deregulated expression of corepressors is observed in cancers of 
the female reproductive system, leukemia, lymphomas and other cancers (reviewed in 
(Kumar et al. 2005)). Impaired localization of corepressors or altered interaction with 
corepressors can also affect transcriptional regulation and has been described to be involved 
in the pathogenesis of Huntington’s nervous system disorder (Boutell et al. 1999). 
Furthermore, aberrant growth factor signaling which influences the functions of corepressors 
and their associated proteins can also dysregulate their functions. Altered kinase signaling 
and posttranslational modifications is a common feature of tumor cells. Pathogenesis can 
also be the consequence of mutations of receptors or chromosomal rearrangements. Nuclear 
receptor transcriptional activity can be impaired when receptor mutations result in a 
decreased ligand binding and/or defective ligand induced release of corepressor. Such 
mutations in the thyroxine-receptor (TRβ1) and the peroxisome proliferator-activated 
receptor-gamma (PPARγ) have been associated to resistance-to-thyroid-hormone syndrome 
(Clifton-Bligh et al. 1998; Safer et al. 1998) and to insulin resistance (Barroso et al. 1999), 
respectively. Acute promyelocytic leukemia and acute myeloid leukemia are caused by 
chromosomal translocations leading to the expression of transcription factors fused to the 
nuclear receptor RAR or to the zinc finger nuclear protein ETO, respectively, which contain 
corepressor interaction domains (Hiebert et al. 1996; Lin et al. 1999). The progression of 
these leukemias is linked to the aberrant recruitment of the N-CoR/SMRT corepressor 
complex containing histone deacetylase activity blocking differentiation and allowing 
uncontrolled growth of hematopoietic cells.  
Although nuclear receptors are traditionally thought of solely as ligand transducers, 
unliganded thyroid hormone receptors and retinoid receptors are emerging as major players 
in many cellular processes and in development through their role as gene repressors. For 
instance, the dynamic and often abundant expression of the retinoid receptors does not 
necessarily correspond to the spatial and temporal availability of retinoic acid during the head 
formation in Xenopus or during skeletal development in the mouse (reviewed in (Weston et 
al. 2003)). Thus, these receptors have important function beyond transducing a retinoid 
signal. Receptor-mediated repression seems as important as activation throughout various 
embryonic processes. Nuclear receptor corepressor (N-CoR)-deficient embryos exhibit 
abnormalities in erythrocyte, thymocyte, and neural development and generally die around 
embryonic age e16 (Jepsen et al. 2000). Moreover, N-CoR has been categorized as a 
principal regulator of neural stem cell fate, in that its activity promotes self-renewal of these 
cells, repressing their differentiation into astrocytes (Hermanson et al. 2002). Knocking out 
other components of repressor complexes in vertebrates results mostly in embryonic lethality Introduction 
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attributed to major proliferation defects and developmental retardation caused at least in part 
by the derepression of otherwise silenced genes. It is now clear that corepressors are 
essential contributors to the biological actions of nuclear receptors and that aberration in 
corepressor function leads to endocrine malfunctions, neoplastic diseases, or severe 
developmental abnormalities.  
1.3  Nuclear receptor corepressor N-CoR 
1.3.1  N-CoR and SMRT 
The best characterized nuclear receptor corepressor N-CoR (Hörlein et al. 1995) and the 
closely related protein SMRT (silencing mediator of retinoid and thyroid hormone receptors 
(Chen and Evans 1995) are involved in the active repression of basal transcription (Glass 
and Rosenfeld 2000). Both are recruited to promoter regions by receptors known to repress 
in the unliganded state, such as thyroid hormone receptor (TR), retinoic acid receptors (RAR) 
and the COUP-TF I/II orphan receptor. Additional nuclear receptors including peroxisome 
proliferator-activated receptors (PPARs) and vitamin D receptors (VDRs) among others have 
been identified to interact as well with N-CoR and/or SMRT in the absence of hormone. In 
addition, a number of nuclear receptors in the presence of their cognate antagonist also 
require N-CoR or SMRT correpressor complexes to mediate repression. Furthermore, N-
CoR/SMRT are recruited by nonreceptor transcription factors that bind specific DNA 
sequences. For example, MyoD, NF-κb and AP-1 that play a role in the stimulation of cellular 
proliferation processes (mLee et al. 2000) or BTB/POZ domain containing protein such as 
PLZF or BCL6 (Melnick et al. 2002). HOX-PBX containing proteins regulating the expression 
of specific gene involved in cell fate and segment identity also recuit N-CoR/SMRT to 
mediate repression (Asahara et al. 1999). N-CoR was also found to be involved in active 
long-term repression of the growth hormone gene, recruited by the pituitary-specific POU 
domain factor Pit-1, in combination with other DNA binding factors (Scully et al. 2000). 
Together these observations indicate that N-CoR/SMRT repressive activity is required in the 
transcriptional regulation of a multitude of genes (reviewed in (Privalsky 2004). Both make 
direct contact with the ligand binding domain of many nuclear receptors and nucleate the 
assembly of a larger array of additional corepressor proteins including histone deacetylases 
(HDACs). N-CoR and SMRT are the principal point of contact between this larger complex 
and the nuclear receptors. Molecular events that regulate the interaction of N-CoR or SMRT 
with the nuclear receptor generally control the recruitment or release of the entire 
corepressor complex (Glass and Rosenfeld 2000; Privalsky 2001).  
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1.3.2 Corepressor  function and regulation 
In contrast to mediator or coactivator complexes, corepressor complexes interfere with the 
transcriptional initiation (Muscat et al. 1998; Wong and Privalsky 1998). These recruit histone 
deacetylases to the targeted promoter which mediate local chromatin structural changes and 
inhibit transcription (Nagai et al. 1990; Heinzel et al. 1997; Nagy et al. 1997). Guenther and 
coworkers reported that SMRT and N-CoR do not serve merely as platforms for HDAC 
recruitment. Both correpressors are able through their SANT domain to activate HDAC3 
(Guenther et al. 2001) and enhance repression by increasing the affinity of HDAC3 enzyme 
for histone substrate (Yu et al. 2003).  Recent studies emphasize the importance of the 
activation state of transcriptional coregulators which is altered by posttranscriptional 
modifications. DNA binding affinity, transcriptional activity and stability of transcription factors 
have been reported to be regulated by modifications such as acetylation (reviewed in 
(Minucci and Pelicci 2006)) or SUMOylation (reviewed in (Girdwood et al. 2004)) among 
other modifications. Transcription factor II B was shown to associate physically with N-CoR 
and the interaction resulted in the inhibition of transcription initiation (Muscat et al. 1998). 
Later, TFIIB was described to required autoacetyltransferase activity for full transcriptional 
activation (Choi et al. 2003). Although the direct link between N-CoR dependent deacetylase 
activity and the inhibition of TFIIB remains to be determined these data suggest that N-CoR 
may be involved in the regulation of the basal Pol II transcription machinery. These 
observations suggest that corepressors repressive activity may no be limited to mediate 
transcription repression through deacetylation of histone amino tails. It is likely that some of 
the corepressor complex-associated deacetylases are able to catalyze deacetylation of 
nonhistone proteins thereby contributing to the regulation of either corepressor complex-
associated proteins and/or other factors that bind to the promoter region.  
Recent publications report that a number of transcription regulators are SUMOylated and that 
this modification correlates in most cases with inhibition of the transcription. Histones, 
nuclear receptors, basal transcription factors and histone deacetylases have been reported 
to be substrates of SUMOylation. However, the exact mechanism by which the reversible 
covalent SUMO modification represses transcription remains unclear. Multiple mechanisms 
have been suggested in accordance with recent data (reviewed in (Gill 2005)). First, SUMO 
might compete with other posttranslational modifications (ubiquitination, acetylation) for 
substrate lysines. Consequently, SUMOylation might inhibit the interaction of the 
SUMOylated substrate with other binding partners, proteins or DNA, that are dependent on 
either an unmodified or an alternatively modified lysine. Second, modification by SUMO 
might induce critical conformational changes in important regulators of transcription. Third, 
covalent attachment of the SUMO polypeptide might confer new interactions, even 
independent of a conformational change in the substrate. In addition, increasing evidence Introduction 
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suggests that a complex crosstalk between acetylation and SUMOylation might be important 
for the regulated expression of many genes (reviewed in (Gill 2005)). SUMOylation enzymes 
have been newly described to interact and modify N-CoR (Tiefenbach et al. 2006) 
suggesting that these recently discovered enzymes (Okuma et al. 1999) may be an 
additional subunit of the corepressor complex. However, the direct link between 
SUMOylation enzymes recruited by N-CoR and SUMOylated substrates has not yet been 
determined. Although the repressive capacity of N-CoR/SMRT is mainly due to the 
recruitment of HDACs and the deacetylation of histones, other posttranslational modifying 
enzymes such as SUMO ligases and nonhistone deacetylases which can associate with the 
corepressor complexes and modulate the activity of transcription factors may also be 
involved.  
Corepressors N-CoR and SMRT are paralogous products of a gene duplication event that 
occurred prior to the vertebrate evolutionary radiation. They are encoded by two distinct loci 
but share a common molecular architecture and approximately 45% amino acid identity. 
Since they share high structural homology and the complexes they form display analogous 
composition with only modest exceptions both utilize related modes of receptor interaction 
and transcriptional repression. Despite these similarities, a number of functional distinctions 
have been defined between N-CoR and SMRT. These two corepressors display different 
affinities for the different nuclear receptors. Additional differences have been detected in 
studies of their posttranslational modifications. Phosphorylation of SMRT in response to MAP 
kinase signaling leads to the dissociation of SMRT from its nuclear receptor partners and to 
its nuclear export; this is not true for N-CoR (Hong and Privalsky 2000). Conversely, Akt 
signaling can phosphorylate N-CoR directly resulting in nuclear export whereas the same 
domain of SMRT is not subject to this regulation (Hermanson et al. 2002). Important 
differences also exist between N-CoR and SMRT at the end of their lifespan. N-CoR 
interacts with RING protein Siah2 and is targeted for proteasomal degradation, whereas 
SMRT appears to be refractory to this form of regulation (Zhang et al. 1998). N-CoR and 
SMRT are differentially expressed in different tissues and at different times in development. 
This indicates that they are functionally distinct and the splicing variants they display further 
diversify the functional properties of these corepressors (reviewed in (Goodson et al. 2005)).  
1.3.3  Structure and function of corepressor domains  
N-CoR and SMRT are both ~270kDa in size, these large molecules can be divided into a C-
terminal half that interacts with nuclear receptors and a N-terminal half that transmits the 
repression signal to the basal machinery and to chromatin. The corepressor complex 
consists of 10-12 associated proteins considered as integral subunits. Docking surfaces are 
principally located in the N-terminal and central regions. The corepressor core complex Introduction 
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includes histone deacetylases and other components that may serve as scaffolds, assist in 
substrat recognition, or regulate corepressor function. The WD-40 protein TBL1 (transducin-
like protein and TBL1 related protein (TBL1-R) complex with N-CoR and SMRT and by 
making additional contacts with HDAC3, stabilize the quaternary structure of the corepressor 
assembly (Yoon et al. 2003). These factors also bind to histones H2B and H4 which may 
help in the chromatin substrate recognition. The G protein pathway suppressor 2 (GPS2) is 
another member of the corepressor complex which interacts with TBL1 and N-CoR (Zhang et 
al. 2002). As TBL1, GPS2 is a component of the G protein-coupled signal transduction 
pathways and may play additional roles as a regulator that couples signal transduction to 
transcriptional repression. The class I deacetylase HDAC3 and class II HDACs (HDAC4, 5 
and 7) interact directly with N-CoR and SMRT (Li et al. 2000; Fischle et al. 2002) whereas 
HDAC1 and HDAC2, integral subunits of the mSin3 complex (Hassig et al. 1997), may 
associate indirectly. Although N-CoR/SMRT does not appear to be stably associated with the 
mSin3 complex, mSin3 and the SAP30 subunit interact with SMRT and N-CoR directly 
(Heinzel et al. 1997; Nagy et al. 1997; Laherty et al. 1998). Since the Sin3/HDAC complex 
lacks any DNA-binding activity, it must be targeted to gene promoters by interacting with 
DNA-binding proteins and is an important corepressor for many nonreceptor transcription 
factors (Laherty et al. 1997). It is thought that N-CoR/SMRT may serve as an adapter 
molecule between the core mSin3 complex and sequence-specific transcriptional repressors 
such as unliganded nuclear receptors. All previously discussed cofactors mainly interact in 
the regions determined as repression domains (RDs). The overall architectures of the N-CoR 
and SMRT proteins are similar. Depited in (Fig. 7), the detailed domain organization specific 
to N-CoR. 
 
 
 
 
 
 
Figure 7: Domain organization in the corepressor N-CoR  
Three repression domains (RD I, II and III) are contained in the amino-terminal half of N-CoR as is the 
SANT domain (SWI3, ADA2, N-CoR and TFIIIB). Two interacting domains with mSin3 (SID I and II) 
have been identified at the amino-terminus as well as at the carboxy-terminus. The nuclear receptors 
interaction domain (NID) is located at the carboxy-terminus and contains 3 CoRNR motifs in N-CoR. 
At the extreme C-terminus the lysine-serine-aspartic acid (LSD) motif which was determined to be 
essential for the interaction between SMRT and Sharp is also found in N-CoR. Introduction 
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Between the first and second repression domain a conserved SANT (SWI3, ADA2, N-CoR, 
and TFIIIB) domain is found (Aasland et al. 1996). This motif is found in a number of 
chromatin remodeling factors. It consists of two 50-amino acid motifs named SANT1 and 
SANT2. The N-CoR and SMRT SANT1 domain are part of the HDAC3 activating domain 
(DAD) (Guenther et al. 2001) and it is also involved in the interaction with the SUMO 
conjugating enzyme UBc9 and the SUMO ligase Pias1 (Tiefenbach 2003 August). The 
SANT2 domain functions as a histone interaction domain (Yu et al. 2003). SMRT and N-CoR 
bind to nuclear receptors, through the set of C-terminal “CoRNR box” motifs (or L-X-X-I/H-I-
X-X-X-L/I) (Hu and Lazar 1999; Perissi et al. 1999). The CoRNR motif forms an extended α-
helical domain compared to the coactivator nuclear receptor binding motif (L-X-X-L-L) 
(McKenna et al. 1999). Corepressor binding motifs dock into a complementary groove 
formed by helices 4/5/6 in the ligand binding domain of nuclear receptors (Xu and Lambert 
2003) (Fig. 5). Dissociation of corepressor from the nuclear receptor is induced upon agonist 
binding resulting in conformational changes of the ligand binding domain and the occlusion of 
the corepressor docking surface by the reorientation of the NR helix 12. For the corepressor 
SMRT, Sharp (SMRT/HDAC1 Associated repressor) was determined as a new interacting 
protein and was determined as a potent transcriptional repressor whose repression domain 
(RD) interacts directly with SMRT and at least five members of the NuRD (nucleosome 
remodeling and histone deacetylation) complex including HDAC1 and HDAC2 (Zhang et al. 
1998; Wade et al. 1999). A conserved LSD motif upstream of the last amino acid residue in 
SMRT was demonstrated to be necessary for the interaction between Sharp and the 
corepressor (Shi et al. 2001). According to the sequence analysis of N-CoR and SMRT, the 
high degree of homology observed at the extreme carboxy-terminal end of the proteins 
indicates that this domain is conserved because of its biological function. Although it is likely 
that this domain has a specific function it was not elucidated for N-CoR. Hörlein and 
coworkers could show that this domain is not required for the repression activity of N-CoR 
and contains no inherent repression activity. This finding and other observations promoted 
me to further investigate the function of the N-CoR extreme C-terminus.  
1.4 Aims  of  the Ph.D Thesis 
The C-terminal region of N-CoR and SMRT is located adjacent to the nuclear receptor 
interacting domain. Since this domain, according to its function, is at the surface of the 
protein it was assumed that the adjacent carboxy-terminal region would rather be exposed to 
the environment than buried in the molecule. Moreover, protease degradation analysis of N-
CoR (Fletterick, R personal communication) suggested that the C-terminal region constitutes 
a functional domain. Furthermore, by homology to platform molecules that contain a 
succession of either functional and/or interacting domains it was postulated that this region is Introduction 
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involved in protein-protein interactions. Indeed, several proteins were identified in a yeast-
two-hybrid screen which could interact with the extreme C-terminal domain of N-CoR (aa: 
2290-2453) (Ducasse 2002). The set of putative interaction partners that interact directly with 
N-CoR in in vitro binding assays were further investigated during my thesis.  
The aim of my Ph.D thesis was to characterize the function of the C-terminus of N-CoR. At 
first, interaction of potential candidates with endogenous N-CoR had to be confirmed in co-
immunoprecipitation experiments and to be verified by confocal microscopy. Subsequently, 
the molecular mechanisms had to be characterized and functional assays had to conducted. 
Furthermore, the effect of the down-regulation of endogenous interaction partners had to be 
analyzed. Therefore, generation of specific siRNAs and evaluation of their efficacy in mRNA 
and protein downregulation after transfection had to be performed. In parallel, the N-CoR 
binding domains in interacting proteins had to be characterized, generating GST-fusion 
proteins and performing pulldown assays. Thereafter, deletions mutants could be generated 
and tested in reporter assays. Effects of the mutants on the repression capacity of N-CoR 
had then to be compared to those obtained with the wild type protein. Finally, a model of the 
potential molecular mechanisms had to be established supporting the biological relevance of 
the interaction of the N-CoR C-terminus with the novel identified partner.  
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2  Materials and Methods 
If not mentioned otherwise, molecular biological methods were used according to Sambrook 
et al. or Ausubel et al. and modified when necessary.  
2.1 General  molecular  biology  techniques 
2.1.1  Analytic and preparative isolation of nucleic acids (DNA/ RNA) 
DNA isolation on anion exchange resin 
DNA Plasmids are generally amplified in bacteria. Since these vectors contain a antibiotic 
resistance gene, they are amplified in transformed bacteria grown under selection pressure 
in media containing corresponding antibiotics. In the first step bacterial chromosomal DNA 
and proteins are separated from the plasmid DNA. Plasmid DNA is isolated from E. coli 
DH10ß cells using different commercially available kits, depending on the DNA amount 
needed. For small amounts up to 20 µg the NucleoleoSpin Plasmid Kit from Macherey-Nagel 
is used (mini preparation). For preparative isolation up to 500 µg the Maxi Kit from Genomed 
is used (maxi preparation). The purification of plasmid DNA from the bacteria is generally 
performed according to the manufacturer's instructions. Briefly, this purification procedure is 
based on alkaline lysis (NaOH-SDS buffer) of the resuspended bacterial cells in the 
presence of RNase A. Neutralization with potassium acetate causes precipitation of SDS, 
thereby forming large complexes containing denatured proteins, chromosomal DNA, and 
cellular debris, while plasmid DNA remains in solution. After clearing the lysate by 
centrifugation, the plasmid DNA is immobilized on a resin matrix (anion exchange resin), 
washed and eluted (high salt concentration). For large scale isolations the plasmid DNA is 
finally precipitated by adding 0.7 volumes of isopropanol to the eluate and centrifuging 20 
min at 12000 g and 4°C. The DNA pellet is washed with 5 ml 70% ethanol and centrifugated 
for 5 more minutes. Plasmid DNA is air-dried and dissolved in sterile, deionized water (200-
500 µl/maxi).(Shapiro 1981) 
DNA Ethanol precipitation 
Ethanol precipitation enables isolation of plasmid DNA from enzymatic reactions (digestion, 
dephosphorylation or PCR reaction). 2.5 times of the volume of the DNA solution of ice-cold 
100% ethanol and 1/10 3 M sodium acetate are added to the DNA sample. Mixture is 
vortexed for 1 min and centrifuged in a cold microfuge (4°C). Afterwards, the pellet is washed 
with 70% ethanol centrifuged 5 min at 13,000 rpm and air-dried. It is then dissolved in an 
appropriate volume of H2O (10-20 µl). 
DNA gel extraction 
After separation of the DNA on a 1% agarose gel, the fragment of interest is cut out with a 
scalpel (minimize surrounding agarose) and the extraction is performed with gel extraction kit 
(Pec-Lab Erlangen) according to the manufacturer’s protocol. Briefly, this procedure involves  Materials  and  Methods 
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the melting of the agarose gel slice followed by separation of the DNA from contaminants 
using spin columns containing a silica-gel membrane. Whereas the DNA fragments adsorb to 
this silica-gel membrane at high salt concentration, contaminants such as agarose, dyes, and 
ethidium bromide stay in the supernatant. DNA fragments are finally eluted with water and 
either directly used in ligation reactions or stored at -20°C. 
RNA Isolation 
To analyze endogenous gene expression, mRNA or total RNA is isolated from cells. 
Expression of target gene is analyzed by quantifying target mRNA by semi quantitative PCR 
or real time PCR. For RNA purification, cells are first lysed and then homogenized through 
QIAshredder spin columns (Qiagen). Ethanol is added to the lysate to provide ideal binding 
conditions. Afterwards, the lysate is loaded onto the RNeasy silica-gel membrane. After the 
adsorption of the RNA all contaminants are efficiently washed away. The pure and 
concentrated RNA is eluted with water.  
Protocol: 
1.  Harvest cells (2x10
6 cells /10 cm dish are splitted 48 h before), 
trypsinize and centrifuge 3000 g/ 5min 
2.  Lyse cells with 600 µl lyse buffer RTL (add fresh ß-
mercaptoethanol, 10 µl/ml), vortex 
3.  Homogenize sample through QIAshredder spin column 
4.  Add same volume of 70% ethanol to lysate 
5.  Load mixture onto the RNeasy column centrifuge quickly 
6.  Proceed to DNase I digestion on the column 
7.  Wash twice with 500 µl RPE buffer centrifuge 15 s at 8000 g 
8.  Dry silica-gel membrane by centrifuging 2 min at 8000 g 
9.  Elute RNA with 50 µl with RNase free-water 
10 µl of sample are kept for RNA concentration determination and FA gel electrophoresis. 
The rest is stored at -80°C. 
RNeasy Mini Kit  Isolation of RNA from cells or tissues lysates  Qiagen  
RNAsin Ribonuclease Inhibitor  Inhibition of RNAses  Promega 
QIAshredder spin columns  Homogenization of cell and tissue lysates  Qiagen  
DNase RNase free DNase Set  Efficient on-column digestion of DNA  Qiagen  
 
2.1.2  Determination of DNA and RNA concentration 
Determination of DNA concentration 
To measure DNA concentrations, purified plasmid preparations are diluted 100-fold in dH2O 
and transferred into a quartz cuvette. The absorption measured at 260 nm in a 
spectrophotometer (WPA S2000) enables determination of the DNA concentration. The 
absorption of 1.0 at λ = 260 nm corresponds to a concentration of 50 µg/ml. The ratio of the 
absorptions measured at 260 nm and 280 nm indicates the quality of the DNA isolation. A 
value between 1.7 and 2.0 indicates a good quality. 
Abs. (260 nm) x DNA extinction coefficient (50 ds DNA) x dilution factor   = DNA concentration in µg/ml 
  Materials  and  Methods 
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Determination of RNA concentration 
The concentration is determined at two different dilutions (1:100 and 1:66) by 
spectrophotometry. The absorption measured at 260 nm in a spectrophotometer (WPA 
S2000) enables the determination of RNA concentration considering that an optical density 
of 1.0 at λ 260nm corresponds to a concentration of 40 µg/ml (Sambrook, 1989). The quality 
of the RNA isolation is related by the ratio 260 nm/280 nm. A value between 1.7 and 2.0 
indicates a good quality. The integrity of the total RNA isolation can also be assessed by 
electrophoresis followed by staining with ethidium bromide (see RNA formaldehyde agarose 
gel electrophoresis). 
Abs. (260 nm) x RNA extinction coefficient (40 for RNA) x dilution factor  = RNA concentration in µg/ml 
2.1.3  DNA and RNA electrophoretic analysis  
Nucleotide acids can be separated and quantified by agarose gel electrophoresis. This 
method is used during the procedure of cloning to isolate a fragment amplified by PCR, to 
isolate an insert or a vector after digestion, to check the isolated plasmid for its correct size, 
to control DNA quality and to compare DNA concentrations. In addition this method is also 
used to visualize semi quantitative PCR products or to control the quality of total RNA 
isolations. 
DNA agarose gel electrophoresis 
DNA fragments are separated by gel electrophoresis in agarose gels of 1-1.5% (w/v). 
Electrophoresis is performed at 8 V/cm gel length with TAE running buffer. To visualize DNA 
under UV light, ethidium bromide is added to the melted gel (3 µl/100 ml Gel) before pouring 
it in a suitable chamber (Mini Sub
R cellGT Biorad). The addition of ethidium bromide permits 
quantitative and qualitative detection of DNA at a wavelength λ = 360nm, because ethidium 
bromide is fluorescent at this wavelength only when it is intercalated into the DNA backbone 
(Helling et al. 1974). 5 µl DNA ladder is used to verify the length of the and to estimate DNA 
concentration. 
TAE buffer (1x)  40 mM Tris-HCl; 1 mM EDTA; adjusted to pH 8.0 with acetic acid 
DNA loading buffer (6x)  0.25% bromophenolblue (w/v); 0.25% xylenecyanol (w/v); 15% Ficoll 
DNA molecular weight marker  Smart DNA ladder 10 kbp-200 bp(Eurogentec)  
RNA formaldehyde agarose gel electrophoresis 
Ribosomal RNA (rRNA) comprises over 80% of total RNA sample in contrary to mRNA 
comprising only 1 to 3%. The major species, in mammalian system, are the 28S and 18S 
ribosomal subunits which quality and quantity is assumed to reflect that of the underlying 
mRNA population. However, these rRNAs are more abundant and stable than the mRNA, 
which turns over much more rapidly. 
The integrity of the total RNA isolation is controlled by formaldehyde agarose gel 
electrophoresis followed by staining with ethidium bromide. Two bands appear on the 
denaturing gel corresponding to the 28S rRNA and 18S rRNA that are both contained in the  Materials  and  Methods 
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isolate. The ratio 2:1 and sharpness of the bands are considered and compared to 
concentration and ratio. If notable degradation appears, the complete RNA isolation is 
renewed. 
5 µl of sample are used to perform this control. 1 volume 5x RNA loading buffer is added to 4 
volumes of RNA sample (5 µl loading buffer + 5 µl RNA + 15 µl RNase free-water) and is 
incubated for 3-5 min at 65°C, subsequently chilled on ice and loaded onto an equilibrated 
FA gel.  
Formaldehyde agarose gel preparation 
1.2 g agarose (RNase free) 
10 ml 10x FA gel buffer  1.2% FA gel 
Add RNase-free water to 100ml 
The mixture is heated in order to melt the agarose and cooled in water bad before adding 1.8 
ml of 37% (12.3 M) formaldehyde and 1 µl of a 10 mg/ml ethidiumbromide stock solution. 
Prior to running, the gel is equilibrated in 1xFA gel running buffer for 30 min. Gel is run at 5 
V/cm. 
Buffers and solutions 
200 mM 3-[N-morpholino]propanesulfonic acid (MOPS) 
50 mM sodium acetate 
10 mM EDTA 
10 X FA gel buffer 
pH to 7.0 with NaOH 
 
100 ml 10x FA gel buffer 
20 ml 37% (12,3 M) formaldehyde 
running buffer 
1X FA gel 
880 ml RNase -free water 
 
RNase free water  0,1 % DEPC (diethyl pyrocarbonate) in water, 
incubated 12 h at 37°C and autoclaved before use  
 
16 µl saturated aqueous bromophenol blue 
80 µl 0,5 M EDTA, pH 8,0 
720 µl 37% (12,3 M) formaldehyde 
2 ml 100% glycerol 
3084 µl formamide 
4 ml 10x FA gel buffer 
loading buffer  
5x RNA  
RNase -free water added to 10 ml 
 
2.1.4  DNA enzymatic analysis and modifications 
DNA Control digestion 
Generally, 5 units /µg DNA of restriction enzyme are used for the cleavage of plasmid DNA. 
Restriction enzyme digestion is carried out in the supplied restriction buffer and, if 
recommended by the manufacturer, 10% BSA are added depending on the enzyme used 
(New England Biolabs, Schwalbach or Fermentas). To avoid unspecific enzymatic cleavage, 
it has to be ensured that the reaction mixtures contained less than 5% glycerin. For control 
digestion, enzymatic reaction is usually performed for 2-3 h at 37°C. Reactions are stopped 
by adding DNA loading buffer and loading the whole sample on an agarose gel. (Roberts. 
1996)  Materials  and  Methods 
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DNA preparation for cloning 
PCR products are either precipitated with ethanol or extracted from an agarose gel before 
digestion. When the restriction enzymes are compatible, the insert is directly double digested 
overnight, if not the digestions are preformed sequentially. 5-10 µg of vector for cloning are 
prepared in parallel with the appropriate amount of enzyme. 
Enzymes  New England BioLabs or Fermentas 
 
DNA dephosphorylation 
To minimized self ligation events, the digested vector is dephosphorylated. The calf alkaline 
phosphatase (CIP, New England BioLabs) is used to catalyze the removal of 5`dephosphate 
groups from the linearized vector. After 1 h incubation at 37°C, enzyme deactivation is 
achieved by heating the sample for 20 min at 85°C. The dephosphorylated vector is then 
precipitated with ethanol and resuspended in H2O. The concentration of the vector that is 
now ready for ligation is estimated by loading some µl of the sample onto an agarose gel. A 
DNA ladder that allows quantification by optical comparison of the bands is loaded together 
with the sample onto the gel.  
Ligation of DNA fragments 
Ligation of a DNA fragment into the backbone of a vector of choice is catalyzed by the T4 
DNA-ligase. Insert and vector have to contain compatible restriction sites. The T4 DNA ligase 
catalyzes phosphodiester bounds formation between the nucleotide 5’phosphates of the 
insert and the nucleotide 3’OH groups of the vector. The best ratio of vector and insert for 
ligation was calculated with the following formula: 
Insert (ng) = Vector (ng) x (Insert length (bp) / Vector length (bp)) 
The insert and 20-200 ng vector are mixed in a 20 µl volume reaction containing the ligation 
buffer supplied with the ligase enzyme and 2 units T4 DNA ligase (Fermentas). The ligation 
reaction is incubated for 2 h at 22°C or alternatively overnight at 16°C. Deactivation of the T4 
DNA ligase is obtained by heating the sample at 65°C for 10 min. 1-8 µl of the ligation 
reaction are used for transformation of 50-100 µl of an electrocompetent DH10ß E.coli strain. 
For blunt end ligation, 50% PEG 4000 and 4U T4 DNA ligase are required additionally. 
DNA recombination 
The Gateway® Cloning Technology (Invitrogen) is based on site-specific recombinations of 
the phage lambda. The reaction is specific and directional, enabling DNA transfer between 
different cloning vectors, while maintaining orientation and reading frame. This method 
effectively replaces the use of restriction endonucleases and ligase, since excision and 
integration take place in the same reaction. The advantage of this method is that it is 
possible to transfer a sequence from one vector backbone to another time efficiently. The 
sequence of interest has first to be inserted in an Entry vector by classical cloning or by 
recombination of a PCR product flanked by two recombination sites. Transfer of the gene in 
a destination vector is then achieved by recombination. Entry vectors are transcriptionally 
silent, contain a kanamycin resistance gene, and are flanked by two recombination sites  Materials  and  Methods 
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(attL1 and attL2), whereas Destination vectors contain all the sequence information required 
for expression, an ampicillin resistance gene and two recombination sites (attR1 and attR2). 
All plasmid recombination sites flank a gene for negative selection, ccdB. Att1 and att2 sites 
confer directionality and specificity for recombination, so that only attL1 will react with attR1, 
and attL2 with attR2. LR Clonase™ reaction enables excision and insertion of the two sites 
and thereby exchanging DNA sequences flanked by the restriction sites. Selecting for 
ampicillin resistance eliminates the starting vector and the by-product. The presence of the 
negative selection marker ensures elimination of vectors that have not been recombined 
during the reaction.  
Protocol 
LR clonase
TM Reaction Buffer  5 µl 
Destination vector (linearized)*  300 ng 
Entry clone  100 ng 
LR Clonase
TM Enzyme Mix  4 µl 
Add water to final volume  20 µl 
* linearize the Destination vector within the attR cassette avoiding the ccdB gene. 
1.  Mix and incubate for one hour at 25°C 
2.  Add proteinase K solution and incubate 10 min. at 37°C 
3.  Transform competent DH10ß; 1 µl per 30 µl cells 
4.  Grow for one hour and select on appropriate LB AMP plate 
To verify successful cloning control digestion is performed with Bsp1407I (BstBI) which have 
restriction sites in the recombination boxes (att Boxes). 
2.1.5  DNA and cDNA amplification by poly-chain reaction 
Polymerase chain reaction (PCR) 
The amplification of DNA fragments is performed in a GeneAmp 9600 thermocycler (Perkin-
Elmer). Amplification reactions are set in a final volume of 50 µl in a 200 µl reaction tube, 
containing 2.5 units Pfx platinum DNA polymerase (Invitrogen), 20-100 ng of template DNA, 
200 µM of each deoxyribonucleotides (dATP, dCTP, dTTP and dGTP), 50 µM MgSO4) the 
corresponding polymerase reaction buffer (1x), and 0.5 µM of both oligonucleotide primers. 
The reaction mixtures are prepared on ice. Samples are set in a PCR machine that is 
programmed as shown below: 
Cycle Temperature  Time 
1X 94°C  3  min 
94°C 30  sec 
(Tm-2)°C 30  sec  35x 
68°C 1  min/kbp 
1X 68°C  10  min 
  4°C unlimited 
The lid is heated to 110°C in order to avoid evaporation of the samples. Before proceeding to 
cycling, the DNA template is completely denaturated for 3 min at 94°C. Depending on the 
primers that are used in the PCR, annealing temperature has to be adapted usually to a  Materials  and  Methods 
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temperature 2°C below the primer melting temperature (Tm). Elongation step is executed at 
68°C, which is the optimal catalytic temperature for the Pfx platinum DNA polymerase. This 
polymerase processes 1 kb per minute and the elongation time has to be adapted according 
to the length of the PCR product. Amplified DNA fragments are checked (4 µl from PCR 
reaction) by agarose gel electrophoresis. Before digestion, amplification products are 
isolated from PCR reaction by ethanol precipitation and resuspended in 20 µl of water. DNA 
can be stored at -20°C. 
Semi-quantitative PCR  
As a template for semi-quantitative PCR 1 µl of 1:40 diluted cDNA obtained by reverse 
transcription (RT PCR, see below) is used. The total volume of reaction is 25 µl (200 µl 
reaction tubes, Sarstedt). The conditions for the reaction are the same as for a PCR reaction 
(see above). Elongation time is 30 seconds because all the fragment lengths are smaller 
then 500 bp. The number of cycles has to be adapted to signal intensity and cDNA dilution. 
E.g., for the house keeping gene 18S 20-25 cycles are sufficient whereas GAPDH requires 
33 PCR cycles.  
Reverse transcription (RT-PCR) 
To generate cDNA from an RNA template First-Strand cDNA Synthesis Kit (Amersham 
Bioscience) is used. This enables the reverse transcription of RNA into cDNA with random 
primer pd(N)6. 0.5µg total RNA isolate are used in 15 µl final volume of first strand reaction. 
The resulting double-strand RNA-cDNA heteroduplex is directly used for amplification by 
PCR. cDNA samples are stored at -80°C. 
Protocol 
1.  RNA sample is brought to the final volume of 8 µl 
Incubated 10 min at 65°C 
2.  5 µl Bulk first-strand reaction mix 
3.  1 µl DTT(from 200 mM solution) 
4.  1 µl pd(N6 (1:10 dilute 0,02 µg) 
5.  Incubate 37°C 1 h 
6.  Store at -80°C 
1 µl of a 1:40 dilution of cDNA reaction is added to 25 µl PCR reaction. 
Site directed mutagenesis 
Using site-directed mutagenesis, the DNA sequence in genetic material can be changed. 
Two synthetic DNA oligonucleotides containing the desired mutation and annealing to the 
same DNA sequence on opposite strands of the plasmid are required for the reaction. 
Amplification of the plasmid with mutated primers permits deletion, insertion or point mutation 
in the plasmid DNA sequence. This reprogrammed DNA molecule can direct the synthesis of 
a protein with an exchanged, deleted or inserted amino acid or can present an additional 
restriction site at a determined position in its sequence. This method is composed of two 
essential steps. In the first step the template with an integrated point mutation is amplified, 
during the second step the non-mutated parental DNA template is destroyed.  
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Complementary oligonucleotides of 25-45 bp length containing the desired mutation flanked 
by unmodified nucleotides sequence (10-15 nucleatides on both sides) are designed and 
synthesized. This primer pair is used for the mutant strand synthesis by PCR with the 
PfuTurbo DNA polymerase (Stratagene). Cycling reaction is followed by DpnI digestion, 
which cleaves methylated and hemimethylated DNA strands only, thereby digesting the 
parental DNA template. Bacteria are transformed and afterwards screened for positive 
clones. 
Mutant strand synthesis  
5-50 ng plasmid template DNA 
1x mutagenesis buffer in a final volume of 50 µl in H2O  
(20 mM Tris HCl, pH 8.8, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM 
MgSO4, 0.1% triton X-100, 0.1 mg/ml BSA) 
125 ng of each primer 
250 µM each dNTP,  
2.5 U PfuTurbo DNA polymerase, (Stratagene) 
For the PCR conditions primer melting temperature and vector length are used to determine 
the temperature of hybridization and the duration of the elongation step while cycle number is 
used as indicated in the manufacturer’s protocol for a single site mutation. DpnI digestion is 
performed by adding 10 U DpnI to the amplification reaction and incubating at 37°C for 1 h. 
One 1 µl of DpnI- treated DNA is used afterwards for transformation. 
QuikChange
® Multi Site-Directed Mutagenesis Kit  Stratagene 
 
2.1.6  pSuper RNAi system 
In several organisms, the introduction of double-stranded RNA has proven to be a powerful 
tool to suppress gene expression through a process known as RNA interference (Sharp. 
1999). However, high production costs limit the utility of this technology. Additionally, RNA 
interference provokes in most mammalian cells a strong cytotoxic response. Recently, 
several DNA-based plasmid vectors have been developed that direct transcription of small 
hairpin RNAs, which are processed into functional siRNAs (small interfering RNAs) by 
cellular enzymes. Therefore the pSuper RNAi System (Invitrogen) can be used to cause 
efficient and specific down-regulation of gene expression (4, Brummelkamp, R. Bernards, 
and R Agami, Science 296, 550 (2002)), resulting in functional inactivation of the targeted 
genes. The pSuper DNA plasmid provides a mammalian expression vector that directs 
intracellular synthesis of siRNA-like transcripts. The vector uses the polymerase-III H1-RNA 
gene promoter, as it produces a small RNA transcript lacking a polyadenosine tail and has a 
well-defined start of transcription and a termination signal consisting of five thymidines in a 
row (T5). Most importantly, the cleavage of the transcript at the termination site is after the 
second uridine, yielding a transcript resembling the ends of synthetic siRNAs, which also 
contain two 3’ overhanging T or U nucleotides (nt).  
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Design of oligonucleotides 
To ensure the silencing of a specific gene, the pSuper vector is used in combination with a 
pair of custom oligonucleotides that contain, among other features, a unique 19-nt sequence 
derived from the mRNA transcript of the gene targeted for suppression (the “N-19 target 
sequence”). The N-19 target sequence corresponds to the sense strand of the pSuper-
generated siRNA, which in turn corresponds to a 19-nt sequence within the mRNA. In the 
mechanism of RNAi, the antisense strand of the siRNA duplex hybridizes to this region of the 
mRNA to mediate cleavage of the molecule. These forward and reverse oligonucleotides are 
annealed and have to be cloned into the vector, between the unique BglII and HindIII 
enzyme sites positioned downstream from the H1 promoter’s TATA box to generate the 
desired siRNA duplex. The forward and reverse oligonucleotides are synthesized with BglII 
and HindIII overhangs at their 5’ ends respectively, therefore no digestion is required prior to 
cloning. To enable more efficiently the screening of positive clones the 5’ BglII overhang of 
the forward oligonucleotide contains a point mutation that destroys the BglII palindrome upon 
ligation. The sequence of the oligonucleotide includes the unique N-19 target in both sense 
and antisense orientation, separated by a 9-nt spacer sequence. The resulting transcript of 
the recombinant vector is predicted to fold back on itself to form a 19-base pair stem-loop 
structure. Analysis indicates that the stem-loop precursor transcript is quickly cleaved in the 
cell to produce a functional siRNA. General steps for cloning oligonucleotides in the double 
digested (BglII and HindIII) pSuper vector: 
1.  Anneal the forward and reverse strands of the oligos that contain the siRNA-expressing 
sequence targeting your gene of interest 
2.  Linearize the pSuper vector with BglII and HindIII  and dephosphorylate with CIP 
3.  Clone the annealed oligos into the vector 
4.  Transform the vector in bacteria 
5.  Transfect pSuper vector into mammalian cells 
Oligonucleotides protocol 
64 mers oligonucleotides are annealed and phosphorylated before ligation into pSuper. 
Complementary oligos are dissolved in water to a final concentration 1 mM. For annealing 1 
µl of each oligos is used in 48 µl annealing buffer, incubated 4 min in 95°C and slowly cooled 
down. This is achieved by incubating the annealing reaction in a recipient field with boiling 
water and allowing to cool down to room temperature. Samples can be frozen at -20°C. 
Synthesized oligos do not contain any phosphate at their 5’ ends; therefore, they have to be 
phosphorylated. 2 µl of annealing reaction are mixed in a 10 µl volume reaction containing 
the PNK buffer, 1 mM ATP supplied with the T4 polynucleotide kinase (PNK) (NEB). This 
enzyme catalyzes the transfer and exchange of Pi from the γ position of ATP to the 5´-
hydroxyl terminus of polynucleotides (double-and single-stranded DNA and RNA). After 30 
min at 37°C T4 PNK is inactivated by heating 10 min at 70°C. 2 µl of annealed and 
phosphorylated oligos are added to 200 ng pSuper for ligation. 
Annealing buffer  100 mM potassium acetate, 30mM HEPES-KOH pH 7.4, 2 mM Mg-acetate 
 
T4 polynucleotide kinase  New England Biolabs 
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2.1.7  DNA sequence analysis 
The DNA sample was sequenced in an ABI377 sequencing machine. The used sequencing 
primers are marked with fluorescent dyes (‘dye primer chemistry’). The sequencing was done 
by the in-house institute service. 
Gene banks existing sequences were used for primers design and to compare clone 
sequences. Sequence information is investigated via internet with BLASTN (comparison of 
the nucleotide sequence with the nucleotide sequence database) and BLASTX (comparison 
with the nucleotide sequence in all the reading frames with the protein sequence database, 
National Center for Biotechnology Information /NCBI http://www.ncbi.nlm.nih.gov/blast/blast.cgi). 
Information concerning amino acid sequences, protein domains and their secondary / tertiary 
structure was also obtained from protein databases. (Brookhaven Protein Data Bank/ PDB, 
http://www.rcsb.org/pdb/; SwissProt. http://www.expasy.ch/sprot/) 
2.2 Cloning  strategies,  primers and plasmids 
2.2.1  Primers used for cloning 
Cloning of the different N-CoR interaction partners out of the YTH screen 
Except for the ESET protein for which the mammalian expression plasmid was sent by Liu 
Yang, specific primers were designed and synthesised (Thermohybaid) for MBD3, CtBP and 
NonO protein. Full-length coding sequences were amplified by PCR for MBD3 and NonO 
from NIH 3T3 (mouse fibroblasts) total cDNA and CtBP from a plasmid sent by Criqui Filipe. 
Primers used for CtBP and MBD3 are listed in the following table: 
CGGGAATTCAATGGGCAGCTCCAAC  CtBP Fw ATG (EcoRI) 
AAAGATATCCAACTGGTCACTCGTATGGTC  CtBP Rev no STOP 
(EcoRV) 
CtBP, C-terminal 
binding protein 
GGGGACAAGTTTGTACAAAAAAGCAGGCTG- 
GAGGGCCACAATGGAGCGGAAGAGGTGGG 
MBD3 FW recombination 
box for GATEWAY 
ACCACTTTGTACAAGAAAGCTGGGTC- 
CACTCGCTCTGGCTCCGGCT 
MBD3 Rev recombination 
box for GATEWAY 
MBD3 
PCR amplified sequences are digested and isolated before ligation in the appropriate Entry 
vector if primers contained restriction sites. If primers contained recombination box 
sequences the amplificat was directly added to BP reaction containing pDONOR vector.  
NonO constructs FL, RRM 1 and RRM2 deletion mutants  
Gateway cloning system was partially used for the cloning of NonO full-length and deletion 
mutants lacking RRM 1 (deletion of RNA recognition motif 1) or lacking RRM2 (deletion of 
RNA recognition motif 2) in different expression vectors. Full-length coding sequence was 
amplified by PCR out of NIH 3T3 cDNA (mouse fibroblasts) and was inserted into pENTR 2B 
entry vector between recombination boxes by conventional cloning (restriction/ligation). 
Deletion mutants were obtained by digestion of NonO full-length and relegation (blunt end 
restriction endonucleases were chosen that did not shift the coding sequence reading frame). 
RRM1 deletion mutant lacking amino acids 87-160 was obtained by double digestion with 
EcoRV (nucl:258) and BSaAI (nucl:480). RRM2 deletion mutant lacking amino acids 160-227  Materials  and  Methods 
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was obtained by double digestion with BSaAI (nucl:480) and NruI after inserting NruI 
restriction site at the position 681 by site directed mutagenesis.  
The cloning in pENTR 2B enabled transfer of the different constructs in pEF6-DEST 51 and 
pDEST14 expression vectors through recombination. Primers used for NonO full-length 
cloning and NruI mutation: 
CGCGGATCCAAAAATGCAGAGCAATAAAGC  NonO Fw ATG (BamHI) 
GAATTCCATATCGGCGGCGTTTATTTG  NonO Rev (1419) (EcoRI) 
NonO Full-length 
without stop codon 
CTGTGACTGTGTCGCGAATGGACCAGTTAG Fw  mut  NruI (681) 
GACACTGACACAGCGCTTACCTGGTCAATC Rew  mut  NruI (681) 
NonO full-length 
NurI mutated (681) 
Gal DBD fused NonO constucts 
GAL4-DBD fused NonO fusion proteins were obtained by cloning PCR fragments amplified 
with the following primers from pENTR 2B NonO Fl and deletion mutants into pCMX GAL4-
DBD mammalian expression vector. Primers were designed considering reading frame and 
compatible restriction sites. 
GCCTCTGTCGTCGACATGCAGAGCAATAAAGCC  Fw NonO Start (SalI) 
CGAATTCCTAATATCGGCGGCGTTTATTTG  Rev NonO (1419) (EcoRI) 
Gal DBD-NonO 
and 
Deletion mutants 
GST fused NonO constructs 
GST fused NonO proteins or NonO domains were obtained by cloning PCR fragments 
amplified with the following primers from pENTR 2B NonO Fl and deletion mutants into 
pGEX AHK bacterial expression vector. Primers were design considering reading frame and 
compatible restriction sites. 
CGAATTCATGCAGAGCAATAAAGCCTTTAAC  Fw (start) NonO (EcoRI) 
GCTCTAGACTAATATCGGCGGCGTTTATTTG  Rev (1422) NonO (XbaI) 
GST-NonO full-length 
and deletion mutants 
CGCGGATCCATCACTGAGGAGGAAATGAG  Fw (259) RRM1 (BamHI) 
GCGAATTCGTACTGAGGAAGGTTGCGG  Rev (480) RRM1 (EcoRI) 
GST-NonO RRM1 
(aa:87-160) 
CGAATTCATGCAGAGCAATAAAGCCTTTAAC  Fw (start) (EcoRI)  
CCGAATTCTCAGGGTGGCTGTTCTCTCTCC  Rev (771) (EcoRI) 
GST-Nt NonO and 
Deletion mutants 
CGGAATTCCCACCCAGATTTGCACAACC  Fw (766) RRM2 (EcoRI) 
GCTCTAGACTAATATCGGCGGCGTTTATTTG  Rev (1422) NonO (XbaI) 
GST-NonO-Ct 
(aa:255-472) 
 
Synthetized oligonucleotides   Thermo electron corporation
Amplify  Software, allowing the check of designed primers 
2.2.2  Primers used for semi-quantitative PCR analysis 
Human RAR-β2  
RAR-β2 Fw  TGGATGTTCTGTCAGTGAGTCCT E.  Pfitzner 
RAR-β2 Rev  CCCACTTCAAAGCACTTCTG E.  Pfitzner 
Mouse/Human GAPDH house keeping gene 
GAPDH Fw  GATGACATCAAGAAGGTGGTG  T.Heinzel 
GAPDH Rev  GCTGTAGCCAAATTCGTTGTC T.Heinzel 
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2.2.3  Primers used for pGEX and pCMX sequencing 
To verify GST and Gal4-DBD fusion in N-terminus 
Nt-GST fusion Fw  CTGGTTCCGCGTGGATCTCGT 
Nt-Gal fusion Fw  CAAAGACAGTTGACTGTATCG 
 
2.2.4  Oligonucleotides used for siRNA expression 
NonO directed siRNA  
Oligonulceotides for the expression of short hairpin containing Si I (nucl: 489-507) 
5’GATCCCCCGAACTGCTGGAAGAAGCCTTCAAGAGAGGCTTCTTCCAGCAGTTCGTTTTTGGAAA 
3’AGCTTTTCCAAAAACGAACTGCTGGAAGAAGCCTCTCTTGAAGGCTTCTTCCAGCAGTTCGGGG 
Oligonulceotides for the expression of short hairpin containing Si II (nucl: 1248-1266) 
5’GATCCCCAGGACCTGCCACTATGATGTTCAAGAGACATCATAGTGGCAGGTCCTTTTTTGGAAA 
3’AGCTTTTCCAAAAAAGGACCTGCCACTATGATGTCTCTTGAACATCATAGTGGCAGGTCCTGGGG 
 
2.2.5  Plasmids used in this work 
Plasmids for mammalian expression 
Name Encoded  protein  references 
pDEST 51 NonO Fl  V5tagged NonO full-length(aa:1-472)  this work 
pDEST 51 ΔRRM1  V5 tagged NonO Δ RRM1 (deletion aa:87-160)  this work 
pDEST 51 ΔRRM2  V5 tagged NonO ΔRRM2 (deletion aa:161-227)  this work 
pDEST 51 MBD3  V5 tagged MBD3  this work 
pSG5 FL ESET  flag tagged ESET full-length (EcoRI/SmaI)  L. Yang  
pDEST 51 CtBP  V5 tagged CtBP  this work 
pCMX N-CoR FL flag  flag tagged full-length N-CoR (aa: 1-2453)  Heinzel  
pCR3.1 PSF HA  HA- tagged PSF full-length  P. Tucker 
pcDNA3 N-CoR Ct NID  N-CoR Ct (1587-2453)  M. Grez 
 
pCMX Gal4  Protein or domain fused to Gal4-DBD  references 
pCMX Gal4-DBD  Gal4 transcription factor DBD  T. Heinzel 
pCMX Gal-N-CoRFlag-Epitop  Gal4-DBD N-CoR (aa 1-2453)  T. Heinzel  
pCMX Gal-N-CoR 1  Gal4-DBD N-CoR (aa 1-312)  T. Heinzel 
pCMX Gal-N-CoR 9+10  Gal4-DBD N-CoR (aa 2174-2453)   T. Heinzel 
pCMX Gal-NonO full-length  Gal4-DBD NonO (aa 1-472)  This work 
pCMX Gal-ΔRRM1 NonO  Gal4-DBD NonO lacking (aa 86-160)  This work 
pCMX Gal-ΔRRM2 NonO  Gal4-DBD NonO lacking (aa 160-227)  This work 
Mammelian reporter plasmids 
2xUAS TK luciferase reporter   promoter contains 2x UAS (Gal4 RE)   T. Heinzel 
RARE luciferase reporter  promoter contains retinoic acide RE  T. Heinzel 
ERE luciferase reporter  promoter contains estrogen RE  E.Pfitzner 
SV 40 beta galactosidase reporter  normalization vector   T. Heinzel 
Supplementary vectors 
GFP  Green fluorescent protein expressing vector  T. Heinzel 
psp vektor  Fill vector  T. Heinzel 
Plasmids for bacterial expression 
Name  Protein or domain fused to GST  References 
pGEX 2TDK  GST   T. Heinzel 
pGEX JDK N-CoR 1-393  GST-N-CoR RD I  T. Heinzel 
pGEX AHK N-CoR SANT1/2  GST-N-CoR SANT (aa:435-683)  T.Heinzel 
pGEX AHK N-CoR 1679-2453  GST-N-CoR C-t NC-Nco2  T. Heinzel 
pGEX N-CoR Ct-2290  GST-extrem C-terminus (aa 2290-2453)  T. Heinzel 
pGEX NonO FL  GST-NonO full-length (aa:1-472)  this work 
pGEX NonO Nt   GST-NonO (aa:1-237)  this work 
pGEX NonO Ct  GST-NonO (aa:255-472)  this work 
pGEX NonO Δ RRM1  GST-NonO lacking (aa:87-160)  this work 
pGEX NonO Δ RRM2  GST-NonO lacking aa:161-227) this  work 
pGEX RRM1  GST-NonO RRM1 (aa: 87-160)  this work 
pGEX RRM2 Ct  GST-NonO (aa: 161-472)  this work  Materials  and  Methods 
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Plasmids for in vitro translation (TNT)  
N-CoR Nt (1-549)  pCMX Gal N-CoR (1-549) TNT  T. Heinzel 
N-CoR Ct (1629-2453)  pCMX N-CoR 102 TNT  T. Heinzel 
pDEST14 NonO FL  NonO (aa 1-472)  this work 
pDEST14 NonO Δ RRM1  NonO lacking (aa 86-160)  this work 
pDEST14 NonO Δ RRM2  NonO lacking (aa 160-227)  this work 
Plasmids for Si RNA expression 
pSuper Si I NonO  NonO target sequence-CGAACTGCTGGAAGAAGCC- this  work 
pSuper Si II NonO  NonO target sequence-AGGACCTGCCACTATGATG-  this work 
pSi N-CoR  N-CoR target sequence-AAGAAGGATCCAGCATTCGGA-  MA. Lazar  
pSi SMRTB  SMRT target sequence-AAGGGTATCATCACCGCTGTG- MA.  Lazar 
Plasmids for antisense expression 
pCR3.1AS NonO  NonO full-length antisense  P. Tucker 
pCR3.1 AS PSF  PSF full-length antisense  P. Tucker 
Vectors used for cloning 
pENTR 2B  for recombination in various destination vectors  GATEWAY
TM Cloning 
Technology Invitrogen 
pEF6-DEST 51  for expression of protein tagged in C-t withV5/His   Technology Invitrogen 
pDEST 14  for TNT translation  Technology Invitrogen 
pDONOR  for generating attL-flanked entry clones   Technology Invitrogen 
pGEX AHK  for expression of GST-fused proteins in bacteria  T.Heinzel 
pCMX Gal DBD  for expression of protein fused in Nt to Gal4-DBD  T.Heinzel 
pSuper  for expression of short interfering RNA  Oligoengine 
pSuper+  modified pSuper for efficient double digestion  this work 
Vector description 
  
pGEX-AHK pCMX  GAL4 
 
pENTR
TM 2B /2718 nucleotides 
• Entry vector expression is silenced 
• attL1/attL2 recombination sites 
• ccdB gene 
• Kanamycin resistance gene 
pEF6-DEST 51 /7464 nucleiotides 
• EF-1alfa promoter 
• attR1/attR2 recombination sites 
• ccdB gene 
• V5 epitope / 6xHis tag 
• Ampicillin resistance gene 
pDEST
TM14 /6422 nucleotides 
• T7 transcription termination region 
• attR1/attR2 recombination sites 
• ccdB gene 
• Ampicillin resistance gene 
pDONOR
TM 201 /4470 nucleotides 
• for Entry vector production by BP reaction 
• attP1/attP2 recombination sites 
• ccdB gene 
• Kanamycin resistance gene 
pSuper basic /3176 bp nucleotides 
• BglII: 928 /HindIII: 934 
• H1 promoter: 708 - 934 
• Ampicillin resistance  Materials  and  Methods 
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Gateway empty vectors all contain the ccdB gene. These plasmids can only be propagated 
in modified E.coli strain such as DB3.1 cells containing the gyrA62 allele which renders the 
strain resistant to the toxic effects of the ccdB gene. 
2.3 Biochemical  analyses 
2.3.1 Protein  extract preparation 
Protein whole cell extract 
Cells are harvested from 10 cm dishes in PBS, transferred into falcon tubes and spun down 
by 1000 rpm for 10 min at 4°C. (Cell pellets can be frozen at -80°C directly after 
centrifugation and removal of PBS supernatant.) Cells are lysed adding 0.8-1 ml NETN, 
RIPA or Coimmunoprecipitation (Co-Ip) buffer with fresh added inhibitors and DTT (frozen 
pellets were thawed slightly on ice). Lysates are kept on ice for 15min before sonication and 
centrifugation. Sonication enables DNA sheering and improves protein solubilization. 10 
pulses with Branson SONIFIER 250 from G.HEINEMANN (70% duty cycle, output control 4) 
are sufficient. Lysates were centrifuged at 13,000 rpm, 4°C for 20min and supernatants were 
transferred into fresh eppendorf tubes. Whole cell extracts can be stored at -80°C. 
NETN  0.5% NP-40, 20 mM Tris pH8, 100 mM NaCl, 1 mM EDTA, 10% Glycerin add 
fresh 1 mM DTT,, 1x PIC, 0.5 mM PMSF 
RIPA 
0.1%NP40, 20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, SDS 0.1% 
deoxycholat 0.25% (w/v), add fresh 1 mM DTT, protease (PIC, PMSF) and 
phosphatase (NaF, Na-orthovanadate) inhibitors 
Co-Ip buffer 
TritonX-100 0.2%, 20 mM Tris pH 8, 25 mM NaCl, 1 mM EDTA, MgCl2 1.5mM 
glycerol 10%, add fresh 1 mM DTT, protease (PIC, PMSF) and phosphatase 
(NaF, Na-orthovanadate) inhibitors  
PIC x1000  1 mg/ml Leupeptin, 2 mg/ml Antipain, 100 mg/ml Benzamidine,  
10 000 U/ml Aprotinin (stored at -20°C) use diluted 1:1000  
PMSF  0.5 M in ethanol (add fresh to final concentration 0.5 mM) stored at RT 
NaF  Phosphatase inhibitor used at 1 mM final concentration 
Na-orthovanadate  Phosphatase inhibitor used at 0.4 mM final concentration 
DTT   1 M dithiotreitol (stored at -20°C) 
Nuclear extract short protocol 
Nuclear extracts and cytoplasmic extracts are obtained from cells with the following 
fractionated cell disruption method. The cytoplasmic fraction is obtained by adding hypotonic 
buffer to cell pellet and incubating on ice for 5 min. Nuclei stay intact whereas the 
cytoplasmic membrane of the cell was disrupted. Nuclei pellet is obtained by centrifugation. 
Supernatant was transferred in new tubes since it was the cytoplasmic fraction. To avoid any 
contamination with cytoplasmic proteins, nuclear pellets are washed once with the same 
hypotonic buffer. Lysis of the nuclear membrane is obtained by thoroughly vortexing and 
sonicating nuclei in the same buffer. Cell debris is spun down and the supernatant which 
constitutes the nuclear fraction is transferred in new tubes. In this buffer protein content could 
be determined with BCA assay before utilization or storage at -80°C. 
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Procedure 
1.  Wash cells on the 100mm dishes with PBS, spin scraped cells in PBS, 10 min 1500rpm 
2.  Add 600 µl hypotonic buffer to cell pellet and resuspend with shorted tips. Incubate 7 min on ice 
3.  Centrifuge 2 min 14,000 rpm to obtain cytoplasmic fraction (supernatant) separated from nuclei 
pellet. 
4.  Wash nuclei pellet with hypotonic buffer before lyse, spin 2min 14,000rpm and remove 
supernatant 
5.  Add 600 µl hypotonic buffer to nuclei vortex and sonicate briefly (2x 10 pulses) to disrupt nuclear 
membrane   
6.  Spin at 14,000 for 20 min and collect supernatant 
 
Hypotonic 
Buffer  
20 mM HEPES pH7.9, 10% glycerine, 0.2% NP40,10 mM KCl, 1 mM EDTA
add fresh DTT, PIC and PMSF  
2.3.2 Protein  analysis 
SDS-polyacrylamide-gel electrophoresis (PAGE) 
SDS polyacrylamid-gel electrophoresis is a technique used to separate macromolecules on 
the basis of electric charge and size. During electrophoresis, macromolecules are forced to 
move through the pores (gel-pore size depends on acrylamid, bisacrylamid containt) when 
the electrical current is applied. Their rate of migration through the electric field depends on 
the strength of the field, size and shape of the molecules. 
Polyacrylamide gels (100 x 80 x 1.5 mm) used in this work consisted of 6%-12% separating 
gel, depending on the size of molecule to separate, and a 3% stacking gel: 
Separating gel  6%  8%  10%  12% 
Mini gel number  2x 4x 2x 4x 2x 4x 2x 4x 
30%Acrylamide/ Bis  3 ml  5 ml  4 ml  6.7 ml  5 ml  8.3 ml  6 ml  10 ml 
Separating buffer  5.6 ml  9.4 ml  5.6 ml  9.4 ml  5.6 ml  9.4 ml  5.6 ml  9.4 ml 
20%SDS  75 µl  125 µl  75 µl  125 µl  75 µl  125 µl  75 µl  125 µl 
H2O  6.3 ml  10.3 ml  5.3 ml  8.6 ml  4.2 ml  7.0 ml  3.2 ml  5.3 ml 
10%APS  75 µl  125 µl  75 µl  125 µl  75 µl  125 µl  75 µl  125 µl 
TEMED  10 µl  16.5 µl  10 µl  16.5 µl  10 µl  16.5 µl  10 µl  16.5 µl 
 
Stacking gel  3% 
Mini gel number  2x 4x 
30%Acrylamide/ Bis  830 µl  1.33 ml 
Stacking buffer  625 µl  1 ml 
20%SDS  25 µl  40 µl 
H2O  3.5 ml  5.6 ml 
10%APS  25 µl  40 µl 
TEMED  5 µl  8 µl 
Protein samples were denatured for 3-5 min at 95°C in sample buffer before separation by 
SDS-PAGE (Sambrook, 1989), using the Mini-Protean II system (BioRad, Munich). 
Electrophoresis was performed at 90V for the stacking gel and 120 V for the separating gel. 
Subsequently, proteins were either stained with Coomassie Brilliant Blue R-250 (Serva, 
Heidelberg) or transferred on nitrocellulose membrane (Schleicher& Schuell) for detection by 
immunoblotting. 
Buffers and solutions 
Acrylamide/ bisacrylamide  30% (w/v) : 0.8% (w/v) 
TEMED Tetramethyethyldiamine    Materials  and  Methods 
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Running gel buffer  1 M Tris-HCl, pH 8.8 
Stacking gel buffer  1 M Tris-HCl, pH 6.8 
20% SDS   20% (w/v) in H2O 
10%APS  10% (w/v) in H2O 
5 x sample buffer 
250 mM Tris-HCl, pH 6.8; 50% glycerine; 10% SDS (w/v); 
0.5% bromophenolblue (w/v); 3% 2-β-mercapto-ethanol 
SDS-PAGE running buffer  25 mM Tris-HCl; 250 mM glycine; 0.1% SDS (w/v); pH 8.3 
 
Protein molecular weight markers  Precision plus proteinTM standards                             Biorad 
Prestained protein marker, broad range                          NEB 
Staining of polyacrylamide gels with Coomassie Brilliant Blue 
After separation of protein mixtures by SDS-PAGE, the gels are incubated in staining 
solution for 15 min. To remove unbound dye the gel is washed 4 times in destaining solution 
for 10 to 15 min (Sambrook, 1989). The stained gels are kept in dH2O until they are dried. 
Staining solution  30% ethanol; 10% acetic acid; 0.025% Coomassie brilliant 
Brilliant blue  Blue R-250 (Serva, Heidelberg) 
Destaining solution  30% ethanol; 10% acetic acid 
Western Blotting  
Western blotting or immunoblotting is a technique permitting the simultaneous detection of a 
specific protein by means of its antigenicity, and its molecular mass. Therefore proteins are 
first separated using SDS-PAGE and transferred to a membrane suitable for detection. 
Protein or antigen will be recognized by specific primary antibodies and the secondary 
species specific conjugated antibodies allow detection.  
After separation by SDS-PAGE, proteins are transferred onto nitrocellulose membrane 
suitable for immuno detection. Wet transfer with a Biorad transfer chamber is run 3 h at RT 
or overnight at 4°C. Gel, nitrocellulose membrane, Whatman paper and fiber pads all well 
soaked in transfer buffer are stacked as followed in a gel holder cassette: 
Anode side (+) 
Fiber pads 
Whatman paper (3mm) 
Nitrocellulose membrane 
Acrylamide gel 
Whatman paper (3mm) 
Fiber pads 
Cathode side (-) 
All subsequent steps are performed with constant shaking. The complete protein transfer is 
checked by incubating the membrane 1 min in Ponceau red staining solution followed by 
incubation in 10% acetic acid before washing the membrane with distilled water until a clear 
staining appears. This staining is also used to compare amount of loaded protein or to render 
lane visible for membrane snipping or to visualized immunoprecipitation antibodies light and 
heavy chains. Ponceau staining is a reversible protein dye disappears by further rinsing with 
water or PBS/0.05% Tween buffer. Membrane is blocked in PBS 0.05% Tween with 5% low 
fat milk for at least 30 min to prevent non-specific binding of the antibodies. The primary 
antibody (antigen specific) is incubated with the membrane overnight at 4°C or 2-3 hours at 
room temperature diluted in a suitable manner (usually 1/500 to 1/10,000) in 2% milk / PBS  Materials  and  Methods 
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0.05% Tween. In 50 ml falcons 3 ml solution is sufficient for homogenous covering of the 
membrane during incubation on a roller incubator. The membrane is then washed 4 times in 
15 ml PBS/0.05% Tween with constant shacking; changing buffer every 10 min. Secondary 
antibody diluted in 5ml PBS/0.05% Tween (usually 1/2,000 to 1/10,000 following instructions) 
is incubated with the membrane for 30-45 min at room temperature. The membrane is 
washed several times before detection of proteins with the ECL luminicence assay (Pierce 
Amersham Biosciences). Proteins which are recognized by the specific primary antibody can 
afterwards be detected by specific secondary antibodies that are coupled to a HRP 
(horseradish peroxidase) enzyme. In the presence of its substrate this enzyme catalyses a 
chemical reaction that leads to activation of luminol whose luminescence is detected by an 
X-ray film. The ECL reaction was performed as shown in the manufacterer’s protocol. The 
exposition time is varied depending on the level of luminescence. 
Buffers and solutions 
PBS 10x buffer  137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4·7H2O, 1.4 mM 
KH2PO4, pH 7.4 (autoclave solution for longer storage) 
SDS 10x buffer  1% SDS, Tris, Glycine. 
Transfer buffer  1X SDS Buffer, 20% ethanol 
Wasching solution  PBS/0.05% Tween 
Blocking solution  5% low fat milk / PBS 0.05% Tween 
Ponceau S staining solution  20 mg/ml Ponceau S, 0,3 mg/ml trichloroacetic acid, 0,3 mg/ml  
sulfosalicylic acid 
Ponceau Fixing solution  10% acetic acid 
Antibodies 
Primary antibodies   Species  Dilutions  Reference 
Gal4-DNA-binding-domain (RK5C1)  mouse, monoclonal  1:500  Santa Cruz 
V5-HRP mouse,  monoclonal  1:5000  Invitrogen 
Flag- tag  mouse, monoclonal  1:2000  Sigma 
N-CoR C-terminal affinity purified  rabbit, polyclonal  1:1500  Heinzel  
NonO NMT-4/403° (N-terminal)  rabbit, polyclonal  1:2000  Traish (Boston) 
PSF rabbit,  polyclonal  1:1000  Tucker (Austin) 
PLC γ1  mouse, IgG1   1:1000  BD Biosciences 
Secondary antibodies (IgG-HRP)       
Anti rabbit  goat, polyclonal  1:15000  Sigma 
Anti mouse   sheep, polyclonal  1:10000  Amersham Biosciences 
Membrane stripping  
Membranes can be probed with different specific antibodies several times. Stripping is 
performed before incubating with another first antibody to eliminate preliminary signals. 7 µl 
β-mercaptoethanol per 1 ml stripping buffer is added freshly. Membrane is incubated in 15 ml 
stripping buffer at 50°C for 20 min. The membrane is afterwards rinsed tree times with dH2O, 
10 min with shaking, and finally once in PBS/0.05% Tween, before blocking it in 5% low fat 
milk / PBS 0.05% Tween. 
Stripping buffer  2% SDS, 65 mM Tris-HCl pH 6.8, 100 mM ß-mercaptoethanol 
 
Determination of protein concentrations 
BCA
TM protein assay (Pierce) is used to measure protein content of extracts. BCA reduces 
divalent copper ion to a monovalent ion under alkaline conditions. A molybdenum/tungsten  Materials  and  Methods 
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blue product is produced whose absorbance can be quantified at 562nm with a visible light 
spectrophotometer (Biorad). Sample and working reagent are incubated 30 min at 37°C and 
absorbance is measured in glass or polystyrene cuvettes. 
2.3.3 Co-immunoprecipitation  experiment 
This method enables precipitation of specific proteins and their in vivo interaction partners. In 
a first step, proteins of interest are recognized by specific antibodies. Secondly, through 
interaction of conserved region (Fc) of antibodies (IgG) heavy chains with protein A and or 
protein G, which are coupled to sepharose beads, targeted proteins and interacting 
molecules can be co-precipited.  
Cells are splitted 24 h to 72 h before harvesting depending on if transfection and or 
treatments which are required. Cells grown on 10 cm dishes are lysed in 0.5-1 ml NETN or 
co-immunoprecipiting buffer with 0.5 mM PMSF and a cocktail of protease inhibitors (PIC), 
sonicated twice 10 pulses with a Branson SONIFIER 250 from G.HEINEMANN (70% duty 
cycle, output control 4). Lysates are centrifuged at 13,000 rpm, 4°C for 20 min and 
supernatants are transferred into fresh eppendorf tubes (50 µl are kept in separate tubes and 
directly boiled with 2x protein loading buffer for the 10% inputs). 1 µg antibodies suitable for 
immunoprecipitation are added to 250 µl lysate (200 µg-500 µg protein) and incubated for 30 
min on ice. As negative control the same amount of pre-immune sera, from corresponding 
species, is added to the lysate. 30-50 µl of protein A/G sepharose beads (Amesham 
biosciences) slurry in lysis buffer are afterwards added and incubated several hours up to 
over night on a spinning wheel at 4°C. Reaction volume is supplemented to 500 µl. Before 
adding the beads, they are equilibrated in the lysis buffer and blocked with 0.1% BSA for 30 
min on a spinning wheel at 4°C. 1 ml lysis buffer is added and spun 30 s at 5.000 rpm at 4°C. 
Supernatant is discarded. Washing step is repeated five times and final centrifugation is 
done at 13,000 rpm for 30 s at 4°C. 30 µl 2x protein loading buffer are added and samples 
are subsequentially boiled at 95°C for 3 min. After short centrifugation, supernatants are 
loaded on a polyacrylamide SDS gel. 
Immunoprecipitation antibodies   Species  reaction  Reference 
V5-tag mouse,  monoclonal  0.5µl  Invitrogen 
Flag- tag  mouse, monoclonal  0.5µl  Sigma 
N-CoR C-terminal (SA92)  guinea pig, polyclonal  2µl  Heinzel  
N-CoR N-terminal (SA 90)  guinea pig, polyclonal  3µl  Heinzel  
NonO 78-1 (C-terminal)  mouse, monoclonal  0.5µl  Traish (Boston) 
RNA Pol II     0.5µl   
 
Co-immunoprecipiting Buffer  20 mM Tris-HCl pH 8, 25 mM NaCl, 1,5 mM MgCl2,1 mM EDTA, 1% 
Triton X-100,10% Glycerine, add fresh 1 mM DTT, PIC and PMSF 
Protein A sepharose   Lyophilized powder was suspended in dH20, washed several times, 
final slurry 50% settle medium to 50% Co-Ip buffer 
Protein G sepharose  Preswollen in ethanol, beads were washed several times in Co-Ip 
buffer, final slurry 50% settle medium to 50% Co-Ip buffer  
 
Protein A sepharose CL-4B  Amersham biosciences 
Protein G sepharose 4 fast flow  Amersham biosciences 
  Materials  and  Methods 
  44
2.3.4 GST-pulldown  assay 
GST-pulldown assays enable determination of protein interactions in vitro. This method was 
used for mapping the interaction domain between NonO and N-CoR. One protein is 
radioactively labeled with 
35S-methionine and the interaction partners or interaction domains 
are fused to GST, expressed in bacteria and isolated on glutathion agarose beads. 
Expression and purification of recombinant proteins 
BL21 codon+ bacteria strain is engineered to contain extra copies of genes that encode 
certain tRNAs necessary for efficient high level expression of heterologous proteins in E.coli. 
Single colonies (or 10 µl of glycerine stocks) containing plasmids encoding the different 
recombinants are grown overnight in 3 ml selective LB medium at 37°C shacking at 220 rpm. 
Overnight cultures are diluted 1:100 into 300 ml LB medium with antibiotics and grown to an 
OD600 of 0.7 to 1 (OD600 doubles about every 20 min). To induce bacterial expression of 
fusion-proteins, IPTG is added to the culture to a final concentration of 0,5 mM. Expression is 
performed at 30°C for 3 h under continuous shaking. Bacteria are collected by spinning at 
5000 rpm for 10 min and supernatant is removed before freezing pellets for 30 min (or 
longer) at -80°C. Cells are thawed on ice before resuspension in 20 ml LysS buffer 
(containing freshly added ß-mercaptoethanol, PMSF and PIC protease inhibitor cocktail). 
Lysozym is added to a 0.2 mg/ml final concentration to destroy bacterial cell walls efficiently. 
Suspensions are directly transferred to a centrifugal tube and incubated 5 min at room 
temperature. To obtain an efficient lysis (samples become very viscous) it is mixed several 
times with a pipette. Samples are set on ice for 15 min while continuing mixing every 5 min 
untills it becomes very viscous. To clear lysates the samples are spun in a precooled (2°C) 
ultracentrifuge at 45000 g for 30 min at 2°C. Ultracentrifugation supernatants containing 
soluble recombinants are aliquoted and stored at -80°C or used immediately. 0.5-1 ml 
glutathione agarose beads are added to 5 ml supernatant in 14 ml falcon tube and incubated 
for 1 h on a spinning wheel at 4°C. Agarose beads are spun at 400 rpm for 2 min at 4°C. 
Supernatant is removed and beads are washed 5 times with 5 ml of 0.5 LysS buffer without 
protease inhibitors. Between washing steps samples are mixed by inverting tubes. Finally the 
beads are transferred in 2 ml Eppendorf tubes in 0.5 LysS buffer containing 1 mg/ml BSA. 
Proteins stored at 4°C are usually stable for up to 6 months.  
Comparable protein amounts are necessary for the GST-pulldown assay; therefore beads 
are equilibrated in 0.5 LysS slurry 50%. 50 µl are spun and boiled with 2x protein loading 
buffer before loading on a SDS acrylamide gel and staining the gel with coomassie. Band 
intensity is estimated and glutathione beads are added for normalization of protein amounts. 
SDS PAGE and coomassie staining are repeated to check amounts of recombinants 
contained in 50 µl normalized glutathione-agarose beads.  
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Lys-S buffer 1x  50 mM Tris pH 7.8, 0.4 M NaCl, 0.5 M EDTA, 10% Glycerol, 
0.1% NP40. 
Add fresh before use  5 mM ß-mercaptoethanol,0.5 mM PMSF and PIC (1:1000) 
Lysozyme  100 mg/ml (store at -20°C) 
IPTG  1 M isopropylthiogalactoside (store at -20°C) 
10% BSA solution  100 mg/ml (store at -4°C) 
Glutathion agarose beads (Sigma)  swollen overnight in dH2O, washed 4x times thoroughly with 
dH2O before resuspended in LysS buffer slurry 50% 
In vitro transcription and translation (TNT) 
For cell free in vitro translation ‘TNT Coupled Rabbit Reticulocyte Lysate System‘ from 
Promega (Heidelberg) is used according to the manufacturer’s protocol. (Pelham and 
Jackson 1976; Jackson et al. 1983). It contains all necessary cellular components required 
for protein translation. This kit enables in vitro transcription and translation. Vectors suitable 
for in vitro expression require a T7 promoter. Coding sequences of protein of interest were 
cloned in pDEST 14 (Invitrogen) for this purpose. Some other proteins relevant for this 
project Gal-fused are also used in GST-pulldown assays and TNT translated since pCMX-
Gal vector backbone contains the requisite promoter. Reaction is incubated for 90 min at 
30°C and stored at -80°C. 
Protocol for a 25 µl TNT reaction 
1 µg template DNA 
12.5 µl rabbit reticulocyte lysate 
1 µl TNT reaction buffer 
0.5 µl T7 RNA polymerase (10 U/µl) 
0.5 µl RNasin inhibitor (40 U/µl) 
1 µl amino acid mixture lacking methionine (1 mM) 
2 µl [
35S]-methionine (10 µCi/µl specific activity >1000 Ci/mmol. Amersham) 
Rnase free H2O is added to 25 µl 
1 µl of the protein sample is boiled for 3 min at 95°C with 2x protein loading buffer and 
separated by SDS PAGE. The gel is shaken in gel dry solution (Bio-rad) for 30 min and dried 
on 3 mm Whatman paper in a gel vacuum dryer for 45 min to 1 h at 80°C. The dried gel was 
exposed to an X-ray film overnight. 
TNT
® T7 Coupled Reticulocyte 
Lysate System 
in vitro Transcription-Translation Reaction; 
Protein expression  
Promega 
[
35S]Methionin    >1.000 Ci/mmol; 10 mCi/ml  Amersham 
 
GST-pulldown assay 
The whole procedure was performed with isolated and normalized recombinant proteins and 
unfused GST on glutathion agarose beads. 10% of the radiolabeled protein that was used for 
reaction was loaded as inputs on SDS-polyacrylamide-gel to compare with the intensity of 
the interaction signal.  
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protocol 
1.  Prepare GST agarose  beads fusion protein in PPi (0.02% NP40), BSA 1 mg/ml 
mix 20 min and then resuspend as 50% slurry 
2.  To 50 µl of GST agarose  beads fusion protein 50% slurry add 100,000-500,000 cpm TNT 
product (usually 1-3 µl TNT reaction) 
3.  Make up to 100 µl with PPI 
4.  Incubate at 37°C for 20 min while shaking at 8000 rpm (longer incubation at 4°C) 
5.  Add 1 ml PPI and spin down (30 sec at 5000 rpm) and aspirate supernatant 
6.  Repeat washing step 5 five times with PPI (0.05% NP40) 
7.  Remove supernatant and add 25 µl 2x SDS protein sample buffer 
8.  Boil 3 min at 95°C and spin down 
9.  Run 20 µl on a minigel, 70-90 min, 120 V 
10.  Fix protein on gel by incubating in fixing solution for 15 min on a shaker or proceed to 
coomassie staining 
11.  Destaining is followed by several washes with water to remove all trace of acetic acid 
12.  Incubate the gel for 20 min in amplify solution  
13.  Dry gel on whatman paper (3 mm) in vacuum dryer for 45 min at 80°C 
14.  Expose autoradiography X-ray film overnight 
 
PPI incubation buffer  20 mM Hepes pH 7.9, 100 mM NaCl, 1 mM EDTA, 4 mM MgCl2, 1 mM 
DTT, 10%glycerol, 0.02% NP40 
PPI wash buffer   20 mM Hepes pH 7.9, 100 mM NaCl, 1 mM EDTA, 4 m M MgCl2, 1 mM 
DTT, 10%glycerol, 0.05% NP40 
PMSF  0.5 M in ethanol (add fresh to final concentration 0.5 mM) 
Fixing solution  10% acetic acid, 40% methanol (not necessary if Comassie stained) 
 
Gel dry solution  Prevents excessive gel swelling and cracking during drying  Biorad 
Amplify  Increases detection efficiency, enhances conversion of ß-
emissions to light efficiently recorded on film 
Amersham 
biosciences 
 
2.3.5 Luciferase  assay 
In order to determine luciferase gene expression in transfected cells, the activity of the 
luciferase enzyme in cell lysates was measured. Prior to lysis, the growth medium of 
transfected cells (and treated) was removed. In each well of 12 well plates cells were lysed in 
150 µl of lysis buffer and shaken 15 min at room temperature. Lysates were transferred into 
1.5 ml tubes (Eppendorf, Hamburg) and cell debris was pelleted by brief centrifugation. 10µl 
extract were transferred on a 96-well microlyte
TM2 plate (ThermoLabsystems, Franklin, MA, 
USA). Luciferase activity was then measured at room temperature for 20 s in a luminometer 
(Microlumat LB 96P, Berthold, Munich) with automatic injection of 50 µl of luciferase solution. 
To consider the transfection efficiency that may vary depending on the plasmid DNA mix 
which was transfected, beta galactosidase encoding vector (SV40-ßgal) was cotransfected. 
This vector is under the control of SV40 promoter. Normalizing luciferase activity through 
beta galactosidase activity resulted in a relative luciferase activity taking in consideration the 
transfection efficiency.  
Harvest buffer 
50 mM Mes-Tris pH 7.8, 10% (v/v final) glycerol, 1 mM 
DTT, 0.1% Triton X-100 in H2O 
Luciferin solution  0.3 mg/ml Luciferin in 5 mM KHPO4 pH 7.8  
Luciferase buffer  130 mM Mes-Tris pH7.8, 30 mM MgCl2, 2.5 mg/ml ATP 
Luciferase solution  1:1 luciferin solution+luciferase buffer 
 
Luciferin  Beetle luciferin, potassium salt  Promega  Materials  and  Methods 
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2.3.6  β-Galactosidase assay 
β-Galactosidase assay is performed to normalize transfection efficiency. (SV40ß-Gal has to 
be co-transfected). Cell lysates in harvest buffer for luciferase assay are used directly. 10 µl 
extract are transferred on a 96-well flat bottom microtest plate (Sarstedt) and 90 µl ß-
galactosidase reaction mix is added. Reaction is stopped with 200 µl of 1 M Na2CO3 after 30 
min incubation at 37°C (protein alkaline denaturation). The reaction mix contains an artificial 
ß-galactosidase substrat ONPG (o-Nitrophenyl-β-D-Galactopyranosid). In the presence of ß-
galactosidase ONPG is converted to galactose and Ortho-nitrophenyl (ONP). ONP is bright 
yellow in alkaline solution and its absorbance can be measured at 420 nm in a 
spectrophotometer.  
ß-Galactosidase reaction mix: 
Mix for 10µl extract / 96 well 
1 µl 100x Mg solution 
22 µl ONPG (Substrat) 
72 µl 100 mM NaPi pH 7,5 
 
Buffers 
100x Mg  100 mM MgCl2, 4,5 M β-mercaptoethanol 
ONPG (o-Nitrophenyl-β-D-Galactopyranosid)  4 mg/ml ONPG in 100 mM NaPi pH 7,5 
NaPi pH7,5 Natriumphosphate buffer pH 7,5    41 ml 200 mM Na2PO4 + 9 ml 200 mM NaHPO4 
Na2PO4  200 mM Na2PO4 
NaHPO4  200 mM NaHPO4 
Na2Co3 stop solution  1 M Na2CO3 
 
2.4 Bacterial  transformation 
Bacterial transformation is the process by which bacterial cells take up naked foreign DNA 
molecules. Bacteria which are able to uptake DNA are called "competent" and are made so 
by different treatments in the early log phase of growth. 
2.4.1  Bacteria transformation by electroporation 
Preparation of electrocompetent cells 
A single colony of DH10ß E.coli cells is inoculated into 5 ml LB medium. Since these bacteria 
do not contain any resistance gene all materials and reagents coming into contact with 
bacteria must be sterile. Bacteria are grown over night at 37°C shaking by 220 rpm. Bacteria 
are diluted 1:100 into 500 ml and grown to an OD600 of 0.7 (OD600 doubles about every 20 
min). Before proceeding to centrifugation of cells, bacteria culture is chilled on ice for 10 to 
15 min. Two sterile polypropylene 500 ml Beckman bottles are used for centrifugation at 
5,000 rpm and 4 °C for 20 min in a J2-21 centrifuge (Beckman) equipped with a JA-10 rotor 
(Beckman). Pellets are resuspended first in 5 ml before adding 250 ml of ice cold sterile 
bidistilled water. This step is repeated before transferring cells into 50 ml polypropylene 
tubes. 40 ml ice cold 10% glycerol is added and cells are centrifuged for 10 min at 5,000 rpm 
(rotor JA -12). Pellet volume is then estimated and an equal volume of ice-cold 10% glycerol 
is added. Aliquots of 50-300 µl are frozen in liquid nitrogen before storage at -80°C.   Materials  and  Methods 
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Protocol: 
The electrocompetent bacteria are thawed on ice. In pre-chilled Bio-Rad electroporation 
cuvettes (0.2 cm wide) 10 pg-0.5 µg plasmid DNA or 1-7 µl of the DNA ligation mix are added 
to 30-100 µl bacteria (for new ligation use more DNA, for already amplified vector use less 
than 10 pg). The Bio-Rad Gene Pulser
TM setting is 2.5 kV, 25 µF and 400 ohm. To help 
bacteria recover after transformation, cells are immediately resuspended in 1 ml of SOC non-
selective medium and incubated at 37 °C for 30 min at 1000 rpm in a Thermomixer 
(Eppendorf). Finally cells are spun in a microcentrifuge at 5000 rpm for 20 seconds, 
supernatant is discarded and cell pellet is resuspended in 100 µl LB and plated on 
appropriate LB-agarose selective medium (containing 100 µg/ml ampicillin or 50 µg/ml 
kanamycin) (Dower et al. 1988). Plates are afterwards incubated at 37°C overnight. Bacteria 
colonies appear the next day. 
SOC medium:  0.5% yeast extract, 2% tryptone (Peptone), 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose (steril filtrated) 
 
2.4.2  Bacteria transformation by heat shock 
Preparation of chemocompetent cells 
A single colony of BL21 codon positive E.coli cells is inoculated into 5 ml LB medium. 
Bacteria are grown over night at 37°C shaking at 220 rpm. Bacteria are diluted 1:100 into 
300 ml and grown to an OD600 of 0.7 (OD600 doubles about every 20 min). The following 
procedure is performed similar to the preparation of electrocompetent cells. Culture is chilled 
before harvesting cells by centrifugation. Total culture is divided in two fractions for more 
facility. After removal of the supernatant cell pellet is resuspended in 100 ml solution 1 and 
kept on ice for 2 h. Cells are then centrifuged and resuspended in 5 ml of solution 2. Aliquots 
at 200 µl each are frozen at -80°C. 
Solution 1:  100 mM RbCl2, 50 mM MnCl2, 30 mM Kac, 10 mM Ca Cl2, 13% glycerine 
prepared before use and equilibrated at pH 5.8 with acetic acid before sterile filtration 
 
Solution 2:  10 mM MOPS pH7, 10 mM RbCl2, 75 mM CaCl2, 13% glycerine 
prepared before use and equilibrated at pH 7 with NaOH before sterile filtration 
Protocol 
Chemocompetent bacteria stock vials are thawed on ice. 10 ng Plasmid DNA is added to 100 
µl (1 µl mini DNA preparation is added to 50 µl Bacteria) and the mixture is incubated for 5 
min on ice. Transformation is achieved by incubating 5 min at 37°C followed by 2 min chilling 
on ice before adding 500 µl SOC medium and incubating for 30 min at 37°C with gentle 
shaking. 100 µl of the mixture is then spread on plates with adequate selective LB-agar 
medium. Plates are incubated over night at 37°C. 
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Bacteria strains used in this work 
E.coli Strain  Genotype References 
BL-21 Codon 
Plus  
F
- ompT hsdSB (rB
-  mB
- ) dcm Tet
r galλ (DE3) endA Hte 
[argU ileY leuW Cam
r]  Stratagene 
DH10B 
F
- mcrAΔ(mrr-hsdRMS-mcrBC)φ80d lacZΔM15 ΔlacX74 deoR 
recA endA1 araD139 Δ(ara,leu)7697 galU galK λ
-rpsL nupG  Life Technologies 
DB3.1* 
F- gyrA462 endA ∆(sr1-recA) mcrB mrr hsdS20 (rB-, mB-) 
supE44 ara14 galK2 lacY1 proA2 rpsL20(Smr ) xyl5 ∆leu mtl1  Invitrogen 
*Gateway empty vectors all contain the ccdB gene. These plasmids can only be propagated in 
modified  E.coli strains such as DB3.1 cells containing the gyrA62 allele which renders the strain 
resistant to the toxic effects of the ccdB gene.  
Bacteria containing Gal4-UAS-TK-reporter plasmid are only grown efficiciently in Superbroth 
LB medium.  
Superbroth LB medium (1 litre)  32 g tryptone, 20 g yeast extract, 5 g NaCl, 5 ml (1M) NaOH 
 
A single bacteria colony is grown overnight shacking at 220 rpm and at 37°C in LB medium 
with the appropriate antibiotics (3-5 ml medium for analytic DNA isolation or preculture, 300 
ml for preparative DNA isolation). For bacteria culture stocks, cells are frozen at -80°C in 
25% glycerin LB-medium.  
2.5 Cell  culture 
Different cell lines are used for protein overexpression, cell extracts, transient reporter 
assays, RNA isolation and confocal microscopy: 
Cell line  Origin and properties DSMZ-Nr./  Reference 
HeLa  Human cell line, isolated from the aggressive glandular 
cervical cancer of a young woman (Henrietta Lacks) 
ACC 57 
(Gey et al., 1952) 
293T  Human embryonic kidney cell line, transformed with large T 
antigen  
ACC 305 
(Graham et al. 1977) 
MCF7 
 
Human breast cancer cell line, retained several characteristics 
of differentiated mammary epithelium, including the ability to 
process estradiol via cytoplasmic estrogen receptors 
ACC 115  
(Soule et al. 1973) 
NIH 3T3  Mouse fibroblaste cell line ,developed from NIH Swiss mouse 
embryo cultures 
ACC 59 
(Andersson et al 1969) 
 
2.5.1 Basic  handling 
Splitting cells 
293T cells (derived from a human kidney carcinoma) are cultivated in DMEM medium 
(dulbeccos minimal essential medium) supplemented with 10% decomplemented FCS (foetal 
calf serum), 5% glutamine and 1% penicilline/streptomycine and grown in an incubator at 
37°C with 5% CO2. When the adherent cells reach confluency, they are splitted into new 
flasks (T75 250 ml). The medium is removed and the cells are washed with sterile 1x PBS 
(37°C) to eliminate trypsine inhibiting factors produced by the cells and serum adhering to 
their surface. Trypsine is added (1ml of trypsine/ flask) to the cells to release them into 
suspension from monolayers. When cells have lost contact, they are thoroughly resuspended 
in 10 ml of fresh DMEM medium to inactivate trypsine and to obtain a homogenous single  Materials  and  Methods 
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cell suspension. 1 ml of diluted cells is transferred into new flask supplemented with 14 ml 
new medium. When cells are cultured in a small flask, cells are passaged 1:10 in new flask.  
Counting cells 
For applications that require a precise cell number counting chambers were used to 
determine the number of cells per unit volume. Cell sample was diluted 1:1 (v/v) in Trypan 
bleu dye exclusion medium. Dead cells are blue and can be distinguished from living cells 
that are birefringent under the microscope. The hemacytometer was carefully and 
continuously filled. The charged chamber was placed on the microscope stage for counting. 
Calculations were performed according to the manufacturer’s instructions. 
DPBS  Dulbecco’s PBS; identical to PBS, but contains 8.1 mM Na2HPO4, pH 7.4, 
sterile filtered                                                                                 Cambrex
DMEM  Dulbeccos modified eagle medium                                            Boehringer 
RPMI  Roswell Park Memorial Institute                                                 Boehringer
L-glutamine  200mM                                                                                       Boehringer 
Pen/Strep  10 000 U Penicilline, 10 000 µg/ml Streptomycine                Bio*Whittaker 
Trypsine/EDTA  0.02% Trypsine; 0.05% EDTA                                                      Seromed 
FCS  Fetal calf serum                                                                           GibcoBRL
Counting chamber  Hemacytometer                                                        Hycor Biomediacal Inc
 
2.5.2 Long  storage 
Cell lines can be frozen and stored at -80°C for a short period (view months) or at -160 
(liquide nitrogen tank) for longer storage. From a 10 cm dish confluent cells are trypsinized. 
Medium is removed after 5 min centrifugation with 1000 rpm. Cell pellet is afterwards 
resuspended in 1 ml freezing medium and transferred immediately in cryotubes on dry ice. 
Cells are stored overnight at -80°C before being transferred into a liquid nitrogen tank. By 
thawing, cells are quickly thawed, washed with 10 ml fresh complete medium in 15 ml test 
tubes and spun at 1000 rpm. Whole vial content is resuspended in 5 ml medium and 
transferred into a small flask. The next day all dead cells are removed by changing medium if 
confluency is reached, cells will be splitted immediately.  
Freezing medium   Minimal essential medium (DMEM or RPMI) containing 47% FCS and 13% 
DMSO (Dimethyl sulfoxide Sigma) 
 
DMSO   Dimethyl sulfoxide                                                                                    Sigma 
 
2.5.3 Transfection 
There are several methods to deliver exogenous DNA into cells. The methods that are used 
facilitate DNA binding to cell membranes and entry of the DNA into the cell via endocytosis. 
Calcium phosphate transfection (Chen and Okayama, 1987; Wigler et al., 1977) shows high 
transfection efficiency in different cell lines, probably protecting DNA against intracellular and 
serum nucleases. This method is also considered as being only minimally toxic to the cells. 
Since we observe also high transfection efficiency in 293T cells with the PEI 
(polyethyleneimine) transfection method, it can be used as an alternative method. The 
different cell lines that are used in this work grow differently. An adequate cell number is 
splitted, depending on the cell line and the dish size in which transfection is performed. 
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Dish size  22 mm  100 mm 
Cell line  Cell number/ well 
HeLa 2.10
4 3.10
5 
293T 2.10
5 3.10
6 
MCF7 3.10
5 3.10
6 
Calcium phosphate-mediated transfection 
Cells are spitted 24 h before transfection. Culture medium has to be removed before adding 
transfection complex to the cells. Water, CaCl2 and DNA are mixed before adding gently 2x 
HEPES-buffered saline while blowing bubbles for 30 s. Serum free medium containing 
(1:3000) chloroquine is added to the precipitate and the complete mixture is gently poured 
into the well (adherent cells can be loosened). 5 h later medium is changed into complete 
medium. Precipitates are visible in the microscope. For experiments including hormone 
treatments cells are grown and kept in complete medium containing charcoal-stripped FCS 
instead of complete FCS (see charcoal-stripped FCS).  
Protocol 
Number of cells/ dish  2-3.10
5 3.10
6 
Transfection reaction  4x 22 mm dishes  10 cm dish 
DNA  1-1.5 µg x 4  10-15 µg 
H2O  250 µl  500 µl 
2M CaCl2  30 µl  60 µl 
HBS 2x  250 µl  500 µl 
DMEM(serum free)  1500 µl  3 ml 
chloroquine  1 µl/3 ml DMEM  1 µl/3 ml DMEM 
Pour into each well  500 µl  4 ml 
 
2x HEPES Buffered Saline  280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4, 12 mM glucose,  
50 mM HEPES, pH 7.2 (sterile filtrated) 
2 M Calcium Chloride   dissolve 14.7 g CaCl2 in 100 ml H2O. (autoclave) 
Polyethyleneimine (PEI)-mediated transfection 
Polyethyleneimine (branched) with an average molecular weight of 25 kDa was obtained 
from Aldrich (Taufkirchen). PEI-mediated gene transfer is considered most efficient at N/P 
ratios between 9 and 13.5 (N = positively charged amine nitrogens in PEI, P = negatively 
charged phosphates of the DNA backbone) (Boussif et al. 1995). The N/P ratios used in this 
work was 9.  
Pipette separately DNA/PBS and PEI/PBS. Both solutions are then mixed and incubated for 
15 min at RT. Growing medium is removed and cells are gently recovered with serum free 
medium. Transfection mix is then dropped equally on the cells and incubated for 4 h at 37°C, 
before changing medium. Cells are treated 24 h after transfection. Protein analysis or 
reporter assays are performed 48 h after transfection. 
Procedure 
Protocol  22 mm dish  100 mm dish 
Solution A (DNA)  30 µl PBS + 1-2 µg DNA  240 µl PBS + 5-15 µg DNA 
Solution B (PEI)  30 µl PBS + 5.4 µl 10 mM PEI  240 µl PBS + 43.2 µl 10 mM PEI 
Transfection mix  Mix A and B solution vortex and incubate 15 min RT 
1 ml serum free medium  5 ml serum free medium 
Transfection 
Drop equally transfection mix on the cells 
 
100mM stock solution  0.45 g PEI in 100 ml dH2O, pH 7.0 (HCl) sterile filtrated with 0.22 µm filter  Materials  and  Methods 
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Transfection reaction was done in triplicates. 1-2 µg of DNA was used to transfect cells on 22 
mm dishes (12 well plates). In order to estimate transfection efficiency, Green fluorescent 
protein expressing vector was cotransfected. GFP expression was monitored by 
fluorescence microscopy 24 or 36 h after addition of the transfection complexes to the cells. 
2.5.4  Transient reporter assays 
Gal4-reporter assay 
This conventional reporter assay is used to determine whether a protein has transcriptional 
repressing or activating activity. This experiment can also be extended to investigate protein 
interactions or substance effects. The protein or protein domain of interest is fused to the 
Gal4 transcription factor DNA binding domain (DBD). The reporter plasmid encodes 
luciferase under the control of a TK promoter and Gal4-specific response elements UAS. 
Reporter, Gal4-DBD fusion proteins and interaction factors are co-transfected to determine if 
the interaction influences Gal4-DBD fused protein activity. Luciferase activity is measured 48 
h after transfection. Calcium phosphate transfection or PEI transfection is used to transfect 
the basic DNA mix for on 22 mm well ; experiment were performed in triplicats on 12 well 
plates: 
UAS TK Luc Reporter  0.3 µg 
Gal DBD N-CoR/ Gal DBD   0.1-0.3 µg 
pDest-V5 NonO / deletion mutants  0.1-0.3 µg 
SV40 ß galactosidase reporter  0.1 µg 
GFP expressing vector  0.1 µg 
Psp fill vector  Add to 1.4 µg 
RARE-reporter assay 
A retinoic acid response element controls the expression of the luciferase on the RARE-
reporter plasmid. Retinoic acid receptor co-transfection is omitted since 293T cells contain 
sufficient endogenous receptors (RARs, RXRs). Upon stimulation with retinoic acid receptor 
agonist or antagonist, transcriptional activation respectively repression occurs. 24 h after 
transfection cells are treated and luciferase activity is measured 24 h after treatment. For 
time course experiments cells are harvested at different times.  
RARE-reporter DNA basic mix for 1 well /12well plate: 
RARE Luc Reporter  0.3 µg 
Protein expressing vector 0.1-0.3  µg 
Silencer plasmid  0.5-0.8 µg 
SV40 ß galactosidase reporter  0.1 µg 
GFP expressing vector  0.1 µg 
Psp fill vector  Add to 1.6 µg 
TRE-reporter assay 
The TRE-reporter encodes for the luciferase under the control of thyroid hormone receptor 
response elements (TRE). 293T cells do not express thyroid hormone receptor (THR); 
therefore THR encoding plasmids have to be co-transfected to obtain responses of the  Materials  and  Methods 
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reporter upon stimulation. The transcription activation is obtained treating cells with Triac 
(triiododothyroacetic acid). Luciferase activity is measured after transfection and treatment.  
TRE-reporter DNA basic mix for 1 well /12well plate: 
TRE Luc Reporter  0.8-1 µg 
Protein expressing vector 0.1-0.3  µg 
TR beta   0.1 µg 
SV40 ß galactosidase reporter  0.1 µg 
GFP expressing vector  0.1 µg 
Psp fill vector  Add to 1.8 µg 
ERE-reporter 
This estrogen response element (ERE) reporter encodes for luciferase under estrogen 
receptor control. ERE-reporter assays are performed in MCF7 cells, since they express 
estrogen receptor naturally. Cells are transfected with Fugene, since only low transfection 
efficiency is achieved with the others transfection methods. Luciferase activity is measured 
after transfection and treatment. 
ERE-reporter DNA basic mix for 1 well /12well plate: 
ERE Luc Reporter  0.3 µg 
Protein expressing vector 0.1-0.3  µg 
SV40 ß galactosidase reporter  0.1 µg 
GFP expressing vector  0.1 µg 
Psp fill vector  Add to 1.4 µg 
 
2.5.5 Treatment  of  cells 
All cells which are being hormonal treated have to be splitted in medium containing stripped 
serum in order to avoid the influence of naturally in FCS contained steroid hormones. 
Charcoal-stripped FCS 
Serum is commonly used as a supplement to basal growth medium in cell culture. The serum 
used for cell growth was fetal calf serum (FCS). Serum provides a wide variety of 
macromolecular proteins, low molecular weight nutrients, carrier proteins for water–insoluble 
components, and other compounds necessary for in vitro growth of cells, such as hormones 
and attachment factors. Serum also adds buffering capacity to the medium and binds or 
neutralizes toxic components. Attempts to replace serum entirely with serum-free medium 
had only limited success. Hormones like retinoic acid or thyroid hormones are to be found in 
FCS, therefore charcoal-stripped FCS is added to the medium used in assays where cells 
were treated. Using stripped serum minimizes the effect of hormones contained 
endogenously in serum and increases the response to specific treatment.  
To remove hormones from the serum, it is incubated with activated carbon (1 g/10 ml 
decomplemented serum, use 50 ml falcons) for 2 h at RT on a roller. Lipophilic molecules 
such as steroid hormones adhere to the carbon and can thereby be separated from the  Materials  and  Methods 
  54
serum. Charcoal is spun down by centrifugation (30 min/ 4000 rpm twice/ tree times). Serum 
is finally sterile filtered (0.22 µm) before storage at -20°C in aliquots.  
Hormonal treatment of cells  
Since adherent cells can be lost partially by changing medium and to avoid a variation of 
ligand concentration, 500 µl containing 3-fold final concentration of the specific hormone are 
applied to the cells in 1 ml stripped FCS medium in each well on the 12 well plate. Treatment 
is generally performed 24 h after transfection. 
The luciferase expression encoded by the RARE-reporter can be activated by ATRA (all-
trans retinoic acid). Different concentrations of agonist are applied to the cells by adding 
ATRA to medium containing stripped FCS. To enhance transcriptional repression, antagonist 
ligand mix109 is added to medium containing stripped FCS. In a similar manner TRE-
reporter transcription can be activated by Triac and the ERE-reporter transcription is 
stimulated upon treatment tamoxifen with. 
Final hormone concentration used in corresponding assays: 
ATRA 5.10
-7M 
ATRA 1.10
-7M 
RA antagonist mix 109  1.10
-7M 
Triac 5.10
-7M 
Tamoxifen 5.10
-8M 
For endogenous gene analysis by semi quantitative PCR, RNA is isolated from cells treated 
in a similar manner.  
Protein turnover 
To observe how stable proteins are, cells were treated with different substance like 
cyclohexmide and MG which are known to inhibit mRNA translation and proteasome 
degradation respectively. Since cycloheximide was dissolved in ethanol, as control cells were 
treated with identical concentration of ethanol in medium. Cells were treated 24 h before 
being harvesting. 
cycloheximid 5.10
-7M 
MG 132  1.10
-7M 
Ethanol 1.10
-7M 
 
Cycloheximide  Antibiotic derived from microbial sources inhibits eukaryotic, but not prokaryotic 
protein synthese                                                                                           SIGMA 
MG 132  Proteasome inhibitor Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal Z-LLL-CHO            
                                                                                                              Calbiochem 
2.5.6 Cell  synchronization 
Several chemicals can be added to proliferating cells to arrest them in certain stages of the 
cell cycle. Double thymidine-nocodazole block was used to arrest cells in mitosis. These 
reversible inhibitors were added to culture medium before being applied to cells. 293T cells 
were grown on 10 cm dishes one day before incubation. Medium containing thymidne was 
applied overnight (16 h) and removed on the next day. 8 h release in normal medium 
preceded nocodazole treatment overnight (16 h).This procedure enables at first to arrest 
293T cells in G1/S with thymidine which inhibits DNA replication fallowed by a synchronize  Materials  and  Methods 
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growth during the releazed phase and a final block in G2/M with nocodazole which promotes 
tubulin depolymerization. Mitotic 293T cell round up and detach from the bottom of the dish. 
Synchronization was monitored by microscopy and chromatin condensation was verified by 
Hoechst staining.  
chimicals  Stock solution  Final concentration  Cell cycle stage 
Thymidine  50 mg/ml H2O  0,5 mg/ml in culture medium (dilution: 1:100)  Bock in G1/S phase 
Nocodazole  1 mg/ml DMSO  50 ng/ml culture medium (dilution: 1:20 000)  Block in G2/M phase 
 
Thymidine and Nocodazole  SIGMA-Aldrich 
2.6  Optical and Confocal Microscopy 
2.6.1  Fluorescence microscopy 
GFP expression monitoring 
Twelve-well plates or 100 mm culture dishes were positioned, lid closed, under a Nikon 
eclipse TE300 fluorescence microscope (Nikon, Düsseldorf) to investigate GFP expression in 
transfected cells. EGFP fluorescence was obtained with a FITC-fluorescence filter set (Nikon 
TE-FM Epi-fluorescence attachment, excitation 480/40 nm, mirror 505 nm, barrier 535/50 
nm). Pictures were captured using a SONY DXC-9100P camera (Sony, Cologne). 
Processing of the images was performed using the LUCIA software and Adobe Photoshop. 
Hoechst/DAPI staining 
Hoechst 33342 (bisbenzimide H 33342) is a specific stain for AT-rich regions of double-
stranded DNA like DAPI and also the fluorescence properties are similar to DAPI. It can be 
used preferentially with living, unfixed cells. The absorption maximum is at 340 nm, the 
emission maximum at 450 nm. Condensed chromatin in mitotic cells was visualized by this 
method. In an Eppendorf tube a drop of medium containing cells arrested in G2/M was 
sufficient for verification. Cells were fixed in 4% paraformalfehyde for 20 min after removing 
medium and proceeding to gentle wash with PBS and centrifugation. For permeabilization 
cells were incubated 5 min. in PBS containing 0.1% Triton. After gentle washing in PBS cells 
were incubated at least 30 min in 0.1 mg/ml Hoechst/PBS. Staining solution was discarded 
before resuspending cells in PBS in a 200 µl. Place a drop on a microscope slide cover with 
a coverslip. A Zeiss Axiovert 200M microscope was used to investigate Hoechst stained 
chromatin in 293T cells. Fluorescence was obtained with a DAPI/Hoechst filter set (01Ex 
365/12) by an excitation wavelength of 365 ± 6 nm. Pictures were captured using a SONY 
DXC-9100P camera (Sony, Cologne). Processing of the images was performed using the 
LUCIA software and Adobe Photoshop. 
2.6.2  Laser scanning microscopy 
Confocal microscopy analysis was performed to investigate localization of endogenous or 
exogenous proteins and their colocalization in cells. Cells were grown and transfected on 
coverslips in 12 well plates. 24 h after transfection cells were used for analysis. Medium was 
removed and cells were washed shortly with PBS. Fixation was then performed incubating  Materials  and  Methods 
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cells in 3% Formaldehyde PBS (1 ml/well) for 10 min. at room temperature followed by 5 min 
washing in PBS. Cells permeabilization is obtained by incubating 5 min in 0.1% Triton X-
100/PBS. Cells were again washed with PBS before immunostaining. To minimize the 
quantity of antibody necessary for efficient staining, coverslips were circled with a 
hydrophobic pen after removing all traces of buffer by aspiration. The hydrophobic barrier 
enables recovery of the sample with a minimal volume. For blocking and washing steps 1 ml 
solution was used per well, whereas for immunostaining 150 µl antibody-containing solution 
were sufficient. To reduce unspecific binding of the antibodies, cells were incubated in 3% 
BSA PBS block solution for 1 h before incubation with primary antibodies diluted 1:100 in 150 
µl block solution for 1-3 h or overnight at 4°C. Prior and post incubation with secondary 
antibodies diluted 1:1000 in 150 µl block solution, cells were washed in 1 ml PBS at least 
tree times for 5 min. Secondary antibodies are coupled to fluorophores whith different 
excitation wavelengths. For colocalization experiment the whole procedure must be repeated 
and the first antibodies must differ in species and the fluorophore bound to secondary 
antibodies have to differ in their excitation wavelengths. 
Antigen Secondary  antibodies  Fluorophore references 
rabbit IgG  Goat, polyclonal  Alexa Fluor 546  Molecular probes 
rabbit IgG  Goat, polyclonal  Alexa Fluor 488  Molecular probes 
mouse IgG  Sheep, polyclonal  Alexa Fluor 546  Molecular probes 
mouse IgG  Sheep, polyclonal  Alexa Fluor 488  Molecular probes 
After immunostaining, coverslips are then rinsed in H2O destillated and dried gently. The 
coverslips were soaked in mowiol solution (mounting medium for fluorescence) which protect 
samples from photobleaching and placed on the slide. TO-PRO-3 can be directly added in 
this solution for staining of the nuclei. The preparation was sealed with nail polish. 
Preparations can be stored in the darck at 4°C for up to 2 weeks. 
Moviol solution  9 g glycerine, 3.6 g mowiol, 9 ml H2O, 18 ml 0.2 M Tris-HCL pH 8.5, 0.1% (v/v) DABCO 
 
Moviol 4-88  Aventis 
DABCO  Fluka 
TO-PRO-3 Molecular  probes 
 
A Leica DM IRBE confocal laser scanning microscope was used to analyze protein 
localization. Processing of images was performed using Leica confocal software (LCS). 
2.7  Common drugs and equipment 
Acrylamide/ bisacrylamide (Roth) 
Agarose ultra pure (Life Technologies, Gibco BRL) 
Ampicillin (Serva Electrophoresis) 
Bromophenol blue (Roth) 
Charcoal (Roth) 
DEPC (Sigma) 
Dimethylsulfoxid, DMSO, C2H6SO (Roth) 
Di sodium hydrogenphosphate dodecahydrate, Na2HPO4.12 H2O (Merck) 
DTT, dithiotreito (Roth)l 
ECL western blotting detection reagent (AmershamPharmacia) 
EDTA (Sigma) 
Ethanol 100% (Roth) 
Formaldehyde 37% (Sigma)  Materials  and  Methods 
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Formamide (Roth) 
Glycerol (Roth) 
HEPES (Roth) 
Hydrochloric acid 1 M, HCl (Roth) 
Kanamycine 
Lithium Chloride, LiCl (Roth) 
Lysozym (Roth) 
Manganese (II) chloride dehydrate, MnCl2. H2O (Merck) 
Methanol (Roth) 
MOPS, C7H15NO4S (Roth) 
Nonfat dried milk powder (AppliChem) 
Phenol and buffer pH 10.5 for saturated Phenol (Sigma) 
Phosphatase alkalin, AP, (Roche) 
PMSF (Aldrich) 
Ponceau S, (Sigma) 
Potassium acetate, C2H3KO2 (Roth) 
Potassium dihydrogen phosphate, KH2PO4 (Roth) 
2-Propanol, Isopropanol (Roth) 
Proteinase K (Roche)  
RNase (Roche) 
Rotiphorese Gel 30, polyacrylamid (Roth) 
Rubidium chloride, RbCl (Fluka) 
SDS ultra pure 20% (Roth) 
Sodium acetate, C2H3NaO2·3H2O (Roth) 
Sodium dihydrogenphosphate monohydrate, NaH2PO4. H2O(Merck) 
Sodium hydroxide, NaOH (Roth) 
TEMED p.a. (Roth) 
Tri reagent (Sigma) 
Trichloromethan/Chlorophorm (Roth) 
Tris, C4H11NO3 (Roth) 
Tris hydrochlorid, C4H11NO3HCl (Roth) 
Tween
R 20 (Roth) 
Other more specific reagents and drugs are mentioned in the protocol text with companies of 
purchase. 
Plasticware and filter systems for laboratory and cell culture use 
Eppendorf (Hamburg); Costar (Bodenheim); Greiner (Frickenhausen); BD Biosciences (Heidelberg); 
Nalgene (Rochester, NY, USA); Schleicher & Schuell (Dassel) 
Tools and equipments 
Biofuge pico (Heraeus) 
Vortex REAXcontrol (Heidolph) 
Pipetus
R-akku (Hirschmann Laborgeräte) 
Electrophoresis power supply- EPS 301 (Amersham pharmaciabiotech) 
Hoefer HE33, mini horizontal submarine unit (Pharmacia Biotech) 
MV120, mini vertical gel system (LTF) 
Rocking table “Rocky”, to wash membranes (Fröbel Labortechnik) 
Thermomixer compact, for 1.5 ml tubes (Eppendorf) 
Dri-Block
R DB-2D (Techne) 
Biocentrifuge/J2-21 centrifuge with rotor JA-10 and JA-20 (Beckman)  
Ultracentrifuge TL-100 (Beckman)  
Centrifuge 2K15 (SIGMA) 
Heraeus Typ. Nr.4400, minifuge GL Heraeus Christ (Heraeus) 
iCycler PCR machine (Bio-RAD) 
1500 TR-CARB
R, liquid scintillation analyser (PACKARD) Results 
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3 Results   
The yeast-two-hybrid screen (Fields and Song 1989) is a suitable method to determine 
protein-protein interactions and was performed with N-CoR amino acids 2290-2453 as bait to 
identify novel potential interaction partners. The obtained yeast transfection efficiency was 
less then twice the diversity of the library implying that the library was only partially screened. 
Nevertheless, more than 100 clones remained after several rounds of selection. After 
determining the specificity of the interaction by blue/white assay and retransformation 80 
clones were sequenced. The putative interacting proteins belong to various protein families 
such as extracellular matrix proteins, heat shock proteins, transmembrane proteins, splicing 
factors, response element binding proteins and transcription factors. It can not be excluded 
that in yeasts some factors enable an indirect interaction between bait and prey proteins. 
Therefore, direct interactions were verified by in vitro Glutathion-S-Transferase pull-down 
assays with a subset of proteins known to play a role in transcriptional regulation. After the 
initial analysis of the yeast-two-hybrid screen during my diploma thesis, the aim of my Ph. D. 
thesis was the functional characterization of the N-CoR extreme carboxy-terminus.  
3.1  in vivo interaction of N-CoR with putative binding partners  
Co-immunoprecipitation (Co-IP) is a commonly used immunochemical method to analyze 
protein-protein interactions in vivo. This technique is based on the capture of selective 
antigens with specific antibodies, and the subsequent isolation of the immune complex via 
protein A and/or protein G immobilized on a solid support (sepharose beads). Analysis of the 
co-immunoprecipitated proteins is performed by SDS PAGE followed by Western blotting. 
For this experiment, several different specific antibodies would have been necessary and not 
all of which were commercially available. In addition, the DNA sequences that were isolated 
from the library vector did not always encode the full-length protein. Therefore, complete 
coding sequences of proteins of interest were cloned into a V5-His tag mammalian 
expression vector (pEF6-DEST 51) and were detected by Western blot with an anti-V5 
antibody. The proteins that were further investigated are listed in table1. 
Table 1: Further investigated proteins, known to play a role in transcriptional regulation and to interact 
directly with the N-CoR extreme C-terminus in GST-pulldown assays. 
 
 
 
 
 
Putative N-CoR interacting proteins 
Methyl-CpG binding domain-containing protein 3                                 (MBD3) 
Similar to ERG-associated protein SET domain, bifurcated                  (ESET) 
C-terminal binding protein 1                                                                  (CtBP1) 
Non-POU-domain-containing octamer-binding protein             (NonO, p54nrb) Results 
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3.1.1  Cloning full-length coding sequences into mammalian expression vector 
Full-length sequences were obtained from plasmids or from NIH 3T3 (embryonic mouse 
fibroblasts) total cDNA. CtBP and ESET complete coding sequences were amplified from 
acquired plasmids used in published works (Criqui-Filipe et al. 1999) (Yang et al. 2002). The 
complete coding sequences from CtBP, MBD3 and NonO were successfully cloned into the 
mammalian expression vector pEF-DEST- 51 (Invitrogen GATEWAY) whereas the plasmid 
encoding ESET full-length protein (Yang et al. 2002) suitable for mammalian protein 
expression tagged with the Flag epitope was directly used for transfection. Different cloning 
strategies were used since the gateway technology provides two cloning options through 
site-directed recombination or restriction sites. Primers were designed depending on the 
cloning strategy. The coding sequences were first inserted into a transcriptionally silent entry 
vector by classical cloning or BP recombination before being transferred into the destination 
vector of choice by LR recombination. PB and LR reactions are based on site-specific 
recombination of the phage lambda. Each clonases BP and LR required specific 
recombination sites to mediate gene transfer. They enable excision of a sequence flanked by 
recombination sites, attB or attL, and insert DNA fragment between corresponding sites attP 
or attR respectively. These sites are modified to ensure DNA exchange in a specific manner 
maintaining orientation and reading frame.  
3.1.2  Exogenous protein expression in 293T cells 
Protein overexpression was analyzed in NETN whole-cell extracts from 293T cell transfected 
with the calcium phosphate transfection method. With this method 70% to 90% transfection 
efficiency was achieved in 293T cells (Fig. 8).  
 
 
 
 
 
 
Figure 8: Calcium phosphate transfection of 293T cells 
14 µg expression plasmid and 1 µg GFP expression vector were transfected into 5.10
6 293T cells. 
Over 70% of the cells express GFP indicating high transfection efficiency. GFP expression was 
visualized by fluorescent microscopy. 
 
 
 Results 
  60
KDa
32
45.7
62
83
C
t
B
P
N
o
n
O
M
B
D
3
32.1 48.6 54.5
Expression of the different proteins and their molecular weight were controlled by Western 
blotting. CtBP, MBD3 and NonO were successfully overexpressed in 293T cells and detected 
with an antibody directed against the V5 epitope (Fig. 9) whereas ESET protein was detected 
with a Flag epitope-directed antibody.  
 
 
 
 
 
 
 
Figure 9: Overexpression of CtBP, MBD3 and NonO in 293T cells 
Transfected cells on a 10 cm dish were lysed in 1 ml NETN buffer supplemented with protease 
inhibitors. 20 µl of each samples (1:1 in 2 x SDS loading buffer) were loaded on an 8% SDS 
polyacrylamid gel and separated by electrophoresis before transfer on nitrocellulose membrane for 
Western blotting. Invitrogen mouse V5 tag directed primary antibody was diluted 1:5000.  
 
The molecular weight (MW) of proteins was verified by comparing bands to the prestained 
protein marker bands. For the different constructs specific single bands were obtained except 
for MBD3. Since extracts were made in parallel and the MBD3 ladder was always observed 
in different experiments, it is likely that the laddering was rather due to posttranslational 
modifications than degradation. 
3.1.3  In vivo analysis of protein interaction 
Co-immunoprecipitation of interacting proteins 
N-CoR is a platform protein essential for the recruitment of histone deacetylases and for the 
formation of the transcription repressor complex, which is endogenously expressed in 293T 
cells. Therefore, endogenous N-CoR was immunoprecipitated from NETN whole cell extract 
(WCE) and co-immunoprecipitating factors were analysed by Western blotting. N-terminus 
directed specific polyclonal antibodies were used to immunoprecipitate endogenous N-CoR 
rather than available efficient carboxy-terminal directed antibodies which could have 
disrupted or impeded the interaction with potential partners. Although, the different V5 tagged 
proteins were successfully expressed and N-CoR was effectively immunoprecipitated; no co-
immunoprecipitation was observed with MBD3, ESET (Fig. 10) or CtBP (data not shown).  
 
 
 Results 
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Figure 10: N-CoR immunoprecipitation 
293T cells were lysed in NETN buffer 48 h after transfection with vectors encoding for the different 
interaction partners. Endogenous N-CoR was immunoprecipitated with guinea pig-specific antibody 
against N-terminal of N-CoR and detected by Western blot with rabbit-specific antibody against the C-
terminal region of N-CoR. The interacting partners were detected with mouse anti-tag epitope 
antibodies. As negative controls, comparable amounts of preimmune sera are used (IgG). (A) 
Overexpressed MBD3 is nicely detected in the input lane but not with the immunoprecipitated N-CoR 
(Ip) in the middle lane. (B) Although expressed ESET protein and N-CoR are detected and specifically 
immunoprecipitated, no co-immunoprecipitation of both proteins is obtained.  
Interestingly, in vivo interaction was determined with the RNA recognition motif containing 
protein NonO. Exogenous NonO-V5 was first observed to associate with endogenous N-CoR 
(Fig. 11 A). Since no antibody was commercially available, antibodies from previously 
published works were required and kindly provided by A. M. Traish (Pavao et al. 2001). With 
these specific antibodies NonO could be detected and immunoprecipitated, respectively. 
Endogenous NonO was co-immunoprecipated with both overexpressed Flag-N-CoR and 
endogenous N-CoR (Fig. 11 B).  
 
 
 
 
 
Figure 11: NonO interacts with N-CoR in vivo 
(A)  N-CoR was immunoprecipitated from 293T cell lysat expressing exogenous NonO-V5. Co-
immunoprecipitated NonO is detected with anti V5 antiboy. Immuno-cross reaction renders heavy 
chain of antibodies used for immunoprecipitation visible. Comparable amounts of antibody are 
observed in the control reaction (IgG). (B) Flag-N-CoR was overexpressed in 293T cells and was 
immunoprecipitated using guinea pig serum directed against N-CoR N-terminus or antibody against 
the Flag epitope. Endogenous NonO co-immunoprecipitates in both cases.  
Receiving NonO-specific antibodies suitable for immunoprecipitation we could performed the 
reverse immunoprecipitation. Endogenous NonO was successfully precipitated from 293T 
NETN whole cell extract and endogenous N-CoR was specifically co-immunoprecipitating 
(Fig. 12).  
 Results 
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Figure 12: endogenous NonO coimmunoprecipitates with endogenous N-CoR  
Immunoprecipitation of N-CoR and reverse immunoprecipitation both show association of endogenous 
NonO with N-CoR. N-CoR immunoprecipition was performed as previously whereas endogenous 
NonO was pecipited with 0.5 µl mouse-specific antibody (78-1-C6) and detected in the Western blot 
with rabbit-specific antibody (403A/NMT-5 aa 371-386).  
Co-localization of interacting proteins 
To confirm co-immunoprecipitation experiments, colocalization of both interacting proteins 
was analyzed by confocal laser scanning microscopy in NIH 3T3 epithelial cells which 
contain high endogenous levels of N-CoR and have large nuclei. NonO-V5 was exogenously 
expressed and optimal immunostaining conditions were established to specifically detect 
endogenous N-CoR and tagged NonO. Colocalization of endogenous N-CoR with 
overexpressed NonO was observed (Fig. 13). Based on the results obtained in 
coimmunoprecipitation and colocalization experiments, NonO/p54nrb RNA/DNA binding 
protein was the focus of further investigations.  
 
 
 
 
 
 
Figure 13: Endogenous N-CoR and overexpressed NonO-V5 co-localize in NIH 3T3 cells 
Immunofluorescence images of endogenous N-CoR and exogenously expressed NonO-V5 shows co-
localization of these proteins in NIH 3T3 mouse epithelial cells. Cells were grown and transiently 
transfected with mammalian NonO-V5 tag expressing vector in 12 well dishes on cover slips. 24 h 
after transfection, cells were fixed, permeabilized and immunostained. Nuclei (bleu) were visualized by 
TO-PRO-3 iodide (Molecular Probes) staining which excitation wavelength is 633 nm. Cross reaction 
and secondary antibodies specificity were tested and did not show any background signal. The 
subcellular localisation of N-CoR (red) and NonO (green) and colocalization (merg in yellow) were 
assayed by confocal microscopy sequential scan.  Results 
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3.2  Role of NonO in the regulation of N-CoR repressive activity  
3.2.1  Analysis in the presence of exogenous NonO  
The co-immunoprecipitation and colocalization of NonO with N-CoR strongly support that 
these proteins interact in vivo. To determine the functional relevance of this interaction, it was 
first analyzed whether N-CoR repressive activity is affected by NonO in the well established 
Gal4-reporter assay.  
Functional analysis using the Gal4 UAS-TK reporter assay 
In this Gal4-reporter, the luciferase expression is under the control of the thymidine kinase 
(TK) promoter and a repeat of two Gal4 response elements (UAS). Proteins or domains of 
the protein of interest are fused to the Gal4-DNA binding Domain (DBD). This region of the 
transcriptional activator Gal4 is sufficient for binding of the fusion protein to the response 
element on reporter DNA. Transcriptional activity is determined by measuring luciferase 
activity. It is known that N-CoR repressive activity is mostly due to corepressor complex 
formation and the recruitment of HDACs. The well-defined repression domains that are 
essential for corepressor complex formation, are contained in the N-terminal half of N-CoR. 
In the Gal4 luciferase reporter assay N-CoR amino-terminal half fused to the Gal4-DBD 
represses whereas fusion protein containing the conserved extreme C-terminus does not 
(Fig. 14). 
 
 
 
 
 
Figure 14: N-CoR repressive activity can be measured with the Gal4-reporter 
To analyze the transcriptional activity of different N-CoR domains, Gal4-reporterwas cotransfected 
with the different constructs fused to the Gal4-DBD. Luciferase activity obtained while overexpressing 
Gal4 transcription activator DBD is considered as the basal reporter activity. Gal4-DBD-N-CoR Nt 
(Gal-Nt) has repressive activity in comparison to Gal4-DBD and Gal4-DBD-N-CoR Ct (Gal-Ct). The N-
CoR C-terminal region has a similar activity as the reporter alone (mock transfected). Relative 
luciferase activity was determined by normalization to levels of β galactosidase expression directed by 
the SV40 β-galactosidase internal control. The graph represents the mean of three independent 
experiments done in triplicates.  
The effect of NonO on N-CoR repressive activity was assessed by expressing increasing 
amounts of exogenous NonO with the Gal4-reporterin the presence of Gal-N-CoR full-length 
(FL). NonO overexpression, even at the highest concentration (0.5 µg), did not significantly 
affect either the fold repression or transcriptional activity of the reporter (Fig. 15).  
 Results 
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Figure 15: N-CoR repressive activity is not affected by NonO overexpression 
0.3 µg Gal4-repoter and 0.3 µg Gal4-DBD or Gal-N-CoR FL expression plasmid with increasing 
amounts of NonO expression vector (0, 0.1, 0.3, and 0.5 µg) were transiently transfected into 293T 
cell. Empty expression vector was used as a mock control. (A) Gal4-N-CoR FL-dependent fold 
repression is similar in the absence or presence of overexpressed NonO. The indicated standard 
deviations represent two independent experiments done in triplicates. (B) Although luciferase activity 
shows some variations within an experiment, these are not NonO concentration-dependent. 
With this assay it was also tested if NonO itself harbors a repressive activity. Therefore, the 
NonO full-length coding sequence was cloned into the pCMX-Gal vector. A Gal-N-CoR-Nt 
expressing vector was double digested with Sal I / Eco RI and the insert encoding N-CoR 
was replaced with NonO full-length sequence. The NonO insert was amplified with primers 
containing Sal I and Eco RI restriction sites. pCMX-Gal-NonO was cotransfected with the 
Gal4-reporter and luciferase activity was measured 48h after transfection. We observed 
strong repressive activity of the Gal-NonO fusion protein in this reporter assay (Fig. 16 A). 
However, the observed repression remained upon TSA treatment (Fig. 16 B), suggesting that 
the observed repression is histone deacetylase-independent.  
 
 
 
 
 
 
Figure 16: NonO shows repressive activity in the Gal4-reporter 
(A) Increasing amounts (0.1, 0.2, 0.3 µg) of Gal4-DBD and Gal-NonO were co-transfected with Gal4-
reporter (0.8 µg) in 293T cells. The basal reporter transcriptional activity is dependant on the Gal4-
DBD concentration. In contrast Gal-NonO repression activity barely changes while increasing 
expression vector amount. Average induction values were determined from two experiments done in 
triplicates.  (B) 24 h after transfection of Gal4-reporter with 0.1 µg Gal4-DBD versus Gal-NonO 
expressing vector, 293T cells were treated with TSA (100 nM) for 24 h. HDACs inhibitors as TSA can 
enhance slightly basal transcription, which is observed in panel B left. Right panel, TSA treatment 
does not relieve repression that is obtained in the presence of Gal-NonO. Average induction values 
were determined from one experiment done in triplicates. Results 
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It is conceivable that Gal-NonO recruits N-CoR to the promoter region and the presence of 
the nuclear receptor corepressor is sufficient for repression. Alternatively it is also possible 
that Gal-NonO enhances stable complex formation with other factors that are involved in 
other processes such as splicing. The resulting occupancy of this regulatory region may be 
sufficient to affect the accessibility of the promoter to the basal transcription machinery. 
It is thought that transiently transfected plasmids assemble with histones into a nucleosome-
like structure but that the chromatin context is thereby only partially achieved. Since N-CoR 
is involved in co-repressor complex formation and in the histone deacetylase mediated 
transcriptional repression, we have analyzed if NonO affects N-CoR repressive activity in a 
chromatin context dependent manner. A similar reporter assay was performed in HeLa cell 
lines containing the Gal4-reporter stably integrated into their genome. The calcium 
phosphate transfection method was used to introduce Gal4-DBD or Gal-N-CoR expression 
plasmids into HeLa cells. Unfortunately, due to the stability of the luciferase protein and 
transfection efficiency, the basal luciferase activity was not significantly affected upon 
exogenous Gal-NCoR expression (Fig. 17). Thus, this cell line could not be used to 
investigate transcriptional repression and the effect of deacetylase inhibitors such as 
trichostatin A (TSA) or valproic acid (VPA) in the presence of exogenous NonO in a 
chromatin context. A cell line containing stably integrated Gal4-reporter and Gal-N-CoR 
coding sequences may have been suitable to determine if NonO affects N-CoR histone 
deacetylase-dependent repression activity. A HeLa cell line was available but was resistant 
to transfection although a variety of efficient transfection methods were tested. 
 
 
 
 
 
Figure 17: Transcriptional regulation of the stably integrated Gal4-reporter in HeLa cells  
4.7 x 10
4 HeLa cells containing a Gal4-reporter integrated into their genome were grown on 12 well 
plates 24 h before transfection. 1.4 µg total DNA per well were calcium phosphate transfected 
including 0.3 µg Gal4-DBD or Gal-N-CoR FL with or without 0.5 µg NonO expression vector, 0.1 µg 
SV40 β-galactosidase control vector, 0.1 µg GFP expression vector and psp fill vector to supplement 
to equal amount of DNA. No significant Gal-N-CoR FL-dependent repression was measured. Two 
independent experiments were performed in triplicates and one representative experiment is shown. 
With the Gal4-reporter Gal-N-CoR FL repressive capacity could be evaluated. In this assay 
strong transcriptional repression is obtained in the presence of Gal-N-CoR-Nt containing 
HDAC interaction domains whereas no effect was observed in the presence of Gal-N-CoR Ct Results 
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which contains the nuclear receptor interaction domain. However, with the transiently 
transfected Gal4-reporter no significant variation of the Gal-N-CoR full-length repression was 
measured upon exogenous NonO expression. This may suggest that NonO does not affect 
corepressor complex formation or that endogenous NonO which is abundantly expressed in 
293T cell is sufficient. To ensure that NonO is effectively not involved in the corepressor 
complex formation reporter experiment should be performed in the absence of NonO using 
RNA interference to specifically down regulate this protein. 
3.2.2  Analysis in the absence of endogenous NonO  
Specific down-regulation of protein expression by small interfering RNA 
Interfering RNA is a novel tool to determine protein function by down-regulation of gene 
expression. Recently, several plasmid vectors have been developed that direct transcription 
of small hairpin RNAs, which are processed into functional small interfering RNAs (siRNAs) 
by cellular enzymes (Brummelkamp et al. 2002). Therefore, the pSuper RNAi System 
(oligoengine) was chosen to analyze NonO function by specifically down-regulating 
endogenous NonO expression. The pSuper vector had to be modified to achieve successful 
cloning (Fig. 18). This modified pSuper vector (pSuper +) was only used to obtain large 
amounts of double digested vector required for cloning.  
 
 
 
 
 
Figure 18: pSuper modifications to optimize cloning  
In the original vector cloning restriction sites Bgl II and Hind III were spaced only by 6-nt which 
drastically reduced double digestion efficiency and successful cloning. (A) A DNA fragment out of N-
CoR coding sequence was cloned in pSuper to separate (949-nt) Bgl II from Hind III restriction sites. 
(B) The inserted fragment was digested with Bgl II and BamH I generating Bgl II compatible cohesive 
ends and was cloned into Bgl II digested pSuper. Bgl II (A/GATCT) / BamH I (G/GATCC) ligation 
product is no longer a recognition site for these endonucleases. Insert orientation was checked by 
digesting recombined vector with Bgl II / Hind III and Eco RI / Bgl II. Clone 4 and 5 contain the spacer 
DNA fragment in the advantageous orientation (B left panel). Eco RI / Bgl II digestion of these both 
clones shows the vector backbone lacking a 281 bp fragment which is not visible (B right panel). 
Two NonO mRNA specific target sites were determined (Fig. 19) for which corresponding 
oligonucleotides were synthesized and cloned into pSuper vector. NonO and PSF antisense 
(AS) containing vectors were also tested for comparison and were kindly provided by Phil 
Tucker (unpublished). These vectors contain full-length NonO and PSF antisense coding 
sequences. The antisense transcripts can interact with the complementary mRNA and 
thereby inhibit its translation and enhance double strand RNA degradation. This method is Results 
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now considered to be less efficient and more toxic for cells than inducing selective 
degradation with small interfering RNAs (Kurreck 2003).  
 
 
 
 
 
Figure 19: Two different target sequences were chosen for siRNA design 
(A) Two different target sequences were chosen to design NonO-specific small interfering RNA. (B) 
Oligonucleotides are designed to fold once transcribed into a RNA hairpin structure which is 
processed to functional siRNA in the cell. Therefore they contain a unique target sequence of 19 to 23 
nucleotides (19-23nt) in both sense and antisense orientation separated by 9 nucleotides (9 nt) spacer 
sequence. The resulting transcript of the recombinant vector folds back onto it self to form a 19-23 
base pair stem-loop structure. (C) Oligonucleotide I and II contain a unique sequence (Si I and Si II) 
derived from the mRNA transcript of mouse NonO (sp|Q99K48|NONO_MOUSE). Corresponding sites 
for Si I and Si II are 487-508 (exon 5) and 1246-1266 (exon 9) nucleotides, respectively. These 
regions are identical in mouse or human NonO coding sequence and differ, partially for Si I and totally 
for Si II, from the sequence of the homologue PSF (polypyrimidine tract-binding protein-associated 
splicing factor) which shares high homology with NonO particularly in the RRM region.  
The unmodified pSuper vector was transfected into cells as a negative control and not 
pSuper+ which contained a DNA fragment out of N-CoR coding sequence that may cause 
undesirable effects in the cells. 293T cells were harvested 48 h and 72 h after transfection 
with the silencing vectors, pSuper, pSuper NonO Si I and Si II, and the antisense expressing 
vectors. Efficacy of the siRNAs was first checked at the mRNA level and subsequently at the 
target protein level (Fig. 20 A). 
 
 
 
 
Figure 20: Analysis of the potency of siRNAs directed against NonO  
(A) Total RNA was isolated from 293T cells grown on 10 cm dishes and harvested 48 h after calcium 
phosphate transfection with 10 µg DNA. 0.5 µg total RNA was reverse transcribed in cDNA which was 
analyzed by semi-quantitative PCR (25 µl reaction contained 1 µl cDNA diluted 1:40 and 0.1 U 
polymerase). For each primer pair cycling and Tm were optimized (p54nrb: 35 x at 62°C / GAPDH: 34 
x at 55.8°C). Untransfected 293T cells show the same amount of NonO mRNA as pSuper or Si I 
transfected cells. Si II and AS-NonO affect effectively NonO mRNA content. AS-PSF reduces also 
NonO mRNA. (B) No extensive NonO protein down regulation was observed even 72 h after 
transfection. Tubulin was detected as a protein content loading control. Results 
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Si II NonO-AS pSuper
The mRNA analysis showed that Si II and NonO-AS were efficiently mediating NonO-specific 
mRNA degradation in 293T cells whereas degradation was observed neither in pSuper nor in 
Si I transfected cells. The NonO-mRNA down-regulation which was observed after 
transfecting PSF-AS vector is presumably due to the high homology of both protein coding 
sequences. Unfortunately, efficacy of Si II and NonO-AS was low at the protein level even 3 
days after transfection (Fig. 20 B). Although no significant specific down-regulation of the 
protein NonO was archieved an unspecific toxic effect of the NonO-AS silencing vector could 
be observed by microscopy (Fig. 21). Cells were not growing properly after transfection of 
the vector containing NonO full-length antisens, limiting protein analysis over 3 days after 
transfection.  
 
 
 
 
 
 
 
 
Figure 21: Toxic effects are observed after transfection of NonO AS but not NonO Si II 
293T cells were PEI transfected with the different pSuper constructs and the NonO-AS expressing 
vector. GFP was cotransfected to verify transfection efficiency. 72 h after transfection noticeable cell 
growth differences were observed by microscopy. Cells expressing NonO-AS did not grow properly 
and the AS transcript seemed to be toxic for the cells whereas cells expressing Si II were growing in a 
comparable manner to cells transfected with pSuper. 
Because of the variability in protein stability and turnover rates in biological systems, the time 
course and degree of protein reduction may differ significantly from that of the target mRNA. 
To verify that NonO protein level differ significantly from that of its mRNA due to its stability 
and low turnover rate, 293T cells were treated with translational (cycloheximide) and 
proteasome (MG132) inhibitors over 24 h and compared to HDAC2 stability (Krämer et al. 
2003) (Fig. 22). In this experiment we observed that the protein NonO is rather stable and 
has a low turn-over rate. 
 
 
 Results 
  69
A
B
CHX MG 132 EtOH
α Tubulin
α NonO
α Tubulin
α HDAC2
Time, hrs 2 4716 24 24716 24 24716 24
α NonO
Poly-ubiquitinylated
PSF
Short exposure
Long exposure
NonO
 
 
 
 
 
 
 
 
 
 
 
Figure 22: NonO protein has a low turnover rate 
5 x 10
5 293T cells were seeded on 6 well plates and were exposed for the indicated period of time to 
the ethanol (0.05%), translation inhibitor cycloheximide (1 µg/ml) and proteasome inhibitor MG 132 (5 
µM). Cells were harvested all simultaneously boiled in 250µl 2 x SDS loading buffer, twice sonicated 
(10 puls) and 5-8 µl were loaded on 8% SDS acrylamide gel. Protein levels of HDAC2, NonO and 
tubulin were determined by Western blot analysis. (A) The expression of HDAC2 relative to Tubulin 
expression was reduced after 24 h cycloheximide treatment and its degradation was proteasome-
dependent. (B) NonO translation and degradation were not sensitive to protein translation inhibitor and 
to proteasome inhibitor treatment, respectively. A shorter exposure in the middle of panel B, shows 
rather constant amount of endogenous NonO at 55 kDa. A long exposure is shown in B above, to 
observe if higher migrating bands like potential polyubuquitinylated form of NonO were detectable. No 
significant time-dependent signal appeared. PSF is detected by NonO-specific antibody and appears 
in all samples at 100 kDa. Tubulin protein levels were determined to compare signal intensity and 
protein content. 
This result indicates that no effective down-regulation of protein expression was achieved in 
an appropriate time span to analyze variations in functional assays performed 48 h after 
transfection although the Si II specifically induced NonO mRNA degradation. In addition it 
was observed that NonO down-regulation induced senescence (G0 arrest) in transformed 
human cells (P. Tucker personal communication). Therefore, no functional assays were 
performed by sequential double transfection experiments with NonO directed siRNA, which 
would efficiently down-regulate NonO protein but led to cell growth arrest. Since neither 
overexpression nor silencing strategies were conclusive, mapping of N-CoR/NonO 
interaction regions was performed in in vitro assays in order to define potential interaction 
regions and create deletion mutants that were then tested in reporter assays looking for 
dominant-negative effects. 
 Results 
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3.2.3  Construction of NonO deletion mutants 
Mapping of interaction regions by in vitro binding assay  
In the NonO protein (non POU domain containing octamer binding protein/ p54nrb) several 
domains and motifs have been defined (fig. 19). Considering the different defined modules 
constituting its structure, two Glutathion-S-transferase (GST) fusion proteins were first tested 
containing the N-terminal half (1-237 aa) with the two RNA recognition motifs and the NonO 
C-terminal half (238-472 aa) containing the helix turn helix motif. Recombinant proteins were 
expressed in E.coli BL21 Codon Plus and purified using glutathion-agarose beads. The N-
CoR C-terminal region (1629-2453 aa) was translated in vitro using the TNT-coupled 
reticulocyte system and labeled with 
35S
 methionine. Both TNT translated protein and fusion 
proteins were incubated together, washed several times and GST-pulldown reactions were 
analyzed by SDS PAGE followed by autoradiography. The NonO region interacting with N-
CoR was determined to be in the NonO amino-terminal half (Fig. 23).  
 
 
 
 
 
 
 
Figure 23: The carboxy-terminus of N-CoR interacts in the N-terminal region of NonO 
35S labeled in vitro translated N-CoR Ct (5 µl) was incubated 20min at 37°C with GST or GST-fusion 
proteins bound to glutathione agarose beads (50 µl) in PPi (0.02% NP40) buffer. After 5 washes 
proteins retained by the GST-fused proteins were analysed by SDS PAGE (8-10% gel) followed by 
autoradiography. Coomassie staining of the gel (lower panel) shows equal amounts of fusion protein 
used for this assay. (Upper panel) The input band intensity corresponds in this experiment to the total 
amount of TNT translate added to each reaction. No background signal was obtained with GST. GST-
NonO FL (1-472) and GST-NonO Nt (1-237) show direct interaction with 
35S N-CoR Ct (1679-2453) in 
contrast to GST-NonO Ct (238-472) which does not. 
Deletion of the N-CoR interaction region in NonO 
Since the N-CoR interacting region of NonO contains two RNA recognition motifs (RRM) and 
these domains could be involved either in RNA binding or in protein-protein interaction two 
deletion mutants lacking one of these RNA recognition motifs were constructed (Fig. 24). 
Required sequence and structure information for cloning were obtained from NCBI, Expasy 
and PROSITE data bases. 
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Figure 24: NonO RRM deletion mutants  
NonO deletion mutants lacking RRM1 (86-160 aa) and RRM2 (160-227 aa) were obtained by deletion 
of the coding sequences (258-480 bp) and (480-681 bp) in the pENTR NonO full-length (1-1422 bp), 
respectively, using endogenous restriction sites (Eco RV and Bsa AI) or inserted restriction site (Nru I) 
by site directed mutagenesis (SMD). After digestion control and sequencing, inserts were transferred 
in Gateway expression vectors (pEF6-DEST 51 / pDEST 14) by recombination. For cloning in the 
pGEX AHK vector deletion mutant sequences were amplified by PCR with the adapted primer pair (Fw 
(start) NonO (EcoRI) / Rev (1422) NonO (XbaI)). 
It was possible to modify the NonO full-length coding sequence within the pENTR vector with 
restriction endonucleases since the required enzymes presented a limited number of specific 
restriction sites in the insert and vector sequences. Restriction sites of interest were 
surrounding RRM target sequences, producing blunt-ends in reading frame. RRM1 and 
RRM2 sequences were deleted from the NonO full-length sequence in pENTR. After 
relegation, amplification in E.coli plasmids was verified by enzymatic digestion and 
sequencing (Fig. 25). From the pENTR plasmids, the coding sequences of NonO RRM1 and 
RRM2 deletion mutants were transferred by recombination in compatible Gateway vectors 
(pEF6-DEST 51 and pDEST14) or by classical cloning using adated primers for amplification 
and cloning in pGEX and pCMX vectors. 
 
 
 
 
 
Figure 25: Deletion mutant cloning strategy 
(A) Position of the different restriction sites of interest for deletion in the insert and vector. (B) Deletion 
of RRM1 (258-480 bp) coding region was achieved by digesting with Bsa AI (480) and Eco RV (258). 
Since  Bsa  AI was a unique restriction site, 10 µg pENTR NonO (3700 bp) was first linearized 
(overnight digestion) before 1 minute partial digestion with Eco RV that presents two additional sites in 
the vector backbone. From the different digestion products the linearized fragment lacking 219 bp was 
isolated, religated and amplified. For RRM2 an additional Nru I restriction site was incorporated by 
site-directed mutagenesis at position 681 of the NonO coding sequence. (C) By Nru I digestion control 
positive clones show an insert loss (1346 bp). Nru I mutated vector was linearized with Bsa AI and 
sequentially partial digested for 2 minutes with Nru I. Largest fragment lacking 204 bp was amplified 
after agarose gel extraction and ligation. All pENTR NonO constructs were control digested with Bam 
HI / Not I (D) and sequenced before cloning into expression vectors. Results 
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3.2.4  Analysis of NonO deletion mutants 
In vitro binding assay 
GST-pulldown assays were performed with the purified NonO deletion mutants fused to the 
GST catalytic domain. The in vitro translated 
35S
 methionine labeled
 N-CoR (1679-2453) was 
specifically retained by GST-NonO full-length (FL), GST-NonO N-terminus (1-237) and GST-
Δ RRM2 immobilized on glutathion-agarose beads, whereas no interaction was detected with 
GST-Δ RRM1 (Fig. 26 A). Since interaction between N-CoR Ct and NonO was impaired with 
the mutant lacking the RRM1 motif, this region was fused to GST and tested for binding with 
35S
 N-CoR (1679-2453). N-CoR Ct retention could be detected with GST-RRM1 suggesting 
that the RRM1 motif is essential and sufficient for the interaction (Fig. 26 B). 
 
 
 
 
 
 
 
Figure 26: N-CoR interaction is disrupted by deletion of the RRM1 motif of NonO 
GST-pulldowns were executed as previously described. The input lane represents 10% of total 
35S-
labeled protein used in each interaction. No unspecific association with GST alone was observed. (A) 
Coomassie staining of the gel (lower panel) shows equal amounts of fusion proteins that were used for 
this assay. The autoradiography (upper panel) of this experiment shows that GST-ΔRRM2 was able to 
retain 
35S N-CoR Ct (1629-2543) to the same extent as GST-NonO FL. In contrast 
35S N-CoR C-
terminus is not able to interact with the deletion mutant lacking the RNA recognition motif 1 (GST-
ΔRRM1). (B) The NonO RRM1 motif is sufficient for the interaction with N-CoR Ct.  
In vivo analysis  
Since the deletions were performed in the pENTR-NonO vector the modified coding 
sequences were easily transferred into the pEF6-DEST 51 mammalian expression vector by 
recombination. Overexpression of the different NonO mutants in 293T cells was analyzed by 
Western blot using an antibody directed against the V5-tag. Both RRM1 and RRM2 deletion 
mutants were detected in whole cell extracts and in the nuclear fractions, in which NonO full-
length is found, (Fig. 27). As expected, nuclear localization was not impaired since the 
predicted nuclear localization signals were downstream of the deleted regions. 
 Results 
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Figure 27: Nuclear localization of NonO and RRM deletion mutants 
On 10 cm plates 293T cells were PEI transfected with 15 µg DNA and harvested 48 h after 
transfection. (A) In whole cell extract all the different NonO constructs (full-length, RRM1 and RRM2 
deletion mutants) were efficiently detected with anti V5 antibody at the different expected molecular 
weights. (B) A fractionation short protocol was used to verify localization of the deletion mutants. As 
the exogenous NonO wild type deletion mutants are localizing in the nuclear fractions. For NonO 
detection in Western blot analysis a total amount of 5µg of protein is sufficient. 
NonO was described to be modified in a cell cycle-dependent manner. It is 
hyperphosphorylated upon mitosis (Proteau et al. 2005). Protein analysis of synchronized 
293T cells was performed to determine wether the deletion affects posttranslational 
modifications of the NonO mutants. 293T cell synchronization was monitored by microscopy 
and Hoechst chromatin staining (Fig. 28). 
 
 
 
 
 
 
 
 
 
Figure 28: 293T cell synchronization with thymidine / nocodazole treatment 
3 x 10
6 293T cells were grown on 10 cm dishes. Cells were synchronized by sequential treatment with 
thymidine (16 h) and nocodazole (16 h) after an intermediate release step of 8 h. (A, left panel) 
Untreated 293T cells grow asynchronously to confluency whereas thymidine and nocodazole treated 
cells arrested in the G2/M phase are no longer adherent and adopt a spherical shape. (A, right panel) 
Hoechst/DAPI staining enables chromatin visualization under UV illumination. Imaging was performed 
with a Zeiss Axiovert 200M microscope and a Zeiss Axiocam camera. Filter setting was 01Ex 365/12 
for Hoechst/DAPI staining and excitation was optimal at 365 ± 6 nm wave length. Condensed 
chromatin events are very frequent in the synchronized cells blocked in the G2/M phase in comparison 
to asynchronously growing cells. (B) Higher magnification of synchronized cells after double block 
shows typical mitotic condensed chromatin in the nuclei. Results 
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For  the  protein  modification  analyses  cells  were  harvested  with  RIPA  buffer  containing 
freshly added protease and phosphatase inhibitors. SDS PAGE and immunoblotting  were 
performed  with  equal  amounts  of  protein.  Endogenous  NonO  protein  showed  a  clear 
additional band after Nocodazole treatment (Fig. 29).  
 
 
 
Figure 29: Posttranslational modification of NonO during mitosis 
Cells  were  lysed  at  different  treatment  time  points  (T:  16  h  thymidine;  R:  8  h  release;  N:  16  h 
nocodazole) in RIPA buffer containing additional phosphatase inhibitors such as sodium fluorid and 
sodium orthovanadate. To ensure detection of posttranslationally modified endogenous NonO protein 
was immunoprecipitated (mouse α NonO) and detected with rabbit NonO-specific antibody (1:5000) in 
Western  blot.  The  same  protein  amounts  were  used  for  the  immunoprecipitation  with  the  same 
amount of precipitating antibody, mouse IgG were used for the negative control. As a control, non-
synchronized cells were lysed at the different time points in the same buffer (CT: 16 h thymidine; CR: 8 
h release; CN/T: 16 h nocodazole). A double band is noticeable in all control samples whereas this 
band  is  not  visible  in  extracts  from  thymidine-arrested  cells.  Modified  NonO  levels  (upper  arrow) 
increase between G1/S phase (thymindine-arrested) and G2/M phase (nocodazol arrested). 
Cell  cycle-dependent  modifications  were  also  detected  for  the  RRM1  deletion  mutant  in 
contrast to the RRM2 deletion mutant (Fig. 30). 
 
 
 
 
 
Figure 30: Cell-dependent modification of NonO deletion mutants 
RIPA extracts were made from cells harvested at different treatment time points (T: 16 h thymidine; R: 
8 h release; T/N: T+R+16 h nocodazole and C: untreated). 50µg of protein were loaded on an 8% 
SDS acrylamide gel. Electrophoresis was run until the 47.5 kDa marker bands reached the bottom of 
the gel. Separated proteins were then transferred onto a nitrocellulose membrane for Western blotting. 
Protein  loading  control  was  checked  by  detecting  PLCγ  (148  kDa).  NonO  overexpressed  deletion 
mutants were detected with anti-V5 antibody (1:5000). Mock transfected cells do not express any V5 
tagged proteins (left) but show variations in N-CoR level. ΔRRM1 is nicely expressed and shows cell 
cycle phase dependent modification whereas ΔRRM2 does not. In addition significant differences in N-
CoR  protein  levels  are  observed  compared  to  those  in  mock-transfected  cells  especially  in  the 
presence of ΔRRM2. 
Interestingly,  when  N-CoR  protein  levels  were  analyzed  at  different  time  points,  a  clear 
reduction of signal intensity was observed in the presence of overexpressed RRM2 deletion 
mutant in comparison to mock-transfected cells or to cells transiently expressing the RRM1 
deletion mutant. This suggests that overexpression of the RRM2 deletion mutant may impair Results 
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N-CoR protein regulation and/or stability. Whether this effect is due to the impaired function 
of the mutant lacking the RRM2 domain and altered cycle-dependent modification could not 
be elucidated. In protein analysis of synchronized cells, we observed that N-CoR protein 
level varies in G2/M arrested cells (T/N) in the presence of the NonO deletion mutants. To 
assess whether NonO mutants can affect N-CoR repressive activity reporter assays were 
performed with both mutants and compared to the effect obtained in the presence of NonO 
wild type. 
Analysis in Gal4-reporter assay 
The deletion mutants were first tested in the Gal4-reporter assay in the presence of Gal-N-
CoR full-length. The N-CoR repressive activity in this assay was affected by overexpression 
of NonO deletion mutants although exogenous NonO expression did not. Both mutants 
enhanced repression in a concentration-dependent manner although ΔRRM2 to a lesser 
extent then ΔRRM1 (Fig. 31). Since in the Gal4-reporter assay effects obtained in the 
presence of exogenous NonO and mutants differed, the effect of these mutants was further 
investigated in additional functional assays. Therefore, reporters under the control of nuclear 
receptor response elements such as thyroid receptor (TRE), retinoic acid (RARE) or 
estrogen nuclear receptor (ERE) were employed to investigate NonO and mutant effects.  
 
 
 
 
 
 
 
 
Figure 31: Gal-N-CoR repression activity is affected by overexpression of RRM deletion 
mutants 
Reporter assays were performed on 12 well plates in triplicates. Fold repression was calculated 
comparing normalized luciferase activity obtained with Gal4-DBD and Gal-N-CoR full-length (1-2543). 
0.5 µg Gal4-repoter and 0.3 µg Gal4-DBD or Gal-N-CoR FL expression plasmid were cotransfected in 
293T cells with increasing amounts of NonO or RRM deletion mutant expression vectors (0, 0.1, 0.3, 
and 0.5 µg) transiently cotransfected into 293T cell. Exogenous wild type NonO does not affect Gal-N-
CoR full-length dependent repression whereas ΔRRM1 expression enhances repression in a 
concentration-dependent manner. ΔRRM2 also impairs N-CoR repression but to a lesser extent. Fold 
repression is increased in the presence of NonO RRM deletion mutants lacking the first or second 
RNA recognition motifs. The graphs represent the mean of three independent experiments. Results 
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3.3 Role of NonO in nuclear receptor-dependent transcription 
3.3.1  Nuclear receptor-dependent reporter assays 
N-CoR is involved in a number of transcriptional repression processes and it is recruited by 
different types of nuclear receptors and transcription factors to target gene promoters. 
Recruitment of N-CoR mediates transcriptional repression which is associated with co-
repressor complex formation, the recruitment of HDACs and the resulting histone 
modifications. Nonsteroid receptors like TR or RAR in the absence of ligand reside in the 
nucleus as heterodimers with RXR (Kliewer et al. 1992) and associate with N-CoR to actively 
repress target genes. However, upon agonist binding they undergo conformational changes 
and become potent transcriptional activators. In contrast, steroid hormone receptors such as 
glucocorticoid and estrogen receptors are retained in the cytoplasm complexed with heat 
shock proteins in the absence of ligands. Ligand binding is required to induce 
homodimerization and translocation of these receptors to the nucleus. N-CoR recruitment by 
this type of receptor is ligand- and DNA binding element-dependent. The association or 
dissociation of cofactors to the nuclear receptors can be investigated in NR-dependent 
transcription assays. To assess whether NonO affects N-CoR nuclear receptor-dependent 
repression, different reporter assays were performed comparing exogenous NonO and 
deletion mutant effects. Thyroid hormone and retinoic acid receptor-dependent reporters 
were used in 293T cells for these investigations as well as an estrogen receptor-dependent 
reporter in MCF7 breast cancer cells. 
The thyroid hormone receptor-dependent reporter 2x DR4 TK Luc (Jow and Mukherjee 1995) 
was tested in 293T cells. Only in the presence of exogenous TR α or β a specific response to 
agonist stimulation with TRIAC (Tri-iodo-thyro-acetic acid) was obtained. Namely, 293T cells 
do not express endogenously thyroid receptor isoforms although they express the 
heterodimerizing partner retinoic X receptor. Exogenous RXR expression with exogenous 
TRs did not improve resulting luciferase activity and the RXR expression vector was 
therefore no longer cotransfected. However, the basal transcriptional activity of this 
transiently transfected reporter was rather low and was not suitable for investigation of 
transcriptional repression modulation (data not shown).  
The RARE-reporter assay (Mangelsdorf et al. 1991) was adapted to cell type and purposes. 
The amounts of cotransfected DNA plasmids (reporter and nuclear expression vectors) were 
modified. Because 293T cells are a highly transfectable cell line, reporter quantity was 
minimized in order to obtain valid luciferase activity measurements. In addition it was 
observed that an excessive amount of reporter renders it less sensitive to stimulation with 
RAR agonist (ATRA) or antagonist (synthetic RAR antagonist mix 193840) for which efficient 
concentrations were determined. Furthermore, in 293T cells endogenously expressing RAR 
and RXR receptors, no significant improvement of the reporter assay was observed upon 
expression of exogenous receptors. Therefore, nuclear receptor expression vector 
cotransfection was omitted. RARE-reporter transfection and stimulation of cells were carried 
out in medium supplemented with 10% charcoal stripped fetal bovine serum to increase 
response specificity. Since RAR/RXR can recruit N-CoR and its homologue SMRT which are 
endogenously expressed in 293T cells it was verified whether this established assay was Results 
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sensitive to N-CoR overexpression or down-regulation by siRNA. Exogenous N-CoR 
expression enhanced repression in the absence of ligand and upon antagonist whereas 
transfecting an N-CoR silencing vector (Ishizuka and Lazar 2003) induced opposite effects 
(Fig. 32). These results confirm that this assay is suitable to investigate the function of N-
CoR/NonO interaction. 
 
 
 
 
 
 
Figure 32: RARE is a suitable reporter assay to investigate the modulation of N-CoR function  
0.3 µg RARE-reporter was cotransfected with 0.2 µg N-CoR expression vector or 0.8 µg N-CoR 
pSilencing vector, SV40 ß-galactosidase internal control and GFP expression vector 24 h before 
treatment. Transfection of 293T cells were carried out in the presence of charcoal stripped serum. 
Cells were harvested 24 h after treatment and luciferase activity was measured. Relative luciferase 
activity (RLU) was determined by normalization to levels of β-galactosidase expression directed by the 
internal control. (A) Exogenous N-CoR expression reduces luciferase transcription in the absence of 
ligand and (B) in the presence of RAR synthetic antagonist (0.1 µM). The opposite effect is observed 
reducing endogenous N-CoR level by transfecting N-CoR silencing vector; however, N-CoR homolog 
SMRT is also endogenously expressed in 293T cells and can be recruited by the retinoic acid 
receptor. Mean of induction values were determined from three independent experiments.  
Interestingly, expression of exogenous NonO affected RAR-dependent reporter regulation 
(Fig. 33). General observed tendency is an enhanced transcription in the absence of ligand 
and in the presence of agonist suggesting that NonO overexpression enhances basal 
transcription as ATRA induced transcription at the different concentrations. However, in the 
presence of antagonist transcription repression remains unchanged upon exogenous NonO 
expression. 
 
 
 
 
 
Figure 33: RARE-reporter response to stimuli is not affected upon exogenous NonO 
expression 
The reporter assay was executed as preciously decribed in the presence and absence of exogenous 
NonO (0.2 µg). Cells were treated for 24 h with RAR antagonist mix 193840 (0.1 µM) (Anta.) and with 
ATRA at two different concentrations (0.1-0.5 µM) (A 0.1 µM; A 0.5 µM). Relative luciferase activity 
was determined by normalizing measured luciferase activity to levels of β-galactosidase expression 
directed by the internal control. (A) Exogenous NonO enhanced basal transcription in the absence of 
ligand but not in the presence of antagonist. (B) In the presence of overexpressed NonO ligand Results 
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concentration-dependent reporter transcriptional activation is enhanced. Mean of induction values 
were determined from two independent experiments.  
Interestingly, in gel filtration assays endogenous NonO was detected in the same high 
molecular weight fractions containing N-CoR. However, upon treatment with retinoic acid 
receptor agonist a shift of NonO to higher molecular weight fractions was observed (Fig. 34) 
suggesting that it is sensitive to agonist simulation. This effect was also seen for RNA 
Polymerase II (Pol II) where complex formation and activity is likely to be enhanced upon 
agonist treatment. NonO was described to interact with Pol II (Emili et al. 2002). To assess 
whether NonO shift was due to its interaction with Pol II co-immunoprecipitation was 
performed with the fractions. Although NonO and Pol II were successfully immunoprecipited 
no co-immunoprecipitation was detected precluding any firm conclusion (data not shown). 
 
 
 
 
 
 
 
Figure 34: Gel filtration analysis upon treatment with the retinoic acid receptor agonist ATRA 
293T cells were grown in medium containing stripped FCS on 10 cm dishes and were treated with 
ATRA (100 nM) for 24 h. Cells were harvest in 600 µl gel filtration lysis buffer. After two rounds of 
sonication (10 pulses) lysates were clarified by sedimentation (10 min at 14000 rpm) and 450 µl lysate 
was applied to a calibrated SUPEROSE 6HR gel filtration column and run by a FPLC apparatus 
(ÄKTA, Amesham Biosciences). One column volume (24 ml) was collected in 1 ml aliquots. Equal 
volumes of collected fractions were subjected to SDS-Page and immunoblotting. (A) Since NonO 
shifted to higher molecular weight fractions upon ATRA treatment, the same experiment was 
performed collecting 500 µl aliquots. (B) 0.5 ml aliquots were collected upon elution to confirm the shift 
obtained with NonO and RNA polymerase II (Pol II) upon ATRA treatment.  
Since N-CoR was not always detectable in gel filtration fractions, especially in the presence 
of ATRA we verified that this was not due to treatment-dependent degradation. Therefore, 
cells were lysed in Laemmli loading buffer and analyzed by Western blot after SDS PAGE 
(Fig. 35). N-CoR protein levels in 293T cells were not affected by ATRA treatment 
suggesting that the lack of detection may be due to antibody detection limits or protein 
degradation occurring during experimental procedures. However, we continued the functional 
assays with the RRM deletion mutants and exogenous NonO wild type. 
 Results 
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Figure 35: N-CoR protein levels are unchanged upon treatment with ATRA 
Endogenously and exogenously expressed N-CoR level were anylized in 293T cells upon ATRA 
treatment. Cells were grown and treated with 100 nM ATRA in medium containing stripped serum. 
Cells were scraped from the dish 24 h after treatment and directly boiled in Laemmli buffer for SDS 
PAGE and Western blotting. Electrophoresis on a 6% acrylamid gel was run over 4 h. N-CoR (270 
kDa) was detected with N-CoR-Ct directed affinity purified polyclonal antibody diluted 1:2000. As a 
loading control PLC γ (148 kDa) was detected. 
Steroid hormone receptor transcriptional regulation differs from that of other nuclear receptor 
classes. Thus, comparable experiments were performed with the estrogen receptor 
dependent reporter (ERE-reporter). For this purpose the ERE-reporter assay was 
established in MCF7 cells which endogenously express estrogen receptors (ER). To ensure 
that the reporter response was ligand-specific and ER-dependent the reporter was 
transfected in MCF7 and 293T cells. In 293T cells which do not express ER ligand-
independent luciferase activity could be measured whereas in MCF7 cells transcription 
activity was estradiol-dependent (Fig. 36). 
 
 
 
 
 
Figure 36: ERE-reporter ligand dependant stimulation in MCF7 
MCF7 cells were plated in RPMI medium supplemented with 10% stripped serum one day before 
FuGENE (Roche) transfection (2 x 10
5 cells per 12 well). 1.4 µg total DNA including 0.6 µg ERE-
reporter, 0.1 µg SV40 β-galactosidase reporter, 0.1 µg GFP expression vector and 0.2 µg NonO FL or 
deletion mutant expression vectors were added to the cells with a reagent/DNA ratio of 3:2. Serum-
free medium was used during transfection and replaced with medium containing stripped-serum 6 h 
later. On the next day cells were treated for 24 h. As estradiol is solubilized in ethanol containing 10% 
DMSO (10
-2M) and diluted to 1.5 mM in 100% ethanol and applied to a final concentration in medium 
of 0.5 µM, cells were treated as control with 100% ethanol diluted 1:3000 in medium. (A) 293T cells 
transfected with the same ERE-reporter reaction mix do not respond to estradiol stimulation whereas 
MCF7 cells do since they contain estrogen receptors (B). The graphs represent the mean of two 
independent experiments done in triplicates. 
NonO wild type and mutants were tested in the ERE-reporter assay and effects were 
compared with those obtained with the RARE-reporter. To facilitate comparison of the results 
obtained in the different reporter assays, normalized luciferase activity was converted to per-
cent, considering NonO wild type values as 100% at the highest agonist concentration. The 
effects that were obtained expressing-NonO or RRM deletion mutants with the different 
reporters differ. Retinoic acid receptor-dependent transcription was affected (Fig. 37 A) Results 
  80
NonO
ΔRRM1
ΔRRM2
%
 
R
L
U
0
75
50
25
Untr.
0
15
10
5
%
 
R
L
U
Anta.
30
70
110
150
R
L
U
 
%
E 0.5µM
0
10
20
30
R
L
U
 
%
Untr.
B
NonO
ΔRRM1
ΔRRM2
A 0.1µM
%
 
R
L
U
A 0.5µM
%
 
R
L
U
%
 
R
L
U
Untr.
A
50
100
200
150
50
100
200
150
0
25
50
whereas estrogen-dependent transcription was not (Fig. 37 B). NonO ΔRRM1 exerted similar 
effects as in the presence of exogenous NonO wild type in the RARE-reporter and ERE-
reporter. However, NonO ΔRRM2 enhanced RAR-dependent transcription to a larger extent 
than in the presence of exogenous wild type NonO and NonO ΔRRM1. This effect was not 
observed with the steroid receptor-dependent reporter. 
 
 
 
 
 
 
 
 
Figure 37: ΔRRM2 mutant enhances transcription in the RARE-reporter 
Reporter assays were performed as described previously in 293T cells and MCF7 cells. For 
comparison of the results obtained in the different reporters in the cell lines normalized luciferase 
activity was converted to percent. (A) In the RARE-reporter (0.2 µg) the RRM2 deletion mutant 
enhances baseline activity and agonist-stimulated transcription. (B) In contrast comparable effects 
were not observed with the ERE-reporter. Mean of induction values were determined from two 
independent experiments for the RARE-reporter and from four independent experiments for the ERE-
reporter. 
The significant increase in luciferase activity in the presence of the RRM2 deletion mutant 
compared to NonO wild type and the RRM1 deletion mutant seems to be reporter-specific 
and ligand-independent since this effect is observed only with the RARE-reporter and upon 
any treatment, untreated, with agonist or with antagonist (Fig. 38).  
 
 
 
 
Figure 38: The ΔRRM2 mutant enhances transcription also upon antagonist treatment 
In the RARE-reporter assay NonO RRM2 deletion mutant overexpression significantly enhances 
transcription in a ligand-independent manner. Either the basal transcription (left panel) or the 
antagonist-dependent repression (right panel) are affected by overexpression of the RRM deletion 
mutants and notably by ΔRRM2 in comparison to NonO wild type. Mean of induction values were 
determined from two independent experiments done in triplicates. Results 
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These observations suggest that NonO may be a modulator of N-CoR function. The stability 
of the nuclear receptor-dependent N-CoR complex seems to be affected rather than co-
repressor complex formation itself since this effect was not observed in the Gal4-reporter 
assay. Supposing that NonO influences nuclear receptor dependent repression level, it is 
conceivable that ΔRRM2 overexpression, lacking the RNA recognition motif 2 which in turn 
impaires its function and affects endogenous NonO function. In order to confirm this 
hypothesis, regulation of endogenous genes was investigated.  
3.3.2  Endogenous gene expression analysis 
Since 293T cells respond to RAR ligand stimulation in RARE-reporter assays without 
exogenous expression of retinoic acid receptors, the regulation of known retinoic acid 
receptor-dependent genes was analyzed in this cell line. Therefore, semi-quantitative PCR 
analysis was performed and established in the human kidney embryonic 293T cell line to 
investigate the regulation of the RARβ2 gene, amongst others genes. Total RNA was 
isolated from 293T cells and randomly reverse-transcribed into DNA. Mature messenger 
RNAs are spliced and lack the intronic sequences that are contained in the corresponding 
genomic DNA sequence. To ensure the distinction of PCR fragments amplified 
complementary DNA (cDNA) or genomic DNA, primers were designed to span intron 
regions. The RARβ2 gene showed a specific and time-dependent response to stimulation 
with ATRA in 293T cells (Fig. 39 A), therefore the analysis of this gene was used to further 
investigate the effects of different NonO constructs in this assay. As internal control the 
GAPDH house keeping gene was chosen, since its RNA expression level was not altered in 
the determined experimental conditions. 293T cells were grown in medium supplemented 
with stripped serum, transfected with empty expression vector (pDEST) versus NonO wild 
type or NonO RRM deletion mutant expression vectors. 24 h after transfection cells were 
stimulated for 24 h or 16 h with ATRA. To obtain comparable cell numbers, cells were 
harvested at the same time point. Total RNA was isolated and its concentration measured by 
spectrophotometry at λ 260 nm. Quality of the isolated RNA products was also checked by 
formaldehyde agarose gel electrophoresis (Fig. 39 B). 0.5 µg RNA was reverse-transcribed 
into cDNA using random hexamers as primers to transcribe the total RNA population so that 
different PCR analyses could be performed on the same cDNA sample. 1 µl of the 1:40 
diluted cDNA reaction was used for PCR analysis. PCR products were loaded onto Ethidium 
bromide-stained, 1.5% agarose gels. Gel images were captured with a CCD camera. A mean 
of several experiments is represented with the corresponding internal control (GAPDH) and 
control samples (pDEST transfected cells) (Fig. 39C). No significant variation of the 
stimulated gene was observed in the presence of overexpressed NonO or RRM1 deletion 
mutant comparing RARβ2-specific signal intensity to that of GAPDH internal control. 
However exogenous expression of RRM2 deletion mutant seems to increase transcription 
which confirms results found in the transient RARE-reporter assay. 
 Results 
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Figure 39: Semi-quantitative PCR analysis of endogenous gene expression in 293T cells 
In 293T cells retinoic acid-dependent gene expression was analyzed upon ATRA treatment. mRNA 
analysis was performed by semi quantitative PCR. (A) RARβ2 gene is responsive to agonist treatment 
in 293T cells. Up-regulation of the gene is observed in a time dependent manner whereas house 
keeping gene expression (GAPDH) is unchanged. (B) Total RNA was isolated from transfected and 
treated cells and its quality was checked by formaldehyde agarose gel electrophoresis. Ribosomal 
RNA subunits 28 S and 18 S appear at a 2:1 ration in clean RNA products. (C) Semi-quantitative PCR 
analysis of the cDNA in the presence of exogenously expressed proteins. Empty expression vector 
pDEST was transfected in control samples. Considering house keeping gene band intensity and 
RARβ2-specific signal, no significant difference in gene regulation is observed comparing mock 
transfected cells to cells overexpressing NonO wild type or the RRM1 mutant and slight transcription 
enhancement is observed in the presence of RRM2 deletion mutant. 
3.4  N-CoR Ct is involved in intramolecular regulation 
Some N-CoR interaction partners have been shown to interact not only with the N-CoR 
amino-terminal region (Nt) which is sufficient for binding but can also interact with N-CoR 
carboxy-terminus (Ct) in vitro (e.g. Sin3A, HDAC3) (Wen et al. 2000). This suggests that 
these two domains may fold independently however are adjacent in the final protein tertiary 
structure. It is conceivable that the carboxy-terminal region is involved in N-CoR 
intramolecular regulation. In GST-pulldown assays, TNT-translated N-CoR Nt (1-549) region 
interacts with the GST fused C-terminal N-CoR region (1954-2453) (Fig. 40).  
 
 
 
 
 
 
Figure 40: N-CoR N-terminal and C-terminal regions interact in vitro 
GST-pulldown assays were performed as previously described. The input lane represents 10% of total 
35S-labeled protein used in each interaction. Coomassie staining of the gel (lower panel) shows some 
degradation products of the GST-Ct N-CoR (1679-2453) in the sample but also the intact full-length 
construct migrating at the correct molecular weight (77kDa) and in comparable amount to GST. 
Autoradiography (above panel) shows direct, specific interaction of the in vitro translated N-CoR Nt (1-
549) with the GST-fused N-CoR Ct. Results 
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In addition in Gal4-reporter assays, the Gal-N-terminus region containing the HDAC 
interaction domains has greater repression potency then the full-length N-CoR protein which 
contains both Nt and Ct regions, suggesting that in the presence of the carboxy-terminus 
some modulation occurs (Figure 4c from (Tiefenbach et al. 2006)) (Fig. 41).  
 
 
 
 
 
Figure 41: Gal-N-CoR full-length represses less than the Gal-N-CoR amino-terminus 
To compare repression potency of different N-CoR regions fused to the Gal4-DBD, UAS-TK-Luc 
reporter (1 µg) was co-transfected with an internal control (SV40 reporter) and the different Gal4 
construct expressing vectors (0.2 µg) into 293T cells on 12 well plates. Fold repression was 
determined relative to the basal reporter activity in the presence of the Gal4-DBD. Gal-N-CoR full-
length and Gal-N-CoR (1-549) (Gal-RDI) show transcriptional repression. However, the repression 
potency or fold repression is greater in the presence of Gal-N-CoR Nt than Gal-N-CoR full-length. This 
was observed in at least three independent experiments. Mean of induction values were determined 
from one experiment done in triplicates. This experiment was performed by Jens Tiefenbach. 
Furthermore, in the RAR-dependent reporter overexpression of Ct-N-CoR (1587-2543) 
impaired transcription activation in the presence of ATRA (Fig. 42). The N-CoR carboxy-
terminus 1587-2543 containing the nuclear receptor binding domain is thought to interact 
with unlignaded receptors at the promoter region. Agonist activation with ATRA induces 
nuclear receptor conformational changes enhancing N-CoR dissociation and coactivator 
recruitment. The equilibrium of dissociation and association is affected in the presence of 
exogenous N-CoR carboxy-terminus expression. 
 
 
 
 
 
Figure 42: N-CoR carboxy-terminus does not dissociate upon activation 
The RARE-reporter assay was performed as previously described. 0.3 µg N-CoR Ct (1587-2453) 
expressing vector was cotransfected with DR5 reporter and an internal control. Normalized luciferase 
activity (RLU) obtained upon stimulation is shown (A) Basal transcription is impaired in the presence of 
N-CoR Ct whereas active repression is not. (B) Transcription activation upon agonist treatment is 
affected upon N-CoR Ct overexpression. Mean of induction values were determined from one 
experiment done in triplicates. Results 
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Taken together, these results indicate that the N-CoR carboxyl terminal-half requires the 
amino-terminal domain to dissociate from activated receptors. The results support that Nt-
and Ct-regions may be adjacent and regulate each other. Therefore, the NonO and N-CoR 
amino-terminal interaction was tested in vitro. Indeed, TNT translated N-CoR-Nt (1-549) was 
pulled down by the GST-NonO amino-half containing the RRM motifs which also interacts 
with the N-CoR carboxy-terminus (Fig. 43). In addition the RRM1 fused to GST seems to be 
sufficient for this interaction. 
 
 
 
 
 
 
Figure 43: The N-CoR amino-terminus interacts with the GST-fused NonO-RRM1 domain 
GST-pulldowns were performed as previously described. Coomassie staining of the gel (lower panel) 
shows the amounts of fusion protein used for this assay. The input lane represents 10% of total 
35S-
labeled protein used in each interaction. The autoradiography (upper panel) of this experiment shows 
that GST-NonO Nt (1-237) retains 
35S N-CoR Nt (1-549) in contrast to GST-NonO Ct (255-472). 
Interestingly, GST-RRM1 (86-160) is sufficient to bind N-CoR Nt. No unspecific association with GST 
alone was observed.  
The RRM1 domain consists of 80 amino acids which are known to fold into a αβ sandwich 
(Maris et al. 2005). It is conceivable that the interaction with the N-CoR N-terminus or C-
terminus occurs within the same region of NonO without necessarily involving identical 
interacting surfaces. It is likely that NonO plays a regulatory role in the nuclear receptor-
dependent gene regulation, since it interacts with both N-CoR-Nt and -Ct regions that in turn 
may be engaged in intramolecular interaction and exert reciprocal regulation. Since the N-
CoR-Nt region which interacts with NonO contains two distinct domains, corresponding GST 
constructs were used in binding assays to assess which of both interacts with 
35S NonO full-
length. The GST fused repression domain I (RDI: 1-393) and the SANT domain containing 
SANT1 and SANT2 motifs (SANT 1/2: 435-683) were tested (Fig. 44). TNT-translated NonO 
preferentially bound to the SANT domain and an additional, although weaker, specific signal 
was obtained with the repression domain I. Interestingly, the SANT domain of N-CoR is a 
regulatory region in the N-CoR amino-terminus. The SANT1 motif was described to be 
involved in HDAC3 activation (Guenther et al. 2001) and in recruitment of SUMO ligases 
(Tiefenbach et al. 2006) whereas the SANT2 motif is involved in histone interaction and 
enhances N-CoR repressive activity (Yu et al. 2003). Whether there is a direct correlation 
between the effects observed in the RARE-reporter by exogenously expressing NonO and Results 
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the recruitment of SUMO ligases at the N-CoR SANT1 domain remains to be elucidated; 
however I performed RARE-reporter assays expressing exogenously Gam-1 which inhibits 
the SUMOylation pathway (Boggio et al. 2004) (Fig. 44).  
 
 
 
 
 
 
 
Figure 44: NonO interacts preferentially with the SANT1/2 domain within the N-CoR-Nt 
GST-pulldowns were performed as previously described. Coomassie staining of the gel (lower panel) 
shows the amounts of fusion protein used for this assay. The input lane represents 10% of total 
35S-
labeled protein used in each interaction. The autoradiography (upper panel) of this experiment shows 
that GST-NCoR SANT1/2 (435-683) retains strongly 
35S NonO full-length. Interaction is also observed 
with GST-N-CoR RDI (1-393) however to a lesser extend. No unspecific association with GST alone 
was observed.  
Surprisingly, similar effects as those obtained upon exogenous NonO expression were 
observed in the presence of Gam-1 (Fig. 45)(published in (Tiefenbach et al. 2006)).  
 
 
 
 
Figure 45: Effect of SUMO modifications in the regulation of RAR-dependent transcription 
0.5 µg RARE-reporter was cotransfected with Gam-1 expressing vector and SV40 internal control. 
Normalized luciferase activity (RLU) obtained upon stimulation is represented in percent. Left panel, in 
the presence of antagonist mix 193840 (100 nM) Gam-1 expression does not affect transcriptional 
repression. Middle panel, luciferase expression is enhanced in the presence of Gam-1. Right panel, 
inhibition of SUMOylation increases RAR-dependent transcription. Mean of induction values were 
determined from three experiments done in triplicates. 
Full repression induced by antagonist treatment was unchanged whereas in the absence of 
ligand and in the presence of agonist increased transcriptional activity was obtained in the 
presence of Gam-1. These observations suggest that post-translational modification such as 
SUMOylation can affect nuclear receptor-dependent transcription, particularly in the absence 
of ligand and in the presence of agonist. Whether NonO modulates N-CoR repressive Results 
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capacity by affecting SUMO-ligase recruitment, thereby reducing N-CoR nuclear receptor 
affinity or inhibiting SUMOylation of corepressors remains to be determined. Since lysine 
residues in the consensus ΨKXE sequence are subjected to SUMO conjugation NonO amino 
acid sequence was checked for potential sites (Fig. 46). 
 
 
 
 
 
 
 
Figure 46: NonO contains a SUMO-acceptor-site 
In the Sp|Q99K 48| NonO_Mouse coding sequence a potential SUMO-acceptor site was found that 
corresponds to the consensus SUMO-acceptor-site which consists of the sequence ΨKXE, where Ψ is 
a large hydrophobic residue, K is the lysine to which SUMO-1 is conjugated, X is any amino acid and 
E is glutamic acid. The potential SUMO acceptor site is in the RRM1 domain in the helix α2 folding 
region.  
Interestingly, a SUMO-acceptor-site was found in the RRM1 domain which is sufficient for 
NonO/N-CoR interaction in vitro. RRM is composed of one four stranded antiparallel β sheet 
and two α-helices packed against the β sheet (Fig. 40 s. discussion). Once conjugated with 
SUMO target lysine (K127) in the α helix 2 possibly affects the interaction capacity of the 
RNA recognition motif and may alter interaction between N-CoR and NonO. 
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4 Discussion 
The yeast-two-hybrid screening system is an efficient method to define new protein-protein 
interactions. When we screened the clontech mouse embryonic (e.17) library with the N-CoR 
extreme C-terminus (2290-2453) in AH109 Saccharomyces Cerevisae we found several 
interacting proteins that belong to various protein families (Ducasse 2002). From these 
potential interaction partners, only a subset was considered which could be directly linked to 
the transcription repressive activity of N-CoR. Other proteins which are involved in folding, 
degradation or protein localization and which play roles in the regulation of protein life span 
were not explored in detailed. Therefore, during my PhD. thesis, I further investigated 
selected proteins including C-terminal binding protein (CtBP), methyl-CpG binding domain-
containing protein 3 (MBD3) or ESET domain containing protein (ESET/SETDB1) which 
were recently discovered. At that time no precise function was described but these proteins 
were thought to be involved in transcriptional regulation or chromatin remodeling. Since 
transcription regulation and RNA processing was considered to be mechanistically coupled 
(Maniatis and Reed 2002) the non-POU-domain-containing octamer binding protein 
(NonO/p54nrb) was also considered as an interesting candidate. NonO belongs to the 
heterogeneous nuclear ribonucleo (hnRNP) -like proteins which were identified in 
transcriptional and spliceosomal complexes. 
For the CtBP, MBD3 and ESET proteins no in vivo interactions with N-CoR could be 
observed in co-immunprecipitation experiments. These results are concordant with new 
publications which support that these proteins do not directly interact with N-CoR. In 1995 
CtBP was discovered as the C-terminal domain of the human E1A adenovirus binding 
protein (Boyd et al. 1993) and a consensus sequence (PXDLS) was determined to be an 
essential motif for interaction with CtBP (Schaeper et al. 1995). This sequence was not found 
in N-CoR. Meanwhile a variety of promoter-specific transcription factors have been shown to 
interact with CtBP which regulates their activity (reviewed in (Chinnadurai 2002)). CtBP is 
now considered to play a widespread role in transcriptional repression in a histone 
deacetylase (HDAC)-dependent and independent manner (Kumar et al. 2004). New data 
suggest that CtBP can also repress transcription inhibiting CBP (CREB binding protein) 
histone acetyltransferase activity with which it interacts directly (Meloni et al. 2005). For the 
methyl CpG binding domain protein 3 (MBD3) which does not possess appreciable 
methylated DNA binding activity as other family members do, its function remains unclear. 
MBD proteins are thought to serve as the bridge between histone modificating enzymes 
(histone deacetylases, histone methyltransferases) and hypermethylated DNA which is the 
most common epigenetic modification of vertebrate genomes that is associated with 
transcriptional repression. However, it is crucial to mammalian development as MBD3  
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knockout mice fail to develop to term (Hendrich et al. 2001). It is now clear that MBD3 
assembles in a distinct MDB3 Mi-2 NURD like complex (nucleosome remodeling deacetylase 
complex). This complex is involved in ATP-dependent chromatin-remodeling either in a 
specifically targeted manner or upon constitutive association with chromatin (Li et al. 2002; 
Le Guezennec et al. 2006). Differences in MBD3 localization at the chromatin and cellular 
levels in lung cancer and normal cells were observed to lead to differential transcription and 
cancer-selective toxicity (Noh et al. 2005). When positive clones were analyzed out of the 
yeast-two-hybrid screen performed with the N-CoR C-terminus the ERG-associated protein 
containing a SET domain (ESET) was found as a potential N-CoR partner. A few months 
later, the full-length mouse cDNA was isolated by Yang L. et al. and was identified as the 
mouse homologue of the human SETDB1. This protein possesses evolutionarily conserved 
SET, preSET, and postSET domains implicated in histone methylation and was 
demonstrated to be a novel histone methyltransferase (Yang et al. 2002). ESET/SETDB1 
has been described to be recruited by MBD1 and the catalyzed histone H3-K9 methylation is 
heritably maintained through DNA replication to support the formation of stable 
heterochromatin at methylated DNA (Sarraf and Stancheva 2004). MBD1 predominantly
 
localizes to methylated DNA regions and recruits co-repressors
 and chromatin-associated 
factors. Recently, ESET/SETDB1 has been determined to belong to the histone di- tri-
methyltransferases that can be recruited by heterochromatin protein1 (HP1), which binds to 
methylated histones, to induce heterochromatin formation (Verschure et al. 2005).  
Interestingly, NonO was found to co-immunoprecipitate with overexpressed and endogenous 
N-CoR (Fig. 11; Fig. 12). Both, endogenous N-CoR and exogenous NonO, were visualized to 
co-localize in cell nuclei (Fig. 13) by confocal scanning microscopy. NonO is thought to be 
multifunctional, since it is found in several multiprotein complexes which are involved in 
different biological processes. The definite function of NonO however remains unclear. After 
confirming the interaction of N-CoR with NonO in vivo the aim of my work consisted in 
determining the biological relevance of this interaction. 
4.1  N-CoR interaction partner NonO is a multi-functional protein 
The deletion of an essential octamer motif contained in promoters and enhancers of 
immunoglobulin (Ig) genes results in a drastic reduction of Ig expression in B cells. This motif 
is recognized by a DNA binding motif, the POU domain (Herr et al. 1988). Looking for 
octamer binding factors that are involved in Ig expression regulation during early B-cell 
differentiation, Tucker et al. (Yang et al. 1993) isolated the non POU domain containing 
nuclear protein NonO (identical to the human p54nrb protein) that footprinted the octamer 
motif indistinguishably from Oct-2 a known Ig expression regulator in mature B cells. NonO 
was shown to bind polynucleotides, either RNA or single stranded DNA, via its ribonuclear  
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protein (RNP) binding motifs or double stranded DNA through a different region containing a 
helix turn helix domain followed by charged residues. Within NonO, there is a stretch of 10 
glutamine residues near the amino-terminus and a proline-rich region near the carboxy-
terminus. Both motifs are surrounding the POU domain in octamer binding factors. They are 
involved in protein-protein interactions within transcription initiation complexes and enhance 
transcriptional activation (Mitchell and Tjian 1989; Muller-Immergluck et al. 1990). Though, 
the role for NonO in Ig gene expression remains to be established it is meanwhile thought to 
be a multi-functional protein since it has been identified in complexes that operate in different 
cellular processes, including splicing and transcription.  
NonO contains 2 copies of the RNA recognition motif (RRM) which is one of the most 
abundant protein domains in eukaryotes. Since this motif was thought to be a common 
feature of splicing factors NonO was first categorized as a protein involved in RNA 
processing. Indeed it was found in splicing protein complexes (Lindsey et al. 1995). 
Subsequently, it was described to bind not only to single stranded RNA but as its homologue 
PSF (PTB-associated splicing factor) (Patton et al. 1993) to bind a conserved RNA 
secondary structure as the stem b1 in U5 snRNA (Peng et al. 2002). This small nuclear RNA 
molecule associated to protein U5 is an essential component of the spliceosome core 
(Stanford et al. 1988). In addition to the high homology of NonO and PSF especially in their 
RRM domain, both proteins share functional similarity and can heterodimerize. However, 
PSF is a larger protein than NonO and presents an extended amino-terminus. Both proteins 
were described to be involved in the maturation of pre-mRNA as well as being implicated in 
other RNA-related processes. They have been determined to play a role in retention of 
hyperedited RNAs in the nucleus (Zhang and Carmichael 2001). NonO was found to be a 
key player in cleavage/polyadenylation during pre-mRNA processing (Liang and Lutz 2006) 
and PSF to be able to down-regulate human immunodeficiency virus type 1 (HIV) mRNA 
after transcription (Zolotukhin et al. 2003). 
Besides its role in a number of steps in RNA metabolism, several reports suggest that NonO 
is involved in gene regulation through its binding to regulatory elements in promoter regions 
such as octamer motifs or enhancer elements (Basu et al. 1997). However, neither direct 
targeting of NonO to specific endogenous gene regulatory regions in vivo, nor the functional 
relevance of these interactions has been shown yet. Depending on the cell type that was 
observed NonO gene regulation varies (Lamb et al. 1992; Basu et al. 1997). Increase or 
decrease of NonO expression was observed in several cellular models and correlates with 
cell fate. For example, NonO gene transcription increases in response to prolactin stimulation 
in rat lymphoma cells (Too et al. 1998). Upon neuronal differentiation in P19 embryonal 
carcinoma cells NonO mRNA is decreased similar to some other general splicing factors  
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(Shinozaki et al. 1999). Additionally, in human breast cancer reduced expression of 
NonO/p54nrb or alteration of its protein structure in association with hERα expression was 
observed to contribute to tumor growth and progression (Pavao et al. 2001). In papillary renal 
cell carcinoma a defined X chromosome inversion results in the fusion of the almost 
complete NonO (p54nrb) to the TFE3 transcription factor DNA binding domain (Clark et al. 
1997). However, whether NonO chimeric protein expression that sequesters TFE3 to new 
localizations within the nucleus, leading to a TFE3 null phenotype, is sufficient to mediate 
transformation is still under debate (Mathur et al. 2003).  
Interestingly, NonO is thought to be involved in nucleic acid-protein complex formation and 
activation and was described to interact with a number of DNA or RNA-binding proteins 
(Yang et al. 1997). These nucleic acid binding proteins are involved in different but not 
completely unrelated cellular processes. For example Straub et al. suggested that the 
topoisomerase I DNA relaxation activity is enhanced by PSF and its smaller homologue 
p54nrb/NonO and that the recruitment of these factors was necessary to convert 
topoisomerase I to a true catalyst (Straub et al. 2000). Both, NonO and PSF were found to 
facilitate the association of RNA with the C-terminal domain (CTD) of RNA polymerase II (Pol 
II). This domain is tightly regulated by phosphorylation which is a determinant for the Pol II 
complex formation. NonO and PSF can interact at the CTD in both activated 
(hyperphosphorylated in the elongation phase) and inactivated state (hypophosphorylated in 
the transcription initiation phase) leading to the suggestion that these RRM binding proteins 
are the direct physical link between RNA polymerase and other pre-mRNA processing 
components during the initiation and elongation phases of transcription (Emili et al. 2002). 
More recently, it was shown that PSF in contrast to NonO does not only couple transcription 
to splicing but also stimulates pre-mRNA processing in a RNA pol II CTD-dependent manner 
(Rosonina et al. 2005).  
Publications about NonO and PSF interactions with transcription factors are increasing and 
some details about their function too. NonO can interact with DNA binding transcription 
factors such as SF1 (Sewer et al. 2002) or nuclear receptors such as retinoic X receptor 
(RXR), thyroid hormone receptor (TR) (Mathur et al. 2001), androgen receptor (AR) (Ishitani 
et al. 2003) and progesterone receptor (PR) (Dong et al. 2005). Class I and II nuclear 
receptors interact with NonO and PSF through their DNA binding domain (DBD) and 
interaction modulates their transcriptional activity. NonO potentiates AF-1 function of the AR 
(Ishitani et al. 2003) whereas PSF represses thyroid hormone receptor-dependent 
transcription interfering with receptor/DNA binding, and recruiting histone deacetylases 
through Sin3A interaction (Mathur et al. 2001). More recently, PSF was described to repress 
nuclear receptor dependent transcription inducing receptor degradation (Dong et al. 2005).  
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Since NonO and PSF show high homology mainly in their RRMs and less or no similarity in 
the C- and N-terminus, respectively it is likely that they differ in their functions. It is now 
believed that PSF and NonO in addition to their role in linking and coordinating transcription 
with pre-mRNA splicing are also involved in the regulation of gene expression. How multiple 
functions of NonO/p54nrb and PSF are regulated is not yet clear and several regulation 
mechanisms such as limiting protein level, post-translational modifications, nuclear 
sublocalization and RNA binding are under investigation. As other RNA-binding proteins 
such as RTA (Norris et al. 2002), SHARP (Shi et al. 2001) and GRIP120 (Eggert et al. 1997) 
have been shown to either coactivate or corepress nuclear receptor-dependent transcription 
it is likely that NonO is also involved in N-CoR-dependent transcriptional regulation. 
4.2  N-CoR and NonO are essential factors for cell viability 
At first Gal4-reporter assays were performed to examine if N-CoR transcriptional repression 
activity was affected by NonO overexpression. The transcriptional repression that is 
measured in this transiently transfected reporter is primarily due to the recruitment of N-CoR 
fused to the Gal4-DBD to the upstream activator sequence (UAS) in the promoter region 
together with the different associated proteins which are part of the corepressor complex. No 
unspecific effect was observed by expressing exogenous NonO at different concentrations 
with Gal4-DBD and the Gal4-reporter. In the presence of Gal-N-CoR full-length repression 
was about 20 fold relative to the basal reporter activity in the presence of Gal4-DBD alone 
and even at the highest NonO concentration this repressive activity remained unchanged 
(Fig. 15). Thus, we may conclude that NonO is not involved in N-CoR complex formation. 
However, to verify this hypothesis, specific NonO expression down-regulation experiments 
were required. Namely, endogenous NonO which is abundantly expressed in 293T cell could 
ensure N-CoR regulation. We therefore designed small interfering RNA targeting specifically 
NonO and its human homologue p54nrb mRNA. These corresponding oligonucleotides were 
synthesized and cloned successfully into the pSuper vector which was modified for this 
purpose.  
Interestingly, the target sequence (Si I: 487-508) which is contained in the middle of exon 5 
in a conserved region showing high similarity with a number of other protein coding 
sequences was inefficient. In contrast, the other sequence (Si II: 1246-1266) which targeted 
a part of the extreme end of exon 9 in a nonconserved region which does not code for any 
known motifs enhanced specific mRNA degradation. Si RNA that targeted sequences within 
a specific mRNA that shows low homology to other protein mRNA sequences may be more 
efficient. Since RNA transcripts are mainly associated with proteins during their lifespan, 
which are involved in RNA processing (splicing, nucleocytoplasmic transport, localization, 
stability, translation, and degradation), it is likely that designing small interfering RNA  
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considering not only the polynucleotide physical properties but also its position on the 
transcript may improve siRNA efficacy. 
Although efficient degradation of the NonO mRNA in 293T cells was obtained with the 
pSuper Si II construct, no efficient specific down-regulation of the protein was achieved (Fig. 
20). This is most likely due to the stability and the rather low turn-over rate of NonO which 
were examined in 293T cells. Levels of the NonO protein were in fact stable upon 24 h 
treatment with translation or proteasome inhibitor (Fig. 22). P. Tucker and collaborators 
observed similar phenomena in human cell lines stably transfected with a NonO antisense 
construct. In addition they observed that loss of colony growth after 6 to 10 days selection 
correlated with a very low level of NonO which induces senescence (Cells are blocked in the 
G0 phase of the cell cycle) (personal communication). This latter observation suggests that 
NonO is an essential factor for cell growth and division. However, for comparable induced 
mRNA degradation we observed that NonO full-length antisense was more toxic to cells than 
the presence of pSuper Si II expressing small interfering RNAs (Fig. 21). The toxic effect was 
confirmed testing expression of the internal control reporter SV40 in the presence of the 
antisense coding vector which showed impaired transcriptional activity (data not shown). 
However, to achieve significant down-regulation of protein expression double transfection 
experiments could be performed. Cells are transfected twice with the silencing vector 
sequentially (cell are passaged before second transfection) and by the second transfection 
reporter plasmids are added. Due to the essential role of NonO for cell viability this was not 
performed. In addition several observations indicate that the NonO/N-CoR interaction may be 
transient and the effect of efficient NonO knock down may not be directly correlated to N-
CoR.  
An initial observation indicated that although NonO and N-CoR specifically interacted in vivo, 
they did not systematically co-immunopricipitate even in the presence of exogenous protein, 
after crosslinking or addition of phosphatase inhibitors or RNase inhibitors, suggesting that 
defined cellular conditions are necessary for interactions. Moreover, the reverse 
immunoprecipitation showed that a large amount of NonO could be precipitated whereas 
only a small amount of N-CoR co-immunoprecipitated. Furthermore, in confocal scanning 
microscopy experiments, only partial colocalization of both endogenous proteins was 
visualized (data not shown). In transiently transfected Gal4-reporters NonO fused to the 
Gal4-DBD showed strong transcriptional repression that was not relieved upon HDAC 
inhibitor treatment. This suggests that Gal-NonO can recruit cofactors which inhibit initiation 
of transcription by the basal transcription machinery in a histone deacetylase-independent 
manner. It is thought that transiently transfected plasmids are partially bound to nucleosomes 
and thereby present chromatin-like structures. However, this partial chromatinization of  
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reporter plasmids renders them less sensitive to HDAC inhibitors such as valproic acid (VPA) 
or trichostatin A (TSA) than reporters integrated into the genome. Thus, it is difficult to 
distinguish in transient transfected reporters whether repression is rather due to co-factor 
recruitment than to post-translational modifications of histones. In addition it is possible that 
interaction of Gal-NonO with N-CoR, PSF and/or other factors would be sufficient to repress 
transcription of transiently transfected reporter plasmids. PSF was described to repress 
transcription by direct interaction with Sin3A (Mathur et al. 2001). Since PSF and NonO can 
heterodimerize we can not prove that Gal-NonO repression is exclusively due to the 
recruitment of N-CoR.  
To assess whether NonO influences post-translational histone modifications rather than co-
repressor complex assembly, HeLa cells stably transfected with the Gal4-reporter were used. 
Unfortunately, no Gal-N-CoR-dependent repression could be measured in this stable cell 
line. Namely, the luciferase basal transcription is quite high in the absence of Gal-N-CoR and 
synthesized luciferase is very stable. No significant reduction of the luciferase activity could 
be measured even after transfecting Gal-N-CoR with high transfection efficiency. 
Consequently, a HeLa cell line that was stably transfected with both Gal-N-CoR and the 
reporter was used in order to avoid high luciferase background activity. Regrettably, no 
conclusion could be drawn regarding the function of NonO in the regulation of the histone tail 
modifications with this double stable transfected cell line since it is resistant to additional 
transient transfection. This was concluded after testing several different transfection 
methods. 
As an alternative for investigating the function of NonO and N-CoR a stable cell line lacking 
N-CoR expression was required. A N-CoR knockout cell line was provided by Geoff 
Rosenfeld (University of California, San Diego). Its very low viability however limited its use 
for transfection experiments. The fact that N-CoR knockout mice are embryonic lethal and 
stable N-CoR down-regulation inhibits cell proliferation demonstrates that N-CoR is as NonO 
an essential factor for the cell. Therefore, no further experiments with the silencing vectors 
were performed and other strategies were required such as overexpression of NonO mutants 
to determine the biological significance of the NonO/N-CoR interaction.  
4.3  NonO modulates the repression capacity of N-CoR 
The NonO N-terminal half which contains two RNA recognition motifs (RRM) was determined 
to be sufficient for the interaction with the N-CoR carboxy-terminus in GST-pulldown assays 
(Fig. 23). Interestingly, these domains are also present in the SHARP protein (SMRT/HDAC1 
Associated Repressor Protein) that was found to interact with SMRT C-terminus in a yeast-
two-hybrid screen (Shi et al. 2001). The RNA recognition motif was first thought to be a 
simple rigid RNA binding domain. However, an increasing number of structures determined  
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by NMR and X-ray crystallography revealed unexpected structural variations correlated to 
primary and secondary structure changes. In addition, more recent work supports that this 
domain can also be involved in protein-protein interaction. The structure and the main 
consensus sequences (RNP1 and RNP2) of the approximately 90 amino acids domain were 
determined in the late 1980s (Adam et al. 1986) (Dreyfuss et al. 1988) and the first crystal 
structure of the RRM domain of the U1 small nuclear ribonucleoprotein A (snRNP) was 
solved in 1990 shedding light on a typical αβ sandwich structure with a specific β1α1β2β3α2β4 
topology (Nagai et al. 1990) (Fig. 47). The high plasticity of this domain ensures high RNA-
binding affinity and specificity that is not necessarily linked to a specific RNA sequence since 
RNA secondary structure can be required for binding. In addition although the small compact 
domain is a central component of RNA recognition it is not the only determinant. N- and C-
terminal extensions, multiplication of the RRM domains or protein cofactors can play an 
important role in the RNA binding specificity. These surrounding regions are often crucial in 
enhancing or inhibiting RNA binding (reviewed in (Maris et al. 2005)). However, additional 
biochemical and structural studies are required to elaborate a more comprehensive picture of 
this domain and its role in the cell. 
 
 
 
 
 
Figure 47: hnRNP A1 RNA recognition motif 2 
A typical  RRM fold in the hnRNP A1 (Xu et al. 1997). Figure out of (Maris et al. 2005) review. The 
RRM folds into an αβ sandwich structure composed of one four-stranded antiparallel β-sheet spatially 
arranged in the β4β1β3β2 from left to right when facing the sheet and two α-helices (α1 and α2) packed 
against the β-sheet. 
Involvement of the RRMs in protein-protein interactions was also reported. Three 
distinguished cases have been described: between two RRM motifs within a protein, 
between RRM motifs of distinct proteins which are capable of RNA binding or not. Criteria 
which allow the distinction of RRM domains that are true RNA-binders from those that are 
not, remain to be defined. It is still not clear if RNA binding is required for specific protein 
recognition or whether these functions are mutually exclusive. Recent work supports that the 
RRM can be engaged concomitantly in RNA and protein binding. For the CBP20 subunit of 
the cap-binding protein complex, it was shown that the RRM domain becomes structured 
only when it is in a complex with both RNA and a non-RRM interaction partner (Calero et al.  
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2002). In addition new data about the La protein support that this protein does not use the 
typical binding surface of the RRM for RNA recognition, leaving this surface potentially 
available to bind other ligands, such as DNA and/or proteins (Maraia and Bayfield 2006). In 
this regard considering that RNA binding may play a role in the N-CoR/NonO interaction, co-
immmunoprecipitation experiments were performed in the presence of RNAse inhibitors and 
conditions suitable for RNA stability. However, these conditions did not enhance association 
of NonO with N-CoR (data not shown) and since required RNA may be present in the in vitro 
transcription/translation reaction and in the GST-pulldown assays one can not exclude that 
RNA plays a role in NonO/N-CoR binding. Alternatively, it is also conceivable that NonO is 
usually associated in other complexes in a RNA-dependent manner and only a fraction of 
free NonO interacts with N-CoR. It would have been interesting to perform RNase digestion 
in cell lysate prior to immunoprecipitation experiments to verify if released NonO interacts 
more strongly with N-CoR. This experiment remains to be done since it was thought that 
RNA is rapidly degraded in lysates in the absence of RNase inhibitor and it was not 
considered that RNA digestion could be required for dissociation of RNA-dependent protein 
complexes.  
The RRMs of the coactivator CoAA were described to play a major role in the regulation of 
reporter transcriptional activity (Auboeuf et al. 2004) and that these domains are not only 
involved in RNA recognition but also in protein-protein interaction. Therefore, two NonO 
deletion mutants were constructed that lack RRM1 (aa: 86-160) and RRM2 (aa: 160-227), 
respectively. In vitro, the RRM1 domain was determined to be essential and sufficient for 
NonO/N-CoR interaction in contrast to the RRM2 motif, the deletion of which did not impair 
the binding of 
35S N-CoR Ct (1629-2543) to the GST fused NonO ΔRRM2 (Fig. 26). Nuclear 
localization signals of the NonO protein were predicted downstream of the deleted regions, 
however domain deletion can result in protein misfolding that in turn buries localization 
signals. Therefore, cellular localization of the mutated mutants was verified. Western blot 
analysis of cytoplasmic and nuclear fractions of 293T cells transfected with vectors 
expressing deletion mutants confirmed that NonO ΔRRM1 and NonO ΔRRM2 localized in the 
nucleus (Fig. 27). Cell cycle phase-dependent NonO posttranslational modifications (Proteau 
et al. 2005) were also verified. It seemed that this was impaired in NonO ΔRRM2 but not in 
the NonO ΔRRM1 mutant (Fig. 30). Both constructs were then cotransfected with the Gal4-
reporter and Gal-N-CoR expressing vector in 293T cells. Interestingly, significant effects 
occurred in the presence of the RRM deleted mutants in contrast to NonO wild type. The 
NonO ΔRRM1 expression strongly enhanced the fold repression of Gal-N-CoR full-length in 
a dose-dependent manner. In contrast NonO ΔRRM2 enhanced repression only at the 
highest concentration, however to a lesser extent then NonO ΔRRM1 (Fig. 31). These results  
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were unexpected since the deletion of RRM1 correlated with a loss of interaction with N-
CoR-Ct in vitro. Nevertheless, these first results showing that NonO deletion mutants are 
able to impair Gal-N-CoR-dependent repression support the hypothesis that NonO is 
involved in the regulation of N-CoR transcriptional repression activity. Thus, from this 
reporter assay it was concluded that NonO has a modulator role in the N-CoR transcriptional 
repression which is impaired upon overexpression of the deletion mutants. Consequently, 
these effects were verified in a nuclear receptor-dependent reporter assay. 
NonO/p54nrb was shown to activate transcription in MMTV-luc reporter (containing the 
mouse mammary tumor virus promoter that can be activated by glucocorticoid and 
progesterone receptors) in the presence of progesterone receptors upon progesterone 
simulation. Auboeuf et al. could also show that NonO can activate transcription in a 
promoter-specific and nuclear receptor-dependent manner (Auboeuf et al. 2004). For our 
experiments a retinoic acid receptor (RAR)-dependent reporter was used. The luciferase 
expression was under the control of RAR response elements (RARE) that are contained in 
the promoter region. Retinoic acid receptor and heterodimer retinoic X receptor (RXR) are 
class II receptors which reside in the nucleus and can bind to specific cognate DNA 
sequences in the absence of ligand. Since RAR/RXR can recruit corepressors such as N-
CoR or SMRT in their unliganded form and in the presence of antagonist, three different 
states of transcriptional regulation were considered. In the RARE-reporter assay transcription 
activation is enhanced in the presence of RAR agonist (all-trans retinoic acid ATRA), partial 
repression is obtained in the absence of ligand and full repression of transcription is 
enhanced in the presence of antagonist (Fig. 48).  
 
 
 
 
 
Figure 48: Nuclear receptor-dependent transcription regulation 
Agonist binding induces conformational change to nuclear receptors that result in the exposition of the 
coactivator binding surface. Corepressor can directly facilitate the conversion of receptor from the holo 
(active) form to apo (repressive) form. Class II receptor and especially RAR/RXR receptor heterodimer 
reside in the nucleus, bind to response element and recruit corepressors in absence of ligand. This 
repression state is the partial repression distinguished from the full repression in the presence of 
antagonist.   
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Thus, in 293T cells endogenously expressing RAR, RXR and N-CoR, reporter and NonO 
versus deletion mutant expression plasmids remained to be transfected. In contrast to the 
Gal4-reporter, RARE-reporter activity was affected upon NonO wild type overexpression. 
Enhanced transcriptional activity was observed particularly in the absence of ligand or in the 
presence of agonist but not in the presence of antagonist. The main difference between the 
RARE and the Gal4-reporter is the recruitment of N-CoR to the promoter region. In the 
RARE-reporter N-CoR recruitment is RAR-dependent suggesting that NonO is involved in 
the regulation of transcriptional repression in a receptor-dependent manner.  
The past model postulated that ligand-bound nuclear receptors are associated with 
coactivators and unliganded nuclear receptors with corepressors (Schulman et al. 1996). 
Indeed, dramatic conformational changes occur in the ligand binding domain in the presence 
of ligands and are determinants for cofactor association. However, it was recently shown that 
ligand binding stabilizes the activated liganded (holo) receptor structure, and that 
corepressor binding also stabilizes the unliganded (apo) receptor structure (Pissios et al. 
2000). Furthermore, Sohn et al. propose that nuclear receptors are in dynamic equilibrium 
between apo- and holo-states and that both ligand and corepressor binding are the driving 
forces (Sohn et al. 2003). According to the latter model and the observation that NonO 
slightly enhanced basal and activated transcription but not full repression, it is conceivable 
that NonO reduces corepressor binding to nuclear receptors in the absence of ligand. This 
could explain why exogenous NonO expression did not affect Gal-N-CoR full-length 
repression activity in the Gal4-reporter assay where the recruitment of N-CoR to the 
promoter region is tethered by the Gal4-DBD fusion. Thus, we conclude that NonO rather 
plays a role in the equilibrium between nuclear receptors bound to coactivators or 
corepressors than in the full repression in the presence of antagonist. This hypothesis is 
supported by the results which were obtained in the presence of NonO RRM deletion 
mutants in both reporter assays.  
Using the Gal4-reporter, NonO ΔRRM2 enhanced repression only at the highest 
concentration (0.5µg) though, to a lesser extent than NonO ΔRRM1 did (Fig.31). In contrast, 
in the RARE-reporter NonO ΔRRM2 ectopic expression enhanced transcription activity by 
about 30% in the absence of ligand and in the presence of agonist or antagonist whereas 
NonO  ΔRRM1 expression did not (Fig. 37; Fig. 38). These results suggest that NonO 
ΔRRM2 which can still interact with N-CoR is able to impair nuclear receptor-dependent 
transcription in a ligand-independent manner. This suggests that this mutant may impede not 
only the recruitment of corepressors to the promoter region by nuclear receptors but also 
reduces the corepressors capability to compete with coactivators for binding to nuclear 
receptors. This hypothesis would be consistent with both reporter assay results for 
comparable concentration (0.2µg) and with the results obtained by endogenous RAR- 
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responsive gene analyses. In a semi-quantitative PCR analysis of the endogenous RARβ 
gene activated transcription is slightly enhanced in the presence of NonO ΔRRM2 (Fig. 39). 
Since the deletion of the RRM2 domain in PSF was correlated with impaired subnuclear 
localization (Dye and Patton 2001) further investigations would be necessary to elucidate the 
exact underlying molecular mechanism of the NonO ΔRRM2 induced effect. In cell 
synchronization experiments NonO ΔRRM2 posttranslational modification seemed to be 
impaired as the protein level of endogenous N-CoR. It is therefore conceivable that NonO 
ΔRRM2 induced incorrect N-CoR subnuclear localization or a decrease of the N-CoR protein 
level which would produce similar results.  
For NonO ΔRRM1, according to the hypothesis that this mutant competes with endogenous 
NonO for cofactor binding but not for N-CoR interaction similar effects were obtained in the 
RAR-dependent reporter as with exogenous wild type NonO expression (Fig. 37; Fig. 38). 
Interestingly, NonO ΔRRM1 fused to the Gal4-DBD showed repression as strong as that 
obtained with Gal-DBD-NonO wild type in the Gal4-reporter (data not shown). This indicates 
that the RRM1 deletion mutant is able to recruit cofactors comparably to NonO wild type and 
reinforces the assumption that the observed repression is rather due to promoter occupancy 
than corepressor recruitment. Unexpectedly, NonO ΔRRM1 mutant enhanced Gal-N-CoR 
repression in a dose-dependent manner in the Gal4-reporter although deletion of the RRM1 
motif abrogates interaction between NonO and N-CoR in vitro. This suggests that NonO and 
other factors may be involved in the regulation of N-CoR activity. It is likely that the enhanced 
Gal-N-CoR repression results from the squelching of NonO cofactors by the NonO ΔRRM1 
mutant impairing endogenous NonO-dependent modulation of N-CoR activity. However, this 
effect was not observed in the RAR-dependent reporter. It is conceivable that NonO ΔRRM1-
dependent squelching effect differs in the RARE-reporter assay in which N-CoR recruitment 
and repression capacity is nuclear receptor-dependent. Interaction-dependent 
conformational changes that may stabilize association of N-CoR with NonO and its cofactors 
may come into play in the presence of nuclear receptors and would differ from that with N-
CoR fused to the Gal4-DBD. Considering the results obtained with NonO ΔRRM1 in both 
reporters, NonO not only seems to affect N-CoR association with nuclear receptors but also 
to regulate the capacity of N-CoR to repress transcription. Whether this regulation results 
from competition between NonO and other N-CoR cofactors to interact with N-CoR, 
interaction-induced conformational changes or altered N-CoR post-translational modifications 
is unclear. 
4.4  N-CoR amino- and carboxy-termini regulate each other 
Whereas the repression domains are contained in N-CoR amino-terminal half the nuclear 
receptor binding sites are carboxyl terminal. Interestingly, although the N-CoR C-terminus 
does not retain repressive activity it contains additional binding sites for proteins which are 
mainly interacting in the N-CoR amino-terminus, such as mSin3A and HDAC3 (Li et al. 2000; 
Wen et al. 2000) which are critical components of the N-CoR corepressor complex. This 
latter observation suggests that the N- and C-terminal ends may be in close proximity in the  
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tertiary protein conformation. Indeed, in GST-pulldown experiments the N-CoR N-terminus 
interacts with the C-terminal domain (Fig. 40). Since NonO was found to interact with the C-
terminus of N-CoR, it was verified in vitro whether it can either interact with the N-terminus. 
Indeed, GST-fused NonO retains TNT translated N-CoR Nt (1-549) and the RRM1 domain is 
essential and sufficient for this interaction (Fig. 43). Since the N-CoR amino acid sequence 
1-549 contains the repression domain I (RDI) and a part of the SANT domain, in vitro binding 
assays were performed to assess which region is involved in the interaction with NonO. In 
these experiments TNT translated full-length NonO strongly interacts with the GST fused 
SANT 1/2 domain, suggesting that it can interact with this regulatory region which recruits 
SUMOylation enzymes and HDAC3. However, interaction between the SANT domain and 
NonO was not found in the yeast-two-hybrid screen that was performed by Jens Tiefenbach 
with the N-CoR region containing SANT 1 and 2 (Tiefenbach 2003 August). These 
interesting findings led us to ask how NonO binding can affect N-CoR repressive activity. Our 
results and some published data suggest that N-CoR N- and C-termini are involved in 
intramolecular interactions and regulate each other. In a Gal-4 reporter assay (Tiefenbach et 
al. 2006) (Fig. 41) Gal-N-CoR N-terminus showed greater repression activity than Gal-N-CoR 
full-length although it contains only one out of three repression domains (RDI) and lacks the 
C-terminal half containing the NR interacting domain (NID). This observation is surprising 
since one would expect that the full-length platform protein N-CoR may repress more 
efficiently than the amino-terminal moiety, forming a larger and more stable corepressor 
complex at the promoter unless the C-terminal part is regulating repression capacity of the N-
terminus. In addition, Li et al. showed, with an assay established by Wong J. (1998) to 
analyze transcription of microinjected DNA in Xenopus oocytes, that TR/RXR unliganded 
repression could be relieved by injection of αN-CoR purified antibodies that recognized the 
C-terminus in contrast to injections of N-CoR-N-terminal directed antibodies (Li et al. 2000). 
This indicates that this region may be either more accessible and/or plays a regulatory role. 
We show in a reciprocal manner that exogenous expression of the N-CoR Ct (1587-2453) 
affects transcriptional regulation of the RARE-reporter assay (Fig. 42).  
Unexpectedly, the N-CoR C-terminal moiety which retains no repressive activity inhibited 
transcription activation of the RARE-reporter upon agonist treatment and reduced basal 
transcription in the absence of ligand. In contrast, in the presence of antagonist full 
repression was not affected. These results point out that there are differences between 
transcriptional repression mediated by unliganded nuclear receptors and antagonist bound 
receptors. Supposing that the N-CoR-Ct is able to associate in an unregulated manner with 
nuclear receptors, dissociation of N-CoR Ct enhanced by conformational changes in the 
ligand binding domain (LBD) upon agonist treatment may be impaired. This could explain the 
reduced transcriptional activation that is obtained in the presence of N-CoR Ct (Fig. 42 B). 
However; this would not explain the enhanced repression that is obtained in the absence of 
ligand (Fig. 42 A). The latter observation supports that regulation of endogenous N-CoR 
repressive activity and its dissociation from activated nuclear receptors is impaired in the 
presence of the overexpressed C-terminal moiety. It is conceivable that the observed effects  
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result from squelching of regulatory factors considering the conserved extreme carboxy-
terminal region of N-CoR as a docking surface for modulators. Interactions within this region 
with factors such as NonO may play a determinant role in the regulation of N-CoR and its 
nuclear receptor-dependent recruitment. It is possible that NonO, which is found in several 
down stream events of nuclear receptor transcription activation such as RNA polymerase II 
initiation complex, elongation complex, splicesome and polyadenylation takes alsopart in 
earlier events such as nuclear receptor activation, corepressor dissociation and/or 
coactivator association.  
4.5  Biological relevance of the interaction of NonO with N-CoR 
N-CoR is a platform protein which is essential for the recruitment of the corepressor complex 
to promoter regions by unliganded or antagonist-bound class II nuclear receptors. Its 
repressive activity is mainly due to the recruitment of HDACs which modify histone tails and 
thereby promote a more condensed chromatin structure which is in turn less accessible to 
transcription factors and the transcription machinery. However, recent publications challenge 
whether the repressive activity of N-CoR is limited to the deacetylation of histone amino tails. 
It was shown that the SANT domain surrounded by the repression domains in the amino-
terminal region of N-CoR is involved in the activation of HDAC3 which directly interacts with 
N-CoR (Guenther et al. 2001). This domain was more recently shown to recruit SUMO E2 
and E3 ligases, and N-CoR SUMO modification contributes to repression by N-CoR 
(Tiefenbach et al. 2006). A number of recent publications report that SUMO modifications of 
transcription factors, corepressors, HDACs and histones mainly enhance their repressive 
activity whereas SUMOylation of coactivators reduces their activating capacity (reviewed in 
(Girdwood et al. 2004; Gill 2005; Minucci and Pelicci 2006)). It is conceivable that HDACs 
may deacetylate nonhistone substrates such as SUMOylation enzymes recruited to the 
corepressor complex and may thus be involved in the regulation of the transcriptional activity 
of transcription factors and coregulators. Together this suggests that N-CoR could be 
involved in the regulation of the activity of transcription coregulators in addition to the 
recruitment of histone deacetylases. According to my data, NonO seems to enhance 
RAR/RXR transcriptional activation capacity by affecting N-CoR binding to nuclear receptors. 
This may correlate to the inhibition of N-CoR conformational changes or post-translational 
modifications that favor N-CoR to interact with unliganded nuclear receptors and to compete 
with coactivators at agonist bound nuclear receptors. Postulating that N-CoR modulates 
coregulator activity, NonO interaction with N-CoR may affect either N-CoR association with 
modifying enzymes or the modification by deacetylation and SUMOylation of transcription 
factors.  
Interestingly, NonO contains a potential SUMO site in the α helix 2 (α2) packed against the 
RRM1  β-sheet (Fig. 46). The potential SUMOylated lysine residue is conserved in its  
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homologue PSF (polypyrimidine tract-binding protein-associated splicing factor). PSF was 
identified as a putative SUMO substrate by proteomics studies (Rosas-Acosta et al. 2005) 
and more recently PSF corepressor activity was correlated to its SUMOylation-dependent 
recruitment of HDAC1 (Zhong et al. 2006). These reports strongly suggest that NonO can be 
conjugated to SUMO and that its function could be modulated by this posttranslational 
modification. Unfortunately, whether NonO is SUMOylated and if this modification alters 
NonO/N-CoR interaction was not determined during my thesis. However, results obtained in 
RARE-reporter assays upon NonO wild type expression were similar to those obtained in the 
presence of Gam-1. Gam-1 is an adenoviral protein, the expression of which leads to the 
general inhibition of SUMOylation in the cell (Boggio et al. 2004) and not exclusively SUMO 
E2 and E3-ligases that are recruited by N-CoR. Inhibiting SUMOylation pathways affected 
TR and RAR-dependent transcriptional regulation in transient reporter assays (Fig. 45) 
(published in (Tiefenbach et al. 2006)). In the presence of Gam-1 enhanced transcriptional 
activation of both TRE and RARE-reporters was observed as well as reduced repression in 
the absence of ligand. In contrast, inhibition of SUMOylation did not affect full repression 
upon antagonist treatment in the RARE-reporter. These results support that SUMOylation 
plays an important role in the nuclear receptor-dependent transcription regulation but seems 
not essential for full repression. Whether there is a direct correlation between NonO-
dependent modulation of N-CoR and SUMOylation remains to be established. 
Although further investigations are required to support the proposed mechanism one can 
speculate that NonO interacts with the extreme carboxy-terminus of N-CoR independently of 
the recruitment of corepressors or modifying enzymes that occurs at the amino-terminus. 
This interaction may in turn enhance stabilization of N-CoR in a less repressive conformation 
for example with a reduced affinity to nuclear receptors. It is also conceivable that NonO 
interaction reduces the activity of SUMOylation enzymes and/or recruitment by N-CoR to the 
promoter. Whether these are the mechanisms by which NonO regulates N-CoR has to be 
confirmed; nevertheless our findings suggest that the RRM containing protein NonO is 
involved in the fine-tuning of receptor-dependent transcription modulating N-CoR repressive 
capacity. The C-terminus of N-CoR is likely a regulatory region that regulates repressive 
activity at the N-CoR N-terminus. This region may be comparable to a sensor that evaluates 
the ratio of corepressors and coactivators in the nuclear receptor environment. For class II 
nuclear receptors (TR; RAR), their binding to DNA in the absence of ligand enables 
transcriptional repression and a rapid answer to ligand stimulation. Their presence at the 
promoter ensures an appropriate limitation to responsiveness which is not only influenced by 
the concentration of ligand but also availability and state of activation of transcription 
coregulators. The disposal of coregulators depends on the cell context, cell differentiation 
states or cell type. Auboeuf et al. have shown that the concentration of coregulators can be  
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critical for mRNA processing decisions in a nuclear receptor and promoter-dependent 
manner (Auboeuf et al. 2002). The recruitment of both, transcription and splicing factors by 
nuclear receptors is essential to ensure coordination between RNA synthesis and the nature 
of the final product. In a comparable manner, it is possible that N-CoR recruitment by nuclear 
receptors is not only determined by the ligand-induced conformational changes in the ligand 
binding domain but is also influenced by the local concentration of transcriptional 
coregulators. NonO could belong to such factors whose accumulation at the promoter would 
enhance nuclear receptor sensitivity to stimulation and reduce N-CoR repressive activity; 
whereas a decrease of NonO local concentration would favor corepressors to compete and 
draw back the nuclear receptor to its apo form (Fig. 49). The variation of the local 
concentration of coregulators such as NonO that are involved in events downstream of 
nuclear receptor activation associating with Pol II complex, spliceosome and polyadenylation 
complexes and affecting corepressor recruitment is a realistic mechanism to coordinate the 
amount and the quality of transcribed RNA in response to stimulation intensity and cell 
context.  
 
 
 
 
 
 
 
 
 
Figure 49: N-CoR repressive activity is modulated by NonO 
Upon agonist binding, nuclear receptors recruit coactivators that decondense chromatin in the 
promoter region and render DNA accessible to the basal transcription machinery. 1) High local 
concentrations of modulating factors such as NonO may maintain N-CoR in a repressive conformation 
that cannot bind to NR in an active form (holo). 2) Decrease of NonO concentration that is involved in 
the transcription initiation complex formation and further downstream events enables N-CoR to adopt 
a conformation that favours N-CoR binding to NR and 3) enhances its capability to stabilize NR in an 
inactive form (Apo).  
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In the last decade the understanding of mechanisms which are involved in gene regulation 
tremendously increased. The sophistication and development of techniques have greatly 
contributed to this new picture. The initial proposed rigid chromatin structure has turned out 
to be a highly dynamic structure constituted of nucleosomes that have an inherent capacity 
to breathe (reviewed in (Mellor 2005)). It is now clear that a series of ordered events is 
required to activate or repress transcription and this is in part regulated by the chromatin 
structure. In euchromatin, discovery of reversible histone post-translational modifications and 
their combination that dictate the sequential recruitment of subsequent transcriptional factors, 
has increased the complexity of the information contained in chromatin. Moreover, 
unexpected layers of regulation in the molecular events were discovered. The capacity of 
nuclear receptors to switch from transcriptional repression to activation can be modulated 
suggesting that nuclear receptors are not only able to respond to hormonal stimulation, but 
integrate information from a large variety of external stimuli to achieve specific profiles of 
gene expression (reviewed in (Perissi and Rosenfeld 2005; Rosenfeld et al. 2006)). 
Furthermore, a number of studies provided evidence that distinct processes that were 
thought to operate sequentially and independently such as transcription and splicing are 
actually physically and functionally linked. RNA Polymerase II is now considered as a main 
player in the orchestration of transcription and RNA processing (reviewed in (Hirose and 
Manley 2000)). The carboxy-terminal domain (CTD) of RNA polymerase II (pol II) plays an 
important role in coupling transcription with precursor messenger RNA (pre-mRNA) 
processing. Efficient capping, splicing, and 3'-end cleavage of pre-mRNA depend on the 
CTD. Moreover, specific processing factors are known to associate with this structure 
(Rosonina and Blencowe 2004). However, it has been shown that promoter type and 
assembly of transcription coregulators in this region are also decisive in splicing events. 
Splicing factors or related proteins were first found to associate with the Pol II complex 
before the functional coupling of transcription and splicing was understood. In this work, I 
could show that NonO, a RRM containing protein, is able to interact with N-CoR and 
modulate its repressive capacity. Taken together, the results presented here combined with 
several recent studies indicate that the observed interactions are not the consequence of 
cotranscriptional splicing but point out a supplementary unexpected level of regulation in the 
control of gene expression. 
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6 Abbreviations 
 
aa       amino  acid(s) 
Ab       antibody 
AAV       adeno-associated  virus 
Ab       antibody 
ADA       adenosine  deaminase 
APC       antigen  presenting  cell 
APL       acute  promyelocytic  leukemia 
APS       ammoniumperoxysulfate 
ATCC       American  type  culture  collection 
ATP       adenosinetriphosphate 
ATRA       all-trans  retinoic  acid 
bp       base  pair(s) 
BSA       bovine  serum  albumin 
cDNA       complementary  DNA 
CHIP       chromatin  immunoprecipitation 
CtBP       C-terminal  binding  protein 
CTD       C-terminal  domain 
DBD       DNA-binding  domain 
DMEM       Dulbecco’s  modified  Eagle’s  medium 
DMSO       dimethylsulfoxide 
DNA       desoxyribonucleic  acid 
ds       double-stranded 
D T T        d i t h i o t h r e i t o l  
ECL       enhanced  chemiluminescence 
E. coli       Escherichia coli 
EDTA       ethylenediaminetetraacetic  acid 
EGF       epidermal  growth  factor 
EGFR       epidermal  growth  factor  receptor 
EGFP       enhanced  green  fluorescent  protein 
ER       estrogen  receptor 
ERE       estrogen  receptor  response  element 
FCS       fetal  calf  serum 
Fig       figure 
FITC       fluoresceinisothiocyanate 
FL       full-length 
F P L C        F a s t   P e r f o r mance Liquid Chromatography 
FRAP       fluorescence  recovery  after  photobleaching 
Fw       forward  primer 
g       gravity 
GST       glutathione-S-transferase 
h       hour 
HAT       histone  acetyltransferase/  acetylase 
HDAC       histone  deacetylase 
HRP       horseradish  peroxidase 
Ig       immunoglobulin 
Ip       immunoprecipitation 
IPTG       isopropyl-β-D-thiogalactopyranoside 
kDa       kilodalton 
M        M o l a r  
MCS       multiple  cloning  site 
MBD3       methyl-CpG  binding  domain-containing  protein3 
min       minute 
mM       milimolar 
M O P S        4 - m o r p h o l i n epropanesulfonic acid 
m R N A        m e s s e n g e r   R N A  Abbreviations 
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M W        m o l e c u l a r   w e i g h t  
N-CoR       nuclear  receptor  corepressor 
NLS       nuclear  localization  sequence 
NonO       non-POU-domain-containing  octamer  binding  protein 
NR       Nuclear  receptor 
Nucl       nucleotide 
OD       optical  density 
ORF       open  reading  frame 
PAGE       polyacrylamide  gelelectrophoresis 
PBS       phosphate  buffered  saline 
PCR       polymerase  chain  reaction 
PEG       polyethyleneglycol 
PEI       polyethyleneimine 
PKA       protein  kinase  A 
PKC       protein  kinase  C 
PLC       Phospholipase  C 
PMSF       phenyl-methyl-sulfonylfluoride 
Pol  II       RNA  polymerase  II 
PSF       PTB-associated  splicing  factor 
PTB       polypyrimidine  trac  binding  protein 
R        r e l e a s e  
RAR       retinoic  acid  receptor   
RARE       retinoic  acid  receptor  response  element 
RE       response  element 
Rev       riverse  primer 
RNA       ribonucleic  acid 
RNP       ribonucleoprotein 
rpm       revolutions  per  minute 
RRM       RNA  recognition  motif 
r R N A        r i b o s o m a l   R N A  
RT       room  temperature 
RXR       retinoid  X  receptor 
s       seconds 
SANT-domain      SWI,  ADA2, N-CoR and TFIIIB-domain 
S.cervisiae      Saccharomyces  cerevisiae 
SDM       site  directed  mutagenesis 
SDS       sodium  dodecylsulfate 
siRNA       small  interference  RNA 
SMRT            silencing mediator of retinoic and thyroid receptor 
snRNP       small  nuclear  ribonucleoprotein 
SUMO       small  ubiquitin-related  modifier 
SV40       simian  virus  40 
T        t h y m i d i n e  
TAE       Tris-buffered  saline 
TBL1       transducin  (beta)-like  protein 
TEMED       N,N’-tetramethyl-ethylene-diamine 
T K        t h y m i d i n e   k i n a s e  
T/N       thymidine  nocodazole 
TR       Thyroid  hormone  receptor 
Tris       tris(hydroxymethyl)-amino-methane 
TSA       trichostatine  A 
UAS       upstream  activating  sequence 
UV       ultra  violet 
VPA       valproic  acid 
v / v        v o l u m e / v o l u m e  
WB       Western  Blot 
w/v       weight/volume  
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